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Abstract in English 
Infectious diseases are a major cause of morbidity and mortality worldwide. This problem is not as 
predominant in industrialized countries due to improved sanitation, food availability, health care 
systems and treatment strategies (including vaccines and antimicrobial therapy). Infections are, 
however, still problematic, not only to the infected patients, but to the society at large due to the 
socioeconomic costs. The continued problems caused by microorganisms despite the advent of 
antimicrobial treatments are both due to emergence of multi-resistant microorganisms, but also 
because microorganisms can employ a biofilm strategy. Biofilm formation is increasingly being 
linked to chronic infections, where the biofilm matrix enables the microorganisms to persist despite 
immune response and antimicrobial therapy. Further adding to the problems in handling infections is 
the realization that the culture-dependent methods employed for decades to identify the causative 
pathogens may have some insufficiencies. 
The purpose of this PhD study has been to evaluate if alternative methods to culture-dependent 
techniques could be used to investigate the microbial communities in infections and provide 
clinically relevant information within a short period of time. 
The usefulness of various alternative methods (including molecular methods and microcopy-based 
visualization) was evaluated based on testing of samples from patients suffering from selected acute 
and chronic infections. Acute infections were exemplified by necrotizing soft tissue infections 
(NSTIs), and chronic infections were exemplified by infections of the lungs and sinuses of cystic 
fibrosis (CF) patients, chronic venous leg ulcers and prosthetic joints. 
A general finding of this thesis was that molecular methods identified additional microorganisms 
compared to the findings by culture. It was, however, also found that various molecular methods 
might give different results, indicating that the further studies are warranted to determine the ultimate 
method for identification of microorganisms in clinical samples. 
In NSTIs the added value of using molecular methods were particularly found in the ability to 
identify microorganisms in samples obtained from patients where administration of antimicrobial 
agents might result in false-negative results by culture-dependent methods. Furthermore, since the 
disease is both fulminant and potentially lethal, the reduced turnaround time that can be obtained by 
some molecular methods might make the use of such methods highly relevant. 
Investigations of samples from CF patients in this PhD project have added to the knowledge of the 
infections that afflict this patient group. Lung infections are the primary cause of premature deaths of 
the patients and investigation of microbial communities indicated that a link existed between low 
microbial diversity and high pathogenicity, since end-stage patients were found to be infected by a 
single dominant pathogen. Non-end-stage patients were found to have polymicrobial lung infections; 
however, the biofilm aggregates in the lung airways were largely monomicrobial and spatially 
segregated. In the sinuses of CF patients molecular methods could identify a more diverse microbial 
community than culture, consisting both of CF pathogens, environmental species and anaerobes. The 
microorganisms in sinuses have been implicated in recurrent lung infections after successful 
antimicrobial eradication and establishment of lung infections in lung-transplanted CF patients. The 
ability to identify all microorganisms in the sinuses may therefore be clinically relevant, although the 
effect of the microbial diversity in the sinuses is presently not fully understood. 
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Molecular investigations of chronic venous leg ulcers indicated that the microbial communities in 
such wounds were highly diverse, and that the distribution of microorganisms within the wound 
varied, both in terms of community composition and abundance of individual species. This finding 
has implications on the appropriate sampling method of such wounds, since a single biopsy sample 
might not represent the entire microbial community. 
In suspected prosthetic joint infections it was found that although culture-dependent and molecular 
methods might give concordant results in some cases, the presence of biofilms on prosthesis surfaces 
might be the reason for cases where molecular methods could identify additional microorganisms. 
The study also indicated that the routine culture conditions used for examination of this infection 
type at clinical microbiology departments were insufficient since they did not allow for growth of 
fastidious microorganisms such as Propionibacterium acnes. 
In addition to the increased knowledge of the investigated infection types, the results of this PhD 
project have shown that molecular methods can be used to derive clinically relevant information that 
may improve outcome for infected patients. Furthermore, the results have contributed in convincing 
medical professional of the added value that can be obtained by using such methods. 
Future studies will hopefully lead to a definition of a method that can identify all microorganisms in 
a sample at a reasonable price and with a short turnaround time, and thus diminish the problem of 
different results obtained by different molecular methods. However, the ability to test antimicrobial 
susceptibility means that culture-dependent methods will not be completely abandoned, and the 
optimal method in a clinical microbiology setting might therefore be one that combines culture-
dependent antimicrobial susceptibility testing with molecular methods to achieve reliable results 
within a short period of time. Further studies are required to elucidate the function and effect of the 
diverse microbial communities in infections, which can hopefully be used to combat infections more 
efficiently in the future.  
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Dansk resume (abstract in Danish) 
Infektionssygdomme er en af de ledende årsager til sygdom og dødsfald på verdensplan. I 
industrialiserede lande er dette dog blevet mindsket, hvilket skyldes både øget hygiejne, 
tilgængelighed af mad samt forbedret ygehusvæsen og behandlings muligheder (heriblandt vacciner 
og antimikrobiel behandling). Til trods for dette er infektioner stadig problematiske, ikke kun for den 
syge patient, men også for samfundet som helhed grundet de samfundsøkonomiske omkostninger der 
er forbundet med infektioner. Trods udbredelsen af antimikrobiel behandling kan bekæmpelsen af 
infektioner være problematisk, hvilket både skyldes udvikling af multiresistente mikroorganismer, 
men også at mikroorganismer kan leve i benyttende biofilm. Dannelse af biofilm gør at 
mikroorganismer kan overleve både kroppens immunforsvar samt antimikrobiel behandling, og et 
stigende antal kroniske infektioner bliver i dag forbundet med biofilm dannelse. Yderligere må det 
erkendes at de dyrkningsbaserede metoder, som i årtier er blevet brugt til identifikation af 
sygdomsfremkaldende mikroorganismer, har en række problemer. 
Formålet med dette PhD projekt har derfor været at vurdere om andre metoder end dyrkningsbaseret 
identifikation kan bruges til at undersøge mikroorganismerne der indgår i infektioner, og give klinisk 
relevant information i løbet af kort tid. 
Nytteværdien af forskellige alternative metoder (herunder molekylære metoder samt 
mikroskopibaseret visualisering) blev vurderet på grundlag af forsøg udført på prøver fra patienter, 
som led af udvalgte akutte og kroniske infektioner. Nekrotiserende bløddelsinfektioner blev brugt 
som illustration af akutte infektioner, mens kroniske infektioner blev eksemplificeret af lunge- og 
bihule infektioner hos cystisk fibrose patienter, af kroniske venøse bensår samt af ledinfektioner i 
forbindelse med proteser. 
Dette PhD projekt har vist at molekylære metoder kan identificere yderligere mikroorganismer i 
forhold til dyrkningsbaserede metoder. Resultaterne indikerede imidlertid også at forskellige 
molekylære metoder kunne give forskellige resultater, hvilket er et tegn på at yderligere studier er 
nødvendige for at kunne definere den bedste metode til at identificere mikroorganismer i kliniske 
prøver.  
For nekrotiserende bløddelsinfektioner ligger merværdien ved brug af molekylære metoder især ved 
muligheden for at identificere mikroorganismer i prøver fra patienter hvor antimikrobiel behandling 
måske kan resultere i falsk-negative svar ved dyrkning. Derudover er muligheden for hurtigt at opnå 
svar ved brug af molekylære metoder yderst relevant for denne type infektioner, idet sygdommen er 
både fulminant og potentielt dødbringende. 
Undersøgelserne af cystisk fibrose patienter i dette PhD projekt har øget den nuværende viden om de 
infektioner, der kan forekomme i denne patient gruppe. Lungeinfektioner er den primære årsag til for 
tidlige dødsfald blandt patienterne. Ved at undersøge den mikrobielle sammensætning i lungerne 
fandtes en mulig forbindelse mellem lav mikrobiel diversitet og høj patogenicitet, da lungerne fra 
patienter med terminal lungeinfektion var domineret af en enkelt patogen art. Patienter med ikke-
terminal kronisk lungeinfektion var generelt inficerede med mange forskellige mikroorganismer. 
Selvom lungeinfektionerne overordnet set var polymikrobielle, var biofilm aggregaterne i luftvejene 
monomikrobielle og ikke i fysik kontakt med hinanden. I bihulerne hos cystisk fibrose patienter fandt 
molekylære metoder en mere forskelligartet sammensætning af mikroorganismer i forhold til de 
dyrkningsbaserede metoder. Denne diversitet blev udgjort både af bakterier der er kendte som 
sygdomsfremkaldende i cystisk fibrose, bakterier der stammer fra det omgivende miljø samt 
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anaerobe bakterier. Mikroorganismer i bihulerne har været associerede med de tilbagevendende 
lungeinfektioner, der forekommer hos cystisk fibrose patienter efter vellykket antimikrobiel 
bekæmpelse af lungeinfektioner, samt inficering af transplanterede lunger i cystisk fibrose patienter. 
Muligheden for at identificere alle mikroorganismer i bihulerne er derfor måske klinisk relevant, 
selvom funktionen af den mikrobielle diversitet i bihulerne endnu ikke er fult forstået. 
Molekylære undersøgelser af kroniske venøse bensår indikerede, at den mikrobielle sammensætning i 
disse sår er meget forskelligartet og at fordelingen af mikroorganismer indeni sårene varierede - både 
med hensyn til den mikrobielle sammensætning og hyppigheden af individuelle arter. Disse fund har 
direkte indflydelse på prøvetagningsproceduren for denne type sår, idet en enkelt biopsi prøve 
sandssynligvis ikke kan repræsentere hele det mikrobielle samfund i såret. 
I prøver fra patienter med mistænkt proteseinfektion blev det vist, at selvom resultaterne fra 
dyrkningsbaserede metoder og molekylære metoder kunne være overensstemmende, var de 
molekylære metoder til tider i stand til at identificere mikroorganismer som ikke blev fundet med de 
dyrkningsbaserede metoder. Dette kan skyldes dannelse af biofilm på protesens overfald. Studiet 
indikerede desuden også, at de vækstbetingelser der blev benyttet i kliniske rutine undersøgelser af 
denne type prøver, ikke var tilstrækkelige til at kunne detektere langsomt voksende bakterier, som for 
eksempel Propionibacterium acnes. 
Udover at bidrage til en øget viden om mikroorganismerne der findes i de udvalgte infektionstyper, 
har dette PhD projekt vist at molekylære metoder kan bruges til at opnå klinisk relevant information, 
som kan forbedre udfaldet for patienter. Desuden har projektet været med til at overbevise 
sundhedspersonale om den merværdi der kan opnås ved brug molekylære metoder. 
Fremtidige studier vil forhåbentlig medføre, at der kan defineres en metode til hurtig identifikation af 
alle mikroorganismer i en prøve, hvilket kan mindske problemet med at forskellige metoder giver 
forskellige resultater. Imidlertid vil dyrkningsbaserede teknikker ikke blive opgivet helt, da disse er 
de eneste som giver mulighed for at teste mikroorganismers modtagelighed overfor antimikrobiel 
behandling. Det er derfor muligt, at den optimale metode i klinisk mikrobiologi består af 
dyrkningsbaseret antimikrobiel modtagelighedstest i kombination med molekylære metoder for at 
opnå pålidelige resultater i løbet af kort tid. Yderligere studier er påkrævet for at opklare hvilken 
funktion og effekt de diverse mikrobielle fund har i infektioner, og denne viden kan forhåbentlig 
omsættes til en mere effektiv bekæmpelse af infektioner i fremtiden. 
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1 Human infections 
Infectious diseases are a major cause of morbidity and mortality worldwide (particularly in 
developing countries) and was estimated to be responsible for 26% of the deaths in the world in 2001 
(Pinheiro et al., 2010). This is largely due to the burden of infectious diseases in developing 
countries, whereas the problem has been greatly reduced in industrialized countries. This is attributed 
to many factors including improved sanitation, food availability and living conditions along with 
development of antimicrobial therapy and vaccines and improved health care systems (Pinheiro et 
al., 2010). The use of vaccines and antimicrobial therapy has led to a certain degree of control over 
acute infections; however, this approach has left the health care system with a new set of problems 
(Donlan and Costerton, 2002; Costerton et al., 2011). Some of the emerging major contributors to 
morbidity, mortality and increased healthcare costs are the ever increasing number of multi-resistant 
microorganisms, hospital acquired infections and chronic biofilm infections. In the United States it is 
estimated that 65 – 80 % of all human infectious diseases are caused by the biofilm phenotype, with 
up to 17 million new biofilm infections and 550,000 deaths each year (Potera, 1999; Donlan and 
Costerton, 2002; Wolcott and Dowd, 2011; Wolcott et al., 2012). The socioeconomic cost of 
infections is high, for instance hospital acquired infections alone have been estimated to amount to 
about 2 % of the Danish hospital costs (Pedersen and Kolmos, 2007).  
Although infections are a recurring problem, it is clear that presence of microorganisms do not lead 
to disease in the majority of cases. Humans are continuously in contact with microorganisms; in fact 
the total number of microorganisms in the human body is at least 10 times greater than the number of 
human cells (Highlander et al., 2011). Most of these microorganisms are commensals or 
opportunistic pathogens that only cause problems if the immune system is weakened or if they gain 
access to a normally sterile part of the body. Dedicated or primary pathogens are not a part of the 
normal human microbiota, and can cause disease in otherwise healthy persons, since they are highly 
specialized in gaining entry and surviving inside human hosts (Alberts et al., 2002). The body 
deploys a multitude of defense mechanisms to protect itself from microorganisms. These can be 
broadly divided into three categories: physical barriers preventing entry to the tissues, the innate 
immune system and the adaptive immune system. The physical barrier is comprised by strong 
barriers such as the skin, hair, and nails, and more vulnerable internal surfaces consisting of mucosal 
membranes. The barriers protect against infection by means of their physical and chemical properties 
and utilization of diverse flora of microorganisms densely populating the surface of some of the 
barriers (Alberts et al., 2002; Highlander et al., 2011; Ichinohe et al., 2011). If the barriers are 
breached, the various cells of the immune system are responsible for containment and eradication of 
infection. The overall effect of the innate immune system is to create a state of inflammation. Here 
vascular dilation results in leaks of blood plasma into the connective tissue, inviting white blood cells 
to move from the blood into the tissue to eradicate microorganisms. This also leads to destruction and 
remodeling of the tissues (Kimbrell and Beutler, 2001; Jensen and Moser, 2010). The adaptive 
immune response comes later than the innate immune response and is characterized by a higher 
degree of specificity. It recognizes species or even strain specific antigens, as opposed to the innate 
immune system that recognizes broad range molecular patterns (Moser and Jensen, 2010). 
Potential pathogens may enter the body by various routes including the internal barriers, through 
seeding from a reservoir or directly through a breach in the skin, for instance by bites or accidental or 
surgical trauma (Ala’Aldeen, 2007; Olsen and Musser, 2010; Hansen et al., 2012). After the 
pathogen has gained entry, it must establish a stable population which normally requires adhesion to 
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host cell surfaces or molecules (Figure 1). The adhesion leads to activation of complicated signaling 
pathways in both the microorganism and the host (Finlay and Cossart, 1997; Alberts et al., 2002; 
Anderson et al., 2006; Ala’Aldeen, 2007). The effect is a dramatic event where the immune system 
tries to clear the infection and the microorganism uses numerous mechanisms to evade eradication 
(Monack et al., 2004).  
Normal: The immune system combats microorganisms.
Acute infection: Microorganisms evade the immune system by several mechanisms including 
invasion of cells, production of capsule, toxins and virulence factors.
Chronic infection: Microorganisms evade the immune system by producing encasing matrix and 
pursuing biofilm mode of growth.
Normal: Often not enough damage to become symptomatic.
Acute infection: Microorganisms excrete virulence factors, toxins and proteases that directly 
damages tissue. Also, the immune system causes damage to the host.
Chronic infection: Biofilm-residing microorganisms have downregulated virulence, and damage is 
primarily caused by continued immune response.
Normal: Infection is cured by the immune system.
Acute infection: Infections are rapidly resolved either by clearance by the immune system or 
antimicrobial therapy or death of the host.
Chronic infection: Neither the immune system nor antimicrobial therapy can completely eradicate 
the infection, which can recur and persist for years. The entire biofilm must be completely removed  
to save patients.
Outcome
Damage
Interaction with the 
immune system
Adhesion to host cells
Gain entry to body
↓
↓
↓
↓
Microorganisms can enter the body through internal barriers, a breach in the skin or by seeding 
from a reservoir.
Adhesion to cell surfaces provides a base from which the microorganisms can proliferate. The 
interaction with host cells leads to activation of the immune system.
 
Figure 1: Overview of the stages of disease development after microorganisms have gained entry to the 
human body. 
There seems to be two fundamentally different types of infection: acute infections, which appear to 
be the result of microorganisms pursuing a planktonic phenotype, and chronic infections that persist 
in the host due to formation of biofilm (Figure 1) (Furukawa et al., 2006; Wolcott and Dowd, 2011). 
Biofilm formation is an ancient prokaryotic adaptation that allows microorganisms to survive in 
hostile environments (Costerton et al., 1999; Hall-Stoodley et al., 2004; Wolcott et al., 2012). 
Historically, studies of pathogenesis have focused on acute infections, but recently biofilm infections 
have been garnering much attention (Furukawa et al., 2006; Wolcott and Dowd, 2011). Acute 
infections are generally aggressive infections with vast tissue destruction, but of short duration due to 
a quick resolution either by clearance by the immune system or by death of the host (Furukawa et al., 
2006; Wolcott and Dowd, 2011). The microorganisms in chronic biofilm infections are generally 
confined to a particular location, contained by the host defenses, although dissemination occurs 
through detachment and shedding of planktonic cells and aggregates by various mechanisms (Parsek 
and Singh, 2003; Hall-Stoodley and Stoodley, 2005; Furukawa et al., 2006; Wolcott and Dowd, 
2011). Unlike acute infections the microorganisms in biofilms exhibit a slower growth rate, and 
chronic infections can persist for years (Donlan and Costerton, 2002). Many bacterial species that 
produce chronic infections can also cause acute invasive infections (Parsek and Singh, 2003). It 
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seems that microorganisms can choose whether to cause an acute infection, growing and spreading 
rapidly in the host, or adopting a chronic biofilm infection strategy (Furukawa et al., 2006).  
In acute infections the evasion of the immune system includes invasion of host cells, production of 
toxins, protective capsules, and virulence factors involved in inhibition of host-derived molecules and 
binding of phagocytic cells (Finlay and Cossart, 1997; Cunningham, 2000; Anderson et al., 2006; 
Barer, 2007; Fuchs et al., 2012). For chronic biofilm infections the evasion of the immune system is 
accomplished by the extracellular polymeric substance (EPS) matrix that encases a structured 
community of aggregated microorganisms (Figure 1) (Costerton et al., 1999; Parsek and Singh, 2003; 
Hall-Stoodley et al., 2004).  
The symptoms of infection are direct manifestations of both the immune response and damage of the 
involved tissue, and have to reach a certain level for the individual to become symptomatic. The 
damage done to the host may be inflicted directly from the pathogens or by the individuals own 
immune response (Figure 1) (Alberts et al., 2002; Ala’Aldeen, 2007). The microorganisms involved 
in acute infections can utilize a wide arsenal of virulence factors and toxins to directly induce damage 
to the host tissue or initiate apoptosis. The microorganisms can then feed on the host tissue by 
secreting proteases that digest the tissue (Finlay and Cossart, 1997; Wolcott and Dowd, 2011). The 
formation of biofilm seems to have an oppressive effect on expression of certain toxins, and the 
microorganisms involved in chronic infections show a moderated virulence (Parsek and Singh, 2003; 
Furukawa et al., 2006). The exact processes by which biofilm-associated microorganisms directly 
cause disease in the human host are poorly understood. Suggested mechanisms include detachment of 
cells or cell aggregates and production of some endotoxins (Donlan and Costerton, 2002). In many 
cases the damage that is inflicted on the patient stems from the individuals own immune defense due 
to an excessive or prolonged innate response (Ala’Aldeen, 2007).  
In most infections the adaptive immune system will eventually win the fight, and infection be 
cleared. Acute infections can often be cleared by a single course of treatment, after which it will not 
return. However, if the infection is not cleared, the continued presence of microorganisms will 
provoke a continued inflammation. In chronic infections the EPS matrix of the biofilm ensures that 
the microorganisms persist despite presence of inflammation, adaptive immune response, and even 
antimicrobial treatment (Monack et al., 2004). The microorganisms residing in biofilms have a 
dramatically lower susceptibility to antimicrobial agents compared to their planktonic counterparts. 
The mechanisms responsible for this are thought to be delayed or impaired penetration of some 
antimicrobial agents through the biofilm matrix or the different physiology and growth states that are 
displayed by the microorganisms in the biofilm (Donlan and Costerton, 2002; Wolcott and Dowd, 
2011). Even if most of the microorganisms in a biofilm are eradicated, the biofilm can be 
reconstituted in the exact same host niche, so that the infection reappears after successful 
antimicrobial therapy (Wolcott and Dowd, 2011). 
Correct identification of the microorganisms involved in infections and evaluation of their 
antimicrobial susceptibility is an important part of medicine to determine an optimal treatment 
strategy. The gold standard for identification of pathogens is largely based on routine culture-
dependent techniques performed at clinical microbiology departments. Determination of pathogenic 
microorganisms has been largely based on a set of criteria proposed by Robert Koch in 1890. Over 
the years these postulates have been reworded and extended, and can be summarized as: 1) the 
microorganism must be found regularly in diseased individuals (but not healthy individuals), 2) it can 
be isolated and grown in pure culture, 3) inoculation of the microorganism will cause disease in 
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healthy individuals (experimental animals) and the same organism must then be re-isolatable from 
the experimentally diseased individual (Highlander et al., 2011; Nelson et al., 2012). The use of pure 
cultures and phenotypic identification methods is often time consuming and most patients will 
therefore receive empirical antimicrobial treatment before the pathogens have been identified. It is 
possible that the administered treatment is sufficient, in which case the culture report from the 
clinical microbiology department is used for confirmation, but the report may also indicate that 
adjustment of the treatment is necessary (Slack, 2007; Turnidge et al., 2011). Although culture-
dependent methods are the gold standard in clinical microbiology, there are some technical 
limitations to the methods if antimicrobial treatment has been administered, if the microorganisms 
exist in a viable but non-culturable state, or if the in vitro conditions do not meet the requirements of 
the microorganisms (Amann et al., 1995; Vartoukian et al., 2010). Additionally, acute and chronic 
infections present different challenges to the diagnosis of pathogens by culture-dependent methods. 
For acute infections routine culture-dependent methods may often be able to identify the infecting 
microorganisms, however, the time required for this identification can be too slow compared to the 
progression of some diseases. For chronic infections caused by biofilms the use of culture-dependent 
methods may be difficult, and often leads to false-negative culture results. A consequence of Koch’s 
postulates has been an adaptation of a monomicrobial view of infections. However, biofilm 
infections are often polymicrobial, which means that the strategy of pathogen isolation and 
investigation of pure cultures may be counterintuitive and unable to clarify the complexity of biofilm 
infections (Burmølle et al., 2010; Nelson et al., 2012; Wolcott et al., 2012). Also, it can be difficult 
to prove that biofilm residing microorganisms and polymicrobial infections in general are etiological 
agents of disease according to Koch’s postulates, since interaction between different microorganisms 
is not taken into account in the postulates (Donlan and Costerton, 2002).  
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2 Objectives of the PhD project 
Based on the reported limitations of culture-dependent methods, the overall aim of this PhD project 
was to evaluate the possibility of using alternative molecular methods as supplement or replacement 
for culture-dependent methods in clinical microbiology. Since multiple molecular methods have been 
developed, this study has been focused on techniques that are commonly used within other fields of 
microbiology, and their ability to obtain clinically relevant information. To achieve this goal the 
specific aims were to: 
 compare the ability to detect and identify microorganisms within a short period of time by 
standard culture-dependent methods used at clinical microbiology departments with 
commonly used molecular methods. 
 use various molecular methods to obtain information on diversity, relative abundance and 
spatial distribution of microorganisms in selected human infections.  
The methods were tested on samples from acute infections as exemplified by necrotizing soft tissue 
infections (NSTIs) and chronic infections, as exemplified by infections of the lungs and sinuses of 
cystic fibrosis (CF) patients, chronic venous leg ulcers and prosthetic joint infections. Besides 
culture-dependent methods, the tested methods included sequencing (by Sanger and next generation 
sequencing), a pathogen detection platform (Ibis T5000 biosensor), quantitative PCR (qPCR) and 
fluorescence in situ hybridization (FISH). 
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3 Identification of microorganisms in disease 
In order to obtain a microbial diagnosis, suitable samples must be collected and submitted to 
appropriate tests. There are several elements to consider regarding acquisition and handling of 
samples (Box 1). It is important that several samples are collected from the infection site in order to 
obtain reliable results since it has been shown that several infections (particularly infections 
involving biofilms) exhibit a heterogeneous spatial distribution of microorganisms throughout the 
infection site (article III, V and VI) (Burmølle et al., 2010).  
 
The type of sample collected depends on the anatomic site of infection, which together with sample 
volume and accessibility of infected material influences the choice of collection method (Table 1). 
After samples have been collected, they are either processed on site or transported to an appropriate 
laboratory. Since it is possible that microorganisms may perish or be overgrown by other species 
during the transport, it is important that transport is rapid and that the viability of any pathogen is 
protected (Slack, 2007).  
Table 1: Common clinical samples used for diagnosis of pathogens in clinical microbiology. 
Infection Anatomic site Appropriate sample
 
Collection method 
Cystic fibrosis Lower respiratory tract Sputum 
Bronchoalveolar lavage fluids 
Endotracheal aspirates 
Expectoration 
Aspiration 
Aspiration 
Chronic venous leg ulcers Superficial wound Pus or irrigation fluid  
Purulence from beneath dermis 
Aspiration 
Swab, biopsy 
Necrotizing soft tissue infections Deep wound Blood culture
a 
Ulcer edge
a
 
Purulence from infection site 
Tissue from infection site 
Aspiration 
Needle aspiration 
Biopsy 
Biopsy 
Prosthetic joint infections Prosthesis Peri-implant tissue
b 
Synovial fluid
b
 
Biofilm from removed prosthesis 
Biopsy 
Aspiration 
Sonication 
Sinusitis Sinus Secretions from aspiration or 
wash 
Biopsy material 
Aspiration 
Biopsy 
Appropriate clinical samples based on (Baron and Thomson, 2011) except 
a
 (Stevens et al., 2005) and      
b 
(Della Valle et al., 2010). 
Samples for standard culture-dependent techniques should be kept in suitable transport media and 
treated directly after arrival at the laboratory. Samples for molecular methods are most often also 
kept in transport media for direct processing, but can also be frozen (Baron and Thomson, 2011). 
Freezing of samples might be done with or without a stabilization reagent, depending on the 
extraction protocol (for instance RNAlater® solution for RNA extraction). Samples for molecular 
Box 1. Sampling considerations 
Time considerations 
 Samples should be collected as soon as possible after onset of disease. 
 Samples for culture should be collected before antimicrobial treatment is initiated. 
Sample site 
 Samples must be collected to represent infection site avoiding microorganisms from the surrounding area. 
 Sampling of appropriate samples using suitable collection methods depends on infection (Table 1), but 
should be done using aseptic techniques and disinfection where possible. 
 Multiple samples should be collected from within the site of infection if possible.  
Transportation  
 Suitable transport conditions should be used, depending on the type of test to be performed. 
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methods need to be subjected to nucleic acid extraction prior to analysis. This is a critical pre-
analytic step for all molecular methods and may require some optimization since extraction methods 
that work for one pathogen in a particular sample type may not work for another pathogen or another 
sample type (Nolte and Caliendo, 2011).  
Overall, the range of different methods for identification of microorganisms consists of phenotypic 
identification, molecular identification and visualization methods. The methods can be group into 
those that require growth and subsequent isolation of pathogens into pure cultures, and methods 
where complex microbial communities can be directly analyzed without the necessity of obtaining 
monomicrobial cultures before analysis. Although the latter can be used to analyze both complex and 
monomicrobial communities, the use of some methods on pure culture isolates may be excessive 
compared to the information that can be obtained (Figure 2). 
Sample
Isolated 
pathogens
Biochemical tests
Antimicrobial susceptibility tests
MALDI-TOF mass spectrometry
Subtyping of species
Next generation sequencing
Genetic fingerprinting
Genetic microarray
QPCR
Sanger sequencing
 -  Cloning
 -  Direct sequencing
Ibis T5000 Biosensor
FISH
Microscopy
Colony morphology
Key
Phenotypic identification methods
Visualization methods
Molecular identification methods
Complex 
community
 
Figure 2: Overview of methods for identification of microorganisms in samples obtained from infected 
patients. The methods are either based on culture and isolation of pathogens or independent of pure 
culture isolation. The latter can also be applied to pure cultures, but this use of some of the methods 
may be excessive compared to the obtainable information. The methods are classified as either 
phenotypic, visualization or molecular methods according to the key. Subtyping of species is included in 
this overview although it is not strictly speaking an identification method. 
Culture-dependent methods have been the backbone of the approved diagnostic methods in the 
healthcare systems since the first use of culture media for recovery of bacteria from human disease 
sites (Atlas and Snyder, 2011). However, in other disciplines of microbiology such as study of 
microorganisms in natural and industrial ecosystems, the detection and identification of 
microorganism is now entirely based on methods targeting microbial RNA or DNA. A wide array of 
molecular methods have been developed (the most common are included in Figure 2), driven by a 
need for faster and more accurate methods with reduced hands-on-time (Barken et al., 2007; 
Costerton et al., 2011). Implementation of these methods in clinical microbiology has been slow and 
is still not complete. In the USA such methods are generally only approved by the Food and Drug 
Administration (FDA) for detection of a small number of pathogens that are difficult to culture 
(Costerton et al., 2011). One of the reasons for the continued use of culture-dependent methods as 
gold standard is the possibility of assessing antimicrobial susceptibility of isolates. 
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3.1 Methods based on culture and isolation of pathogens 
In clinical microbiology a number of classical tests are used for identification of medically important 
microorganisms. These are typically based on growth of microorganisms in a predetermined, 
artificial environment that is designed to mimic the conditions of the natural habitat of the 
microorganisms. Common culture media contains water, growth factors, and sources of carbon and 
nitrogen and may be liquid, semi-solid, or solid (Atlas and Snyder, 2011). Typically the tests used at 
clinical microbiology departments do not give a full identification of all isolated microorganisms; 
most laboratories use simple and incomplete methods of identification depending on the level of 
information required. Such shortcuts are taken to achieve timely reporting of relevant pathogens and 
the choice of analytical approaches is constrained by cost. For example, typing of microorganisms is 
not performed in the daily routine, but only used in special cases (Slack, 2007). 
3.1.1 Isolation of pathogens 
Individual microorganisms are isolated from complex samples by use of solid media, where the 
colonies can be distinguished from each other based on their properties (Figure 3). Inoculation of the 
media requires different techniques depending on the sample type; fluids may have to be centrifuged, 
swabs can be rolled directly onto plates, tissue and bone should be minced, and processing of 
prosthetic material may require sonication before inoculation (Baron and Thomson, 2011; Larsen et 
al., 2012). A wide variety of media are available, each with a specific use. Samples from sites that 
are normally sterile may be investigated with media designed for propagation of all possible 
microorganisms, while other media can be used to promote growth and identification of specific 
microorganisms while restricting growth of others (Atlas and Snyder, 2011). Based on the site of 
infection, suspected pathogens and the doctor’s requests, appropriate medium and incubation 
conditions are chosen. Samples for anaerobic culture have special growth conditions, and since these 
grow more slowly than aerobic and facultative microorganisms, at least five days of incubation is 
necessary before it can be reported as negative (Baron and Thomson, 2011). In cases such as 
Propionibacterium acnes, a longer incubation of up to two weeks may be necessary (article VI) 
(Larsen et al., 2012).  
 
Figure 3: Streaking of solid media plate enables isolation of distinct colonies that can be further 
investigated in order to obtain identification of pathogen, test antimicrobial susceptibility and determine 
the subtype of the species (if this is indicated). 
If more than one colony type is present, subcultures of each are made to ensure a pure culture of the 
unknown microorganisms for further characterization and identification (Atlas and Snyder, 2011). 
Also, the potential pathogens must be differentiated from members of the normal microbiota. This is 
largely based on recognition of usual contaminants and pathogens of the particular sample site 
according to Koch’s postulates. Identification of pathogens can be aided by correlating culture results 
with microscopy evaluations and the relative quantities of each isolate. However, in samples from 
presumably sterile anatomic sites potential pathogens occur in any quantity (Baron and Thomson, 
2011).  
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It may be possible to classify the microorganisms based on growth on specific selective media, 
nutrient requirements, colony morphology and odor (Atlas and Snyder, 2011; Petti et al., 2011). 
However, it is often necessary to perform additional tests to determine species identity and 
antimicrobial resistance patterns (Figure 2 and Figure 3).  
3.1.2 Biochemical tests 
Biochemical tests are performed to determine the biochemical profiles of isolated microorganisms, 
which can enable classification of the microorganisms. There are several biochemical tests available; 
overall they are all based on the interaction of the isolates with substrates. Generally, the reactivity of 
the tests is based on pH reaction, enzyme profile, antigen-antibody binding, carbon source utilization, 
or volatile and non-volatile acid detection, which can be detected by color change or 
chromatographic changes (Carpenter, 2011; Petti et al., 2011).  
Traditionally, the biochemical tests have been tube-based and the results of the tests were compared 
to charts of expected biochemical reactions. Due to the demand for faster methods, several manual 
testing kits and instrument based semi-automated or automated methods have been developed (Petti 
et al., 2011). Commonly used biochemical tests include catalase-, hemolysis-, indole- and oxidase 
tests among others (Atlas and Snyder, 2011). A specific type of biochemical tests is immunoassays, 
where antibodies are employed to detect specific molecules in the sample. There are several different 
types of immunoassays using different strategies to detect the binding of antibodies to their target 
molecules. One of the most commonly used techniques is enzyme-linked immunosorbent assay 
(ELISA). Here an enzyme will catalyze a substrate into a detectable (typically colored) product, and 
such assays has the advantage that they allow for automation of the process, and many platforms are 
available that can perform a wide repertoire of tests (Carpenter, 2011). 
3.1.3 MALDI-TOF mass spectrometry 
Mass spectrometry (MS) can been used to determine the chemical identity of materials by using 
ionization radiation to disrupt the sample material thus forming charged compounds that can be 
identified according to their mass-to-charge ratio. This principle can be used to identify 
microorganisms by using matrix-assisted laser desorption ionization-time of flight MS (MALDI-TOF 
MS), which is increasingly being implemented at clinical microbiology departments as an alternative 
to biochemical testing (van Veen et al., 2010; Nolte and Caliendo, 2011; Vandamme, 2011). The 
method can be used directly on intact whole cells (Holland et al., 1996; Krishnamurthy and Ross, 
1996), but cell wall disruption and protein extraction may be necessary in some cases to enrich 
proteins and peptides if whole-cell MALDI-TOF MS analysis is inconclusive (Sauer and Kliem, 
2010; van Veen et al., 2010). 
Identification by MALDI-TOF MS is based on the following characteristics: 1) spectral fingerprints 
vary between microorganisms, 2) among the compounds detected in the spectrum, some peaks 
(molecular masses) are specific to genus, species, and sometime to subspecies, 3) obtained spectra 
are reproducible as long as the bacteria are grown under the same conditions (Carbonnelle et al., 
2011). The procedure thus provides a unique mass spectral pattern for the microorganisms based on 
which the identity can be determined (Seng et al., 2009; Sauer and Kliem, 2010; Carbonnelle et al., 
2011). The patterns can be analyzed efficiently in high throughput using various algorithms 
(Freiwald and Sauer, 2009; Sauer and Kliem, 2010). 
MALDI-TOF MS is referred to as a molecular method in this thesis although it strictly speaking is a 
chemotaxonomic method, since microorganisms are classified based chemical markers. The method 
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requires that the investigated microorganisms are from pure cultures to ensure sufficient amounts of 
cells and because mixed mass spectra currently cannot be resolved (Freiwald and Sauer, 2009). 
3.1.4 Antimicrobial susceptibility tests 
Determination of antimicrobial susceptibilities of significant isolates is one of the principal functions 
of the clinical microbiology laboratory (Jorgensen and Ferraro, 2009; Turnidge et al., 2011). The 
main objective of susceptibility testing is to predict the outcome of treatment with an antimicrobial 
agent, and to guide clinicians in the selection of the most appropriate agent (Turnidge et al., 2011). 
There are several options with regard to methodology and selection of agents for susceptibility 
testing. The selection of agents depends on the likelihood of encountering resistant microorganisms, 
which agents are commonly prescribed by physicians, and in particular which species are being 
tested for susceptibility (Turnidge et al., 2011). There are several methodologies available; overall 
these can be categorized as disk diffusion and dilution methods. Disk diffusion methods are used to 
categorize microorganisms as susceptible, intermediate or resistant. The method uses commercially 
prepared filter paper disks impregnated with an antimicrobial agent at a specified concentration. The 
disks are applied to the surface of an agar plate inoculated with the microorganism, and after 
incubation the plates are evaluated to see if zones of growth inhibition appear around the disks. The 
zones are connected to the susceptibility of the microorganism and diffusion rate of the microbial 
agent through the medium (Jorgensen and Ferraro, 2009; Patel et al., 2011). Disk diffusion testing 
has an inherent flexibility in drug selection and is low in cost (Turnidge et al., 2011). Dilution 
methods (such as broth and agar dilution and antimicrobial gradient strips) are used to determine the 
minimum inhibitory concentration, which is the lowest concentration of microbial agent that will 
inhibit growth over a defined period of time. This is determined by exposing microorganisms to 
serial dilutions of the antimicrobial agent (Patel et al., 2011; Turnidge et al., 2011). Dilution methods 
have the advantage that they produce a quantitative result and may be useful in testing some 
anaerobic or fastidious microorganisms (Jorgensen and Ferraro, 2009; Turnidge et al., 2011). 
Furthermore, automated instruments have become available for susceptibility testing. Depending on 
the system these may have limited flexibility in agent selection and may not detect subtle resistance 
mechanisms, but can generate results faster than conventional methods (Turnidge et al., 2011).  
3.1.5 Subtyping of species 
In some cases identification of subtypes of microorganisms is desired, for instance, in 
epidemiological studies. Subtyping is not a method for microbial identification, but rather for 
differentiating bacterial isolates beyond the species level. A wide array of methods can be used to 
achieve this end, the choice of which depends on the intended application and the wanted level of 
differentiation. Commonly used methods include phenotypic-based methods (such as serotyping and 
phage typing), different types of genetic fingerprinting typically following PCR amplification of 
certain genes and gene sequencing. One of the first DNA sequence-based subtyping methods was 
multilocus sequence typing (MLST), which can be used for distinguishing and relating bacteria on 
the intra- and interspecies level (Gerner-Smidt et al., 2011). The method characterizes bacterial 
isolates based on the sequences of internal fragments (450-500 bp) of typically seven house-keeping 
genes scattered around the genome, referred to as loci (Maiden et al., 1998; Enright and Spratt, 
1999). For each locus, a sequence that varies in even a single nucleotide is assigned a distinct allele 
number, and the combination of the alleles of the seven loci constitutes the sequence type of each 
isolate. MLST ignores the total number of differences in the sequences of each allele, and sequences 
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are given different allele numbers whether they differ at a single nucleotide site or at many sites 
(Enright and Spratt, 1999). The use of multiple loci is essential to achieve the resolution required to 
provide meaningful relationships among strains (Maiden et al., 1998).  
One of the strengths of MLST is the availability of international databases on the internet containing 
data derived from thousands of isolates of the major pathogenic species. Since the method is based 
on sequencing the results can readily be compared to these databases (Maiden et al., 1998; Enright 
and Spratt, 1999; Gerner-Smidt et al., 2011). The use of housekeeping genes means that the found 
sequence types are stable over time, since these genes are typically under little selective pressure and 
the accumulation of changes therefore is relatively slow. This might, however, lead to limited 
discriminatory power, and more rapidly evolving genes may therefore be used instead. (Enright and 
Spratt, 1999; Gerner-Smidt et al., 2011).  
MLST is primarily used on isolates, however, recent work has indicated that the method potentially 
can be used directly on clinical samples (sputum from CF patients) (Drevinek et al., 2010). 
3.2 Methods that do not require isolation of pathogens 
Several methods exist that do not require growth of microorganisms and can be used to directly 
investigate complex samples, including microscopy and molecular methods.  
The development of the polymerase chain reaction (PCR) using two primers, thermostable 
polymerase and thermal cycling (Saiki et al., 1988) was a milestone in biotechnology and a profound 
advance within molecular diagnostics. The method allows for fast amplification of a nucleic acid 
target. PCR has many applications and several techniques have been developed for the analysis of the 
resulting amplification products (Box 2).  
 
One of the key molecules for identification of microorganisms is ribosomal RNA (rRNA) genes that 
have variable and conserved regions, which are utilized in broad-range phylogenetic analysis (Barken 
et al., 2007). The conserved region constitutes target sites for primers, while the variable regions 
form the basis for phylogenetic analysis, and the identification of microorganisms is thus based on 
ancestry (Amann et al., 1995; Coenye and Vandamme, 2003; Vandamme, 2011). Besides broad-
range molecular methods it is possible to use molecular methods that are target-specific. These do, 
however, require some degree of prior knowledge of infecting microorganisms, but may be faster to 
perform and have increased sensitivity (Maiwald, 2011). PCR-based methods are numerous and 
commonly used in many settings. However, these methods do not offer the opportunity to investigate 
the spatial distribution of microorganisms, which is possible by microscopy methods.  
Box 2. Analysis of PCR products 
Real time analysis 
 Fluorescence quantification PCR products are quantified in real time by addition of a fluorescence reporter to 
the amplification reaction. 
Post amplification handling 
 Fingerprinting PCR products are analyzed based on band pattern arisen from methods such as gel- or capillary 
electrophoresis. 
 Sequencing PCR products are analyzed based on the nucleic acid sequence. 
 Mass spectrometry Base composition of PCR products are inferred from precise mass determination. 
 Hybridization Presence of specific nucleic acid sequences is determined by target-probe hybridization. 
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3.2.1 Microscopy 
The microscope has played an important role in biology and medicine since the first description of 
microscopic life forms (Wiedbrauk, 2011). In clinical microbiology microscopic examination can be 
used to obtain different goals; 1) evaluate the quality of the sample, 2) observe presence of potential 
pathogens and 3) provide presumptive identity of potential pathogens (Baron and Thomson, 2011). 
Several types of microscopes have been developed; the most frequently used in the clinical setting is 
the compound light microscope. Other microscopes that are used in the clinical microbiology 
laboratory include dark-field microscopes, phase-contrast microscopes and fluorescence microscopes 
(Wiedbrauk, 2011). While dark-field and phase contrast microscopes can be used to directly observe 
microorganisms in clinical material, it is otherwise usually necessary to alter the sample to improve 
contrast and aid differentiation of microorganisms from sample material. This can be accomplished 
by adding positively charged color stains, which will bind to the negatively charged surface of most 
microorganisms. Examination of samples using stains is a rapid way to obtain a presumptive 
bacteriological diagnosis (Baron and Thomson, 2011). There are two basic types of stains: simple 
stains which color all objects in the same manner (allowing for enumeration of organisms and some 
determination of shape and size) and differential stains which are used to detect differences in 
structure among microorganisms. The most commonly used differential stain is the Gram stain (Atlas 
and Snyder, 2011). 
Gram stain 
The differential Gram staining procedure uses crystal violet and safranin stains. Gram positive cells 
will retain the crystal violet stain, whereas the stain can be washed away from Gram negative cells, 
which are subsequently stained by the safranin counter stain. The method thus enables classification 
of Gram positive and Gram negative bacteria based on differences in their cell wall structure. 
Identification of the Gram negative and Gram positive microorganisms is primarily based on 
morphology, and is a crude method that often needs to be confirmed by other methods (Atlas and 
Snyder, 2011). 
Microscopy of Gram-stained smears is the best routine method to distinguish between contaminants 
and microbes present at the infection site. The infection site should demonstrate many 
polymorphonuclear leucocytes and few squamous epithelial cells. Presence of squamous epithelial 
cells would suggest contamination with members of the normal microbiota (Baron and Thomson, 
2011; Bjarnsholt et al., 2011).  
3.2.2 FISH 
Since the first description FISH more than two decades ago (Giovannoni et al., 1988; DeLong et al., 
1989; Amann et al., 1990), the technique has become one of the most widely used approaches to 
study microorganisms directly in natural systems without prior cultivation and isolation. The 
principle of FISH is based on hybridization of fluorescently labeled oligonucleotide probes to 
ribosomal rRNA. A typical FISH protocol includes four steps; 1) fixation and permeabilization of the 
sample, 2) hybridization, 3) washing steps to remove unbound probes and 4) detection of cells that 
contained the target sequence and therefore retained the probe and became fluorescently labeled. The 
detection of fluorescently labeled cells is typically achieved by microscopy, and is possible due to the 
large number of ribosomes in active cells. The probes are relatively small (generally between 15 and 
30 nucleotides) which should enable them to cross permeabilized cell walls and access the binding 
site (Giovannoni et al., 1988). However, some cell types require additional treatment by enzymes or 
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chemicals to ensure sufficient permeabilization (Nielsen et al., 2009). Based on the composition of 
the probe it is possible to specifically target a narrow phylogenetic group or any other higher 
phylogenetic hierarchical group (Amann et al., 2001). Efficiency of probe binding depends on the 
hybridization and washing conditions and the three-dimensional structure of rRNA since not all 
sequences are equally accessible for the probes. Loop and hairpin formation as well as rRNA-protein 
interactions hinder hybridization, leading to differential sensitivity of oligonucleotide probes 
(Giovannoni et al., 1988; Moter and Göbel, 2000). 
Using FISH it is possible within a relatively short time to obtain knowledge of phylogenetic 
characteristics, microbial community structure and spatial and relative distribution of individual 
microorganisms in their natural habitat (Nielsen et al., 2009). However, the signal intensity of the 
hybridized probes can sometimes be below the detection limit. To resolve this several variations of 
the FISH protocol has been developed. These include use of helper oligonucleotide probes, signal 
amplification with reporter enzymes and peptide nucleic acid (PNA) probes (Kerstens et al., 1995; 
Nielsen, 1999; Fuchs et al., 2000). PNA probes have a non-charged peptide backbone to reduce 
electrostatic repulsion, which can otherwise impede binding. The use of PNA probes have been 
reported to allow stronger hybridization and the protocols for hybridization are much faster than for 
oligonucleotide probes (Egholm et al., 1993; Bjarnsholt et al., 2009; Thomsen et al., 2012). The 
reduced background fluorescence and hands-on time makes the use of PNA-FISH more suitable for 
investigation of clinical samples than conventional FISH. 
3.2.3 QPCR 
An increasing number of published clinical studies have shown the usefulness of qPCR for diagnosis 
of microbial pathogens. The increased use of qPCR is caused by the simple, sensitive and fast nature 
of the method (Espy et al., 2006; Barken et al., 2007; Wittwer and Kusukawa, 2011). Because 
amplification and analysis of PCR product occurs in the same step (real-time analysis) the risk of 
contamination is minimized and turnaround time improved (Espy et al., 2006; Nolte and Caliendo, 
2011; Wittwer and Kusukawa, 2011). The principle of qPCR is relatively simple; it is a PCR reaction 
with addition of fluorescence reporter (either intercalating fluorescent dyes that bind to double 
stranded DNA or specific probes labeled with fluorescent dyes) that can be measured using precision 
optics. The results can be used quantitatively based on the assumption that there is a linear 
relationship between quantity of input template and the amount of generated product and therefore 
signal, which is measured during the exponential phase of amplification. Based on this relationship 
qPCR measures how rapidly fluorescence signals exceed a threshold; the fewer cycles it takes to 
cross the threshold the higher the initial template concentration (Bustin, 2004; Nolte and Caliendo, 
2011).  
Although the results from qPCR can be quantitative, this term should be interpreted with caution, 
taking into account that the results are logarithmic and that variation of measurements changes with 
concentration (Bustin, 2004). At best a 0.5 log10 variance (corresponding to a threefold difference) is 
documented to exist between repeats of the same initial template concentration. This is important to 
bear in mind during evaluation of results, so that small differences do not take on assumed relevance 
(Wolk and Hayden, 2011).  
A number of FDA-approved and commercial qPCR assays for detection of viruses, bacteria, fungi, 
and parasites have become available. Viruses remain the most common target for qPCR in the 
clinical microbiology laboratory; however, the applicability of qPCR is much wider (Wolk and 
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Hayden, 2011). Packages of qPCR assays that enable screening of multiple microorganisms 
commonly found in specific diseases are focuses for development and commercialization.  
3.2.4 Genetic fingerprinting 
One of the most basic ways to verify PCR products or interpret polymorphic DNA fragments (such 
as those that arise from 16S rRNA PCR on complex samples), is the use of genetic fingerprinting 
(Bassam et al., 1992). Polymorphic DNA fragments may differ in length or sequence, which can be 
interpreted by simple procedures such as gel electrophoresis or capillary electrophoresis of 
fluorescently labeled fragments (van Belkum, 1994; Frye and Healy, 2011; Gerner-Smidt et al., 
2011). In this way a genetic fingerprint can be obtained, either directly on the DNA fragments or 
after treatment with enzymes (restriction length polymorphism, terminal-restriction fragment length 
polymorphism (T-RFLP) and amplified fragment length polymorphism) (Marzorati et al., 2008; 
Gerner-Smidt et al., 2011). Fingerprints are recorded as banding patterns which can be obtained by 
several gel-based electrophoresis methods, where the fragments are separated according to length 
(standard gel electrophoresis, pulse field gel electrophoresis) or sequence (denaturing gradient gel 
electrophoresis, temperature gradient gel electrophoresis) (van Belkum, 1994; Marzorati et al., 2008; 
Gerner-Smidt et al., 2011). 
For gel-based electrophoresis detection methods, interpretation of results is performed either visually 
or by using a gel documentation system to scan and record the gel images. (Frye and Healy, 2011). 
3.2.5 Sanger sequencing 
Determination of the nucleotide sequences of DNA molecules by the chain-termination method 
(named the Sanger sequencing method) has been one of the most influential innovations in biological 
research. The key principle of Sanger sequencing is the use of modified nucleotides; 
dideoxynucleotide triphosphates (ddNTPs). The method uses primers that anneal to single-stranded 
target DNA, and incorporate nucleotides by the aid of DNA polymerase. When a modified nucleotide 
is incorporated strand elongation cannot continue, so four reactions are made, each with a different 
ddNTP. The product will be four mixtures of partial sequences of varying length, which can then be 
separated according to size by gel electrophoresis according to the original method. Since the ddNTP 
are labeled (originally with radioisotopes) the pattern of products can be read, and the nucleotide 
sequence determined (Sanger et al., 1977). The method has been improved and streamlined by use of 
fluorescent labeling and capillary electrophoresis. This has enabled use of a single reaction with 4 
differently labeled ddNTPs, and changed the output format from a sequences ladder to fluorescent 
peak trace chromatograms (Nolte and Caliendo, 2011). Software translates these traces into DNA 
sequence, while also generating error probabilities for each base-call. After gradual improvement 
over the years Sanger sequencing can now achieve read-lengths of over 1000 bp, and per-base 
accuracies as high as 99.999% (Shendure and Ji, 2008). 
A condition for the Sanger sequencing method to work is that the target sequence is pure to avoid 
mixed chromatograms that are difficult to interpret. To obtain pure products fingerprinting 
techniques or cloning can be used before sequencing. Sanger sequencing has historically only been 
used directly on PCR products when it can be assumed that a sample contains a single species of 
microorganism (Maiwald, 2011). 
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Separation of PCR products by cloning 
Separation of nucleic acid fragments by cloning is a technique that can be used before sequencing of 
polymorphic DNA fragments. The so-called clone libraries are created by inserting the individual 
DNA fragments into cloning vectors, which are subsequently transformed into bacterial cells. Each 
of the resulting cells should contain one plasmid with a single DNA fragment. Following 
proliferation of the transformed cells, sufficient copies of the plasmids are produced for sequencing 
(Cohen et al., 1973).  
To obtain reliable results that represent the original sample an adequate number of clones should be 
sequenced. What constitutes “adequate” depends on the complexity of the sample since clone 
libraries have some biases towards low-abundance targets (Higuchi et al., 2011; Maiwald, 2011). 
Equations to estimate if the number of clones is adequate have been developed, such as Good’s 
coverage estimator and the Chao estimator. 
Construction and sequencing of clone libraries is labor intensive, time consuming and costly, and the 
method is therefore not appropriate for implementation at clinical microbiology departments. 
Methods to circumvent construction of clone libraries while still enabling sequencing of complex 
samples are therefore highly relevant to fully utilize the potential of sequencing. 
Direct sequencing of PCR products 
Identification of pure cultures based on 16S rRNA gene sequencing has been well established and in 
some cases implemented at clinical microbiology departments, but the ability to perform direct 
sequencing of selectively amplified molecular marker genes fragments from complex clinical 
samples is of increasing interest (Kommedal et al., 2008; Nolte and Caliendo, 2011).  
In an effort to apply Sanger sequencing directly to mixed microbial community, a web-based 
application has been developed by iSentio (Bergen, Norway) for interpretation of chromatograms of 
mixed PCR products from multiple species. The application is build on an algorithm that sort out the 
ambiguous signals from mixed chromatograms in order to identify the different contributing bacteria. 
The application only reports identities having a similarity that reaches an empirically set cutoff, and 
in cases where more than one species from the same genus are found, only the highest scoring 
species are reported. Using these constraints mixed chromatograms from polymicrobial samples 
containing up to three different species can be sequenced directly in a time efficient manner 
(Kommedal et al., 2008, 2009). 
3.2.6 Next generation sequencing 
Although the throughput of Sanger sequencing has been advanced by the development of capillary 
electrophoresis and algorithms to resolve complex chromatograms, the experience of sequencing the 
human genome showed that the method was not able to efficiently analyze complex diploid genomes 
at low cost (Lander et al., 2001; Wheeler et al., 2008; Higuchi et al., 2011). To resolve the issues of 
throughput, price and requirements of cloning that are inherent to the Sanger sequencing method, 
several next generation sequencing platforms have been developed that offer great improvements in 
terms of total sequence production and reduction of cost and time (Barken et al., 2007; Wheeler et 
al., 2008; Higuchi et al., 2011; Liu et al., 2012).  
Although there are differences in the strategies used by the different next generation sequencing 
platforms, their workflow are conceptually similar and differ from Sanger sequencing in a number of 
ways. They all feature clonal amplification of libraries that are prepared by in vitro ligation, which 
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obviate the need for laborious cloning of DNA library into bacteria. Also, the sequencing occurs by 
synthesis, meaning that the DNA sequence is determined by the addition of nucleotides to the 
complementary strand rather than the strategy of chain termination used in Sanger sequencing. 
Finally, the DNA templates are spatially segregated and sequenced simultaneously in a massively 
parallel manner, unlike Sanger sequencing that requires a physical separation step (e.g. transfer of 
individual templates to wells in a microtiter plate) (Shendure and Ji, 2008; Higuchi et al., 2011; Liu 
et al., 2012). 
There are several applications of next generation sequencing regardless of the platform, including 
mapping of structural rearrangements, epigenetics (by analysis of DNA methylation or 
immunoprecipitation followed by sequencing), transcriptome analysis and RNA sequencing 
(Shendure and Ji, 2008; Liu et al., 2012). In the context of microbial identification the most relevant 
application of next generation sequencing is amplicon sequencing and whole genome sequencing 
(Mardis, 2008; Liu et al., 2012). These applications have conceptually different approaches, and are 
either based on PCR amplification or fragmentation of DNA before sequencing (Figure 4).  
 
Figure 4: Conceptual differences between amplicon and genome sequencing. For amplicon sequencing 
PCR is used to amplify target region before next generation sequencing, while genome sequencing uses 
fragmentation of genomic DNA before next generation sequencing. If genomic DNA originates from a 
complex sample sequencing of all the genomes is referred to as metagenome sequencing. 
Compared to Sanger sequencing the read-length that can be obtained by next generation sequencing 
may be short. This can be problematic for assembly of sequences into full genomes after genome 
sequencing. However, the potential utility of short-read sequencing has been tremendously 
strengthened by the availability of whole genome assemblies for major model organisms, as these 
effectively provide a reference against which short reads can be mapped (Shendure and Ji, 2008). 
The short reads does, however, influence the ability to perform de novo assembly.  
The sequencing field is advancing rapidly, and evolution of next generation sequencing platforms has 
brought huge advancements in performance accuracy, applications, consumables, manpower 
requirement and obtainable read length (from 250 bp to 700 bp for the Roche 454 system, 35 bp to 75 
bp for the ABI SOLiD system and 36 bp to 150 bp for the Illumina system) (Shendure and Ji, 2008; 
Liu et al., 2012). Furthermore, new technologies are being developed, including compact sequencers 
and third generation sequencing platforms. Although no consensus definition of third generation 
sequencing has been established yet, two main characteristics have been described. These include an 
ability to perform sequencing with no prior PCR (single-molecule sequencing), and capture of signal 
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(either fluorescent or electric current) in real time instead of the strategy of “washing and scanning” 
used in next generation sequencing. These characteristics mean that sequencing analysis can be 
performed very rapidly but still in high throughput and that read lengths are greatly increased. Third 
generation platforms include the PacBio RS by Pacific Bioscience, and the Oxford Nanopore 
sequencer (Schadt et al., 2010; Liu et al., 2012). The compact sequencers (among others the Ion 
Torrent platform) sit between next generation sequencing and third generation sequencing since they 
require “washing and scanning”. The Ion Torrent performs sequencing by synthesis by measuring 
changes in pH due to release of hydrogen ions as part of the base incorporation process. This 
methodology dramatically accelerates the time to result and reduces costs but does not result in 
longer read lengths (Schadt et al., 2010). For clarity reasons the term NGS will be used to cover all 
these platforms throughout the rest of the thesis. 
3.2.7 Ibis T5000 biosensor 
In contrast to most other methods, the Ibis T5000 biosensor uses high-performance mass 
measurements to analyze nucleic acid sequences. The Ibis T5000 biosensor is based on a multilocus 
approach, and uses PCR to amplify broadly conserved regions, including ribosomal sequences and 
housekeeping genes, by use of “intelligent primers” (Hofstadler et al., 2005; Vandamme, 2011). The 
choice of primers follows a strategy of redundancy, and is made up by several broad-range and clade-
specific primers, so that one type of microorganism should be targeted by more than one primer set 
(Hofstadler et al., 2005). The PCR products that are in the 80–140 bp size range, are desalted and 
analyzed by electrospray ionization (ESI) MS. The resulting spectral signals are then processed to 
determine the accurate masses of both strands of all the PCR products. This allows sufficient 
accuracy to determine the base composition of each amplicon based on the discrete masses associated 
with different combinations of the four nucleotide bases. The base compositions from multiple 
primer pairs are used to “triangulate” the identity of the organisms present in the sample (Hofstadler 
et al., 2005; Ecker et al., 2006). The method is commercially available in the form of the Ibis T5000 
biosensor and Abbott PLEX-ID instruments (Ecker et al., 2006, 2008; Jacob et al., 2012). These 
instruments have several pre-prepared assays, in the form of 96 well plates, offering broad range 
identification of bacteria, fungus and virus, targeted identification of a specific microorganism or 
characterization of microorganisms based on subtyping and drug resistance determination (Ecker et 
al., 2006, 2008; Eshoo et al., 2009; Grant-Klein et al., 2010). The applicability of the instruments are 
wide and can be used both for identification and characterization of a broad range of pathogens and 
for molecular genotyping, by following the same general principle as MLST but detecting variation 
based on base composition and not sequence (Ecker et al., 2008, 2009; Hall et al., 2009; Gerner-
Smidt et al., 2011). 
 
Figure 5: Illustration of the principle of the Ibis T5000 biosensor, where PCR products are analyzed by 
mass spectrometry. The mass spectra that are obtained for the various primer sets are converted into a 
base count for each PCR strand, which forms the basis for determination of species identity by 
triangulating the results from multiple primer sets and comparing them to an integrated database. The 
picture was modified from (Ecker et al., 2006)  
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To analyze a sample, extracted nucleic acids are transferred into wells of the microtiter plate that 
each contains one or more primer pairs. The following PCR amplification produces a mixture of PCR 
products, representing the complexity of the original sample. The Ibis T5000 and Abott PLEX-ID 
contain robotics that handle the desalting of the samples in 96-well plate format and sampling into 
the ESI mass spectrometer, which leads to a minimized hands-on time. The software associated with 
the instruments identifies the microorganism by first determining the masses and associated base 
compositions from the mass spectrometry data, and then comparing the results across primer pairs 
(Ecker et al., 2006). To do this a key element of the system is utilized; a curated database that 
associates base counts with primer pairs for thousands of microorganisms (Ecker et al., 2006; Nolte 
and Caliendo, 2011).  
The Ibis T5000 biosensor has the potential of providing the relative amount of each of the detected 
microorganisms in a sample by use of an internal calibrant. This is a nucleic acid sequence that is 
similar to the primer target sites and is amplified during PCR of the sample. The generated calibrant 
amplicon has a deletion that uniquely distinguishes it from the amplicons that are produced from the 
sample. Since the concentration of the calibrant in each PCR is known, the calibrant can be used to 
obtain quantitative results, but also functions as an internal positive control (Ecker et al., 2008). 
3.2.8 Genetic microarrays  
The basic principle of genetic microarray is build upon hybridization experiments to screen for 
specific DNA sequences from a sample, performed in a small and highly parallel format. In a genetic 
microarray hundreds to thousands of nucleotide probes are bound to a solid surface, typically glass, 
in precise patterns. The sample nucleic acids can hybridize to these probes, and ultimately the array-
bound sample can be detected (Gerner-Smidt et al., 2011; Nolte and Caliendo, 2011). The target 
nucleic acid can be either RNA or DNA, and a variety of sample preparation methods exist for 
different array types. Common for the methods is either amplification of the target while tagging or 
incorporating biotinylated or fluoresceinated nucleotides, or staining of nucleic acids using 
fluorescence dyes (Southern, 2001; Nolte and Caliendo, 2011). In order for the target to bind to the 
probes the amplicons must be single stranded to ensure hybridization to the immobilized probes with 
complementary sequences (Southern, 2001). After hybridization of sample to the microarray, binding 
of targets can be detected, and the amount of hybridized sample can be quantified based on signal 
intensities (Barken et al., 2007). 
The genetic microarray platform has many types of applications depending on the probes attached to 
the surface. These include transcriptome analysis (e.g. comparison of mutants and wild-type strains, 
or strains under different growth conditions), analysis of gene expression, identification of single 
nucleotide mutations, detection of species specific sequences, virulence genes and genes encoding 
antimicrobial resistance, and discovery and characterization of pathogens (Barken et al., 2007; Nolte 
and Caliendo, 2011). Gene expression analysis by microarrays has been used to study several 
pathogens and been implemented for cases such as viral hepatitis infections (Miller and Tang, 2009). 
Furthermore, arrays have been described for the detection of some pathogenic prokaryotes, 
eukaryotes and viruses (Wang et al., 2002; Wilson et al., 2002). Despite these experiences and the 
advantage of high throughput analysis offered by the method, the genetic microarrays have so far had 
little direct impact on diagnostic microbiology (Barken et al., 2007; Miller and Tang, 2009).  
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4 Comparison of methods 
It is clear that many methods exist for detection, identification and subtyping of microbial species. 
No matter which method is used for investigation of microorganisms, the key to success or failure 
lies with proper transport conditions, storage conditions and general handling of the primary sample. 
Furthermore, the first steps taken during analysis are often pivotal for the outcome. The results from 
culture-dependent methods are dependent on the choice of nutrients and incubation conditions 
applied during the first inoculation of samples. Similarly, the results that can be obtained by the 
molecular methods depend on the choice of protocol for extraction of nucleic acids. The sensitivity of 
the molecular analyses is directly affected by the quality of nucleic acids used as input. To represent 
the true microbial community in a sample the extraction protocol must be unbiased and 
simultaneously remove inhibitors. Also, since the sensitivity is influence by the ratio between target 
and background nucleic acids, selective DNA extraction may be suitable for clinical samples that 
often contain nucleic acids from the host that can reach dominating concentrations (article III), 
which may interfere with PCR. Elimination of these unwanted nucleic acids (for instance by 
MolYsis™ pretreatment) may improve sensitivity (article VI) (Gebert et al., 2008), but it is possible 
that nucleic acids from some microorganisms are also eliminated (Horz et al., 2010).  
Another consideration for analysis by molecular methods is the possibility that extracted DNA 
originates from non-viable microorganisms, for instance, from cells that have been eradicated by 
antimicrobial treatment, which is not clinically relevant. To avoid analysis of these molecules it is 
possible to use RNA-based methods or pretreatments such as propidium monoazide photo-induced 
cross-linking of extracellular DNA and DNA in cells with compromised cell membranes (Nogva et 
al., 2003; Rudi et al., 2005). At present no ideal method for nucleic acid extraction has been found, 
and the optimal extraction protocol may vary depending on the sample type. Extraction issues mean 
that although the molecular methods have high analytical sensitivity, the sensitivity for detection of 
microorganisms within a sample may be reduced. Theoretically, culture has a higher sensitivity than 
molecular methods since only a single cell needs to be present to result in growth. However, the 
reality is that some microorganisms are not detected by the standard culture-dependent methods used 
at clinical microbiology departments. Lack of detection can be caused by exposure to antimicrobial 
agents, biofilm formation, entry into a viable but non-culturable state, slow growth rates, improper 
handling of anaerobes or requirement of as yet undiscovered growth conditions (often referred to as 
unculturable, although this term may be misleading and due to insufficient culture optimization) 
(Vartoukian et al., 2010).  
It is possible to investigate microorganisms directly in the sample by microscopy, which is not 
possible by culture-dependent methods or molecular methods. Direct investigation of sample material 
means that no concentration of targets occurs, and introduction of biases associated with these steps 
can thereby be avoided. However, microscopy-based methods have high detection limits.  
Besides the general issues that are connected with culture-dependent methods, microscopy and 
molecular methods, the individual methods have different advantages and limitations (Table 2) that 
influence which method might be more suitable to use for investigation of microorganisms in 
different settings and sample types. 
Table 2: Overview of the methods (Ecker et al., 2008; Seng et al., 2009; Frye and Healy, 2011; Miller, 
2011; Savelkoul and Peters, 2011; Liu et al., 2012)  
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4.1 The optimal method? 
The best method for identifying microorganisms should provide sensitive, universal, flexible and 
quantitative results even in complex samples within a short period of time, preferably with potential 
for automation. Based on these criteria, the phenotypic identification methods are not optimal, both 
due to lack of growth of some microorganisms, but also because the identification of microorganisms 
by these methods can be laborious, time-consuming and costly depending on the number of tests that 
must be performed (Table 2). Furthermore, phenotypic markers might show variability due to 
environmental cues such as the condition of the culture, subculture and storage (Sauer and Kliem, 
2010). The time and cost is to a large extend linked with biochemical testing, and the increasing 
implementation of MALDI-TOF MS as an alternative to these tests have been reported to reduce 
costs of bacterial identification by 68-89% and allow much faster identification of microorganisms 
(Seng et al., 2009; Gaillot et al., 2011). Although MALDI-TOF MS is mostly used for identification 
of isolates, it has been shown to be applicable to pellets from positive blood culture bottles (after 
lysis of erythrocytes); however, polymicrobial infections cannot be resolved (Prod’hom et al., 2010). 
Since culture-dependent methods are not optimal for identification of all microorganisms a definition 
of new gold standard method is required. However, the best method will vary depending on the goal 
of the investigation, and the best method in a research setting differs from the best method in a 
clinical laboratory, since the latter is restrained by time and cost consideration to a larger extend than 
research. Furthermore, in research it is important to investigate all microorganisms in samples while 
clinical microbiology is more focused on the treatment of the infections.  
4.1.1 From a research perspective  
Investigation of all microorganisms and their interactions in a complex sample can be obtained by a 
number of different methods. For identification of the microorganisms, sequencing (by Sanger 
sequencing and NGS) and subsequent comparison with reference sequences in databases is 
particularly relevant since these results are generally unambiguous. Despite the general agreement of 
the importance and applicability of sequencing, there is no universal consensus on the degree of 
sequences divergence permissible within a species or genus, and the cut-off value is variable and 
depends on the gene target and the microorganism. Sanger sequencing has the distinct disadvantage 
that pure targets are required, which necessitate use of either fingerprinting or clone library 
construction. While fingerprinting may have insufficient resolution, construction of clone libraries is 
very time consuming and labor intensive (Table 2). Although it might be possible to perform Sanger 
sequencing directly on DNA from a mixed microbial community by using the Ripseq algorithm to 
interpret mixed chromatograms, the number of species that can be resolved in a single sample is 
limited. Massively parallel amplicon sequencing by NGS platforms overcome these problems and the 
continued and rapid developments in this field have improved sequence quality, read-length, 
bioinformatic data analysis and reduced costs to a degree that makes the use of such methods very 
attractive compared to Sanger sequencing.  
Currently studies of microbial communities are primarily based on molecular marker genes. A typical 
target for bacterial identification is the 16S rRNA gene, whereas fungal identification does not have 
such a “gold standard gene”, though internal transcribed spacer regions and 28S rRNA genes have 
been shown to be useful for fungal identification (Petti et al., 2011). The use of a single marker 
molecule limits the ability to identify all microorganisms in a sample, since the different DNA 
sequences are competing for the same reagents during PCR. Therefore, species present in low 
concentrations are at risk of not being detected. Also, design of universal primers that targets all 
 
 
23 
 
bacteria is not possible (Baker et al., 2003). For instance, “universal” 16S rRNA primers designed for 
qPCR and frequently used in the literature, can underestimate the total number of bacteria present in 
a sample (article III). The ability to perform sequencing without prior PCR is therefore highly 
relevant in order to study the true microbial diversity in samples, and can be achieved by using NGS. 
Performing whole genome- and metagenome sequencing might offer insights into the potential 
properties of microorganisms in infections and yield information that is clinically relevant. The work 
that is required to translate the sequence information into clinically relevant information (and validate 
the findings) is at present too exhaustive to be applicable in clinical microbiology departments. As 
more microbial genomes and molecular marker genes are sequenced, the value of using microarrays 
to navigate microbial genomes in a high-throughput manner is increased. The value of the 
microarrays lies in the ability to screen multiple samples, and can be used complimentary to NGS 
applications. It is, however, possible that NGS will eventually out-compete microarrays. 
The use of microscopy-based methods can enable investigation of the actual microorganisms, rather 
than their genetic material, and thus be used to obtain relevant information (both in a research setting 
but also in a clinical setting). Using FISH specific microorganisms can be targeted and visualized, 
which can be helpful for detection of the specific target, for investigation of spatial distribution in 
clinical samples or observation of atypical morphotypes. FISH has the advantage that it offers 
increased specificity compared to microscopy with or without staining, where identification of 
microorganisms is based on morphology and chemical or physical properties (Table 2). 
4.1.2 From a clinical perspective  
One goal for clinical microbiology is the ability to screen for panels of probable pathogens, and many 
methods are available to achieve this, including FISH, qPCR and microarrays. FISH has the 
advantage of low cost and limited equipment requirements and can be the fastest way to detect 
microorganisms, although it may require experienced personnel to locate the microorganisms in the 
samples by microscopy. However, the limited sensitivity means that it is only suitable for some 
samples. QPCR may be performed faster than FISH and has a higher sensitivity. Compared to other 
PCR based methods, qPCR is less prone to contamination since there is no post-amplification 
handling, which contributes to the speed of the method. Furthermore, the results can be used 
quantitatively (Table 2). These advantages have meant that qPCR has become the main stay for 
diagnosis of viral infections. Both FISH and qPCR require assumptions to be made regarding the 
identity of pathogens. The choices of primers and probes dictate which microorganisms can be 
detected; and although multiplexing might possible, the capability for this is limited. The principle of 
microarrays is similar and microorganisms are detected by probe hybridization, but use of this 
method reduces the problem of assumption-based detection due to the high degree of multiplexing 
offered by the method (Table 2). Microarrays have been used directly on extracted nucleic acids, 
pooled PCR products from multiple universal genes and products from random PCR (Gerner-Smidt 
et al., 2011). The use of microarrays has been limited due to complexity of array design, and high 
price (both acquisition price and running price due to use of fluorescence staining of target nucleic 
acids). Compared to these methods, the Ibis T5000 biosensor has the advantage that the multilocus 
approach, detection redundancy and base composition determination makes it less dependent on 
assumptions to be made prior to analysis. Furthermore, the commercial available assays for microbial 
identification also include detection of some antimicrobial resistance genes, and the use of an internal 
calibrant makes it possible to obtain quantitative results. The relative novelty of the method does, 
however, mean that the price of this method is high, and validation of the approach is currently not 
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sufficient for implementation in clinical microbiology. Amplicon sequencing, particularly using 
compact NGS platforms, would similarly diminish the need for assumptions of pathogen identity to 
be made prior to analysis. The use of Ibis T5000 biosensor, microarrays and amplicon sequencing 
will allow for more complete analysis of microbial communities. This would offer a sense of 
confidence that the disease causing pathogens has been detected, and might also give an idea of the 
focus of infection that can be clinically relevant. 
Quantitative results are of interest in clinical microbiology, based on the assumption that abundance 
of species is indicative of importance and may be used to evaluate if an antimicrobial treatment has 
worked. Several methods can be used to obtain quantitative results, including FISH, qPCR, 
microarrays and reportedly amplicon sequencing. Generally, quantitative interpretation of data 
obtained after broad-range PCR is problematic due to biases in the PCR amplification, and internal 
calibrants are necessary to obtain reliable quantitative results. Case in point, the abundance of 
amplicon sequences is sometime reported as reflecting the relative abundance of species in a sample 
(Monchy et al., 2011), but comparison of quantitative results by amplicon sequencing, qPCR and the 
Ibis T5000 biosensor indicated that this is not true (article I). A consideration for the use of 
quantitative measurements as an indicator of importance is that, although organisms might be present 
in low numbers they may be highly active or pathogenic and thereby potentially important players in 
infection, indicating that evaluation based on presence in numbers should be done cautiously.  
Commonly used subtyping methods such as MLST and genetic fingerprinting might have insufficient 
resolution. Typing by whole genome sequencing or the Ibis T5000 biosensor offers both a higher 
resolution and can be done quickly, which is particularly important in epidemic outbreaks. Although 
microarrays can be designed for typing of species, their use is more suitable for screening for certain 
species types. Whole genome sequencing represents the ultimate typing method, and this use of NGS 
is readily applicable, but may be restrained to reference laboratories.   
Evaluation of the behavior of microorganisms in a clinical sample (e.g. observation of presence in 
biofilms) is of great importance in clinical microbiology since this can affect the treatment outcome. 
To this end microscopic visualization will continue to be relevant in clinical microbiology setting, 
and use of FISH might improve the results. Generally, the main focus of clinical microbiology is on 
the treatment of infections and therefore the optimal methods in this setting would be the ones that 
can measure if a treatment is functional. Currently, only culture-dependent methods allow for 
antimicrobial susceptibility testing, and although it might be possible to use molecular methods to 
detect antimicrobial resistance genes, this information may not be sufficient. It is quite possible that 
the optimal method would be a combination of culture-dependent antimicrobial susceptibility testing 
with molecular analysis to ensure rapid and sensitive reporting. The initial implementation of 
molecular methods in clinical microbiology has been targeted to specific samples or pathogens, since 
a large part of added value of the methods lies in the ability to analyze culture-negative samples, 
particularly those arisen from administration of antimicrobial treatment. 
The implementation of new methods into clinical microbiology requires extensive validation and 
optimization of robust standardized laboratory protocols, as exemplified by the current paradigm 
change from biochemical testing to chemotaxonomic-based identification (i.e. MALDI-TOF MS). 
This has been driven by the validation and optimization work that has been taking place since the 
1990s, along with development of software packages for data analysis and establishment of 
comprehensive databases (Kliem and Sauer, 2012). This indicates that it might still be several years 
before molecular methods are implemented in clinical microbiology departments.  
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5 Application of molecular methods  
Molecular methods have several applications within the clinical microbiology field, and several cases 
have been published where various molecular methods have been used on samples from different 
types of infections. In the following, the knowledge obtained by using molecular methods to study 
microbial communities in samples from patients with NSTIs, chronic wounds and CF is examined, as 
these types of infections were the central focus of this PhD study.  
5.1 Case: NSTIs 
The group of infections covered by the term NSTI is diverse and includes infections of the skin, 
subcutaneous tissue, fascia or muscle that are associated with necrotizing changes. NSTIs are rare but 
highly lethal infections, requiring rapid diagnosis and treatment (including antimicrobial therapy and 
aggressive surgical debridement) (Anaya and Dellinger, 2007). The gold standard for diagnosis of the 
microorganisms involved in NSTIs is standard culture-dependent methods, despite the rapid 
progression of the disease. Use of molecular methods for identification of microorganisms involved 
in NSTIs is limited in the literature, and the most frequent use of molecular methods is on isolates. 
The typical analyses are sequencing of 16S rRNA gene fragments to confirm finding of uncommon 
pathogens, or subtyping of species by MLST and/or PCR on virulence-, superantigen-, toxin- and 
adhesin genes followed by fingerprinting (Table 3). 
Table 3: Overview of cases where molecular methods have been used on isolates to either confirm 
findings by culture or for typing of species. 
Confirmation of culture by16S rRNA gene sequencing Typing of isolates 
Microorganism Reference Microorganism Reference 
Bacillus cereus (Lee et al., 2010) Klebsiella oxytoca (Oishi et al., 2008) 
Campylobacter rectus (Lam et al., 2011) Klebsiella pneumoniae (Gunnarsson et al., 2009) 
Klebsiella oxytoca (Oishi et al., 2008) Staphylococcus aureus (Miller et al., 2005; Morgan et 
al., 2007; Thuong et al., 2007; 
Changchien et al., 2011) 
Raoultella planticola (Kim et al., 2012) 
Shewanella algae (Myung et al., 2009) 
Sphingobacterium 
multivorum 
(Grimaldi et al., 2012) Streptococcus dysgalactiae 
subsp. equisimilis 
(Kittang et al., 2010) 
Streptococcus dysgalactiae 
subsp. equisimilis 
(Kittang et al., 2010; Nei 
et al., 2012) 
Streptococcus equi subsp. 
zooepidemicus 
(Korman et al., 2004) 
Streptococcus equi subsp. 
zooepidemicus 
(Korman et al., 2004) Streptococcus pneumoniae (Ballon-Landa et al., 2001) 
Streptococcus pyogenes (Demers et al., 1993; Kaul et 
al., 1997; Norrby-Teglund et 
al., 1998; Erdem et al., 2004; 
Hassell et al., 2004; Jing et al., 
2006; Meisal et al., 2008) 
Vibrio vulnificus (Muldrew et al., 2007) 
  
Besides the use of molecular methods for confirmation of culture-based findings and typing of 
isolates, a few studies exist where molecular methods have been used to directly identify 
microorganisms. These include 16S rRNA gene sequencing of isolates that could not be identified by 
conventional methods (Clarke et al., 2010; Bempt et al., 2011). A few studies used molecular 
methods on tissue, including PCR-based methods in cases that gave culture-negative results 
(Muldrew et al., 2005) or as a rapid method for detection of Streptococcus pyogenes (Louie et al., 
1998). Additionally, use of FISH has been reported in two cases; to identify microorganisms 
commonly involved in NSTI (Figure 6) (Trebesius et al., 2000) and to distinguish the more 
pathogenic S. pyogenes from non-group A streptococci (Sing et al., 2001).  
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Figure 6: FISH images of NSTI samples (Trebesius et al., 2000). A: The use of multiple probes means 
that binding of two or more different probes results in mixed colors. B: Patient 2 was found to have S. 
pyogenes (yellow, probes Strpyog-Cy3 and EUB338-FLUOS). C: Patient 3 was found to have 
Pseudomonas aeruginosa (yellow/orange, probes Pseaer-Cy3 and EUB338-FLUOS) and other bacteria 
(green), one with rod (green arrow) and one with a spherical morphology (white arrow). The scale bar 
represents 10 µm. 
By using a combination of PNA FISH and DAPI staining it can be possible to visualize both 
microorganisms and human cells in the infected tissue from NSTI patients (Figure 7) (article I). 
Only few bacteria could be detected in the infected areas and the observed bacteria were located in 
clusters. Conversely the amount of inflammatory cells was high. Observation of both inflammatory 
cells and coagulation indicates that the human hosts are combating the infections. 
The low abundances of bacteria have interesting possible explanations. It might indicate that the 
tissue destruction in large part may be caused by the host immune system. It may also be that the 
antimicrobial treatment administered to the patients before procurement of samples has rendered 
them metabolically inactive, and therefore difficult to detect by FISH. Another explanation might be 
that the pathogens have moved on from the destroyed area. It is, however, also possible that 
microorganisms were present but in concentrations below the detection limit. Further studies are 
needed to determine the cause of the observed low microbial abundance. 
A B
↓
↓
↓
↓
 
Figure 7: Visualization of samples using universal bacteria PNA FISH probe and DAPI staining (article 
I). Few microorganisms (bright red, indicated by white arrows) could be detected in the samples from 
two NSTI patients. A large amount of human host cells were observed (blue). Additionally, in the 
sample from patient 9B (frame A) coagulated blood could be observed (orange, indicated by red arrow), 
which was not observed in sample from patient 8A (frame B). The scalebars represent 15 µm. 
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Use of broad-range PCR based methods for detection of all microorganisms directly in NSTI samples 
has only been published in a single case study (Muldrew et al., 2005). To investigate the applicability 
of such methods for rapid identification of NSTI pathogens, total DNA from samples from 10 NSTI 
patients were investigated by direct rRNA gene Sanger sequencing, construction of near full-length 
16S rRNA gene clone libraries and the Ibis T5000 biosensor. The findings by molecular methods 
were compared with culture results obtained as a part of routine diagnostic of the patients (article I).  
Identification of microorganisms based on culture-dependent methods was confirmed by all the 
applied molecular methods in 35% of the investigated samples. For the remaining samples, molecular 
methods either found partial concordance of the results (molecular methods typically identified 
additional microorganisms) or gave discrepant results (due to negative culture reports) (Table 4). 
Table 4: Overview of the microorganisms found in 20 tissue samples obtained from 10 NSTI patients by 
culture-dependent methods and molecular methods (DS: direct Sanger sequencing, CL: clone libraries 
and Sanger sequencing and I: Ibis T5000 biosensor) (article I). 
Sample Culture Molecular methods  
Concordance of results 
1A Streptococcus pyogenes Streptococcus pyogenes
DS, CL, I
 
1B Streptococcus pyogenes Streptococcus pyogenes
DS, CL, I
 
1C Streptococcus pyogenes Streptococcus pyogenes
DS, CL, I
 
1D Streptococcus pyogenes  Streptococcus pyogenes
DS, CL, I
 
2A Streptococcus pyogenes Streptococcus pyogenes
DS, CL, I
 
2B Streptococcus pyogenes Streptococcus pyogenes
DS, CL, I
 
4A* Streptococcus sp. Streptococcus pyogenes
DS, I
, Streptococcus didelphis
I
  
8A* Streptococcus pneumoniae Streptococcus pneumoniae
 DS, I
 
8B* Streptococcus pneumoniae Streptococcus pneumoniae
 DS, I
 
9A Streptococcus pyogenes Streptococcus pyogenes
DS, CL, I 
9B Streptococcus pyogenes Streptococcus pyogenes
DS, CL, I
 
10A Negative Negative
DS, CL, I
 
10B Negative Negative
DS, CL, I
 
Partial concordance of results 
3A Acinetobacter baumanii  Acinetobacter baumanii
CL, I
, Streptococcus pyogenes
DS 
5A Clostridium paraputrificum, Bacteroides 
fragilis 
Clostridium paraputrificum
CL, I
, Bacteroides fragilis
I
, 
Streptococcus agalactiae
I
, Streptococcus pyogenes
DS
, 
Uncultured bacterium
CL
  
6A* Streptococcus pyogenes, Escherichia coli Streptococcus pyogenes
DS, I
, Escherichia coli
I
, Mycoplasma 
hominis
DS
, Bacteroides fragilis
I
, Staphylococcus epidermidis
I
, 
Staphylococcus hominis
I
, Cladosporium cladosporioides
I 
7A* Fungus Candida albicans
I
, Mycoplasma spp.
 DS, I
, Fusobacterium 
necrophorum
DS, I
 
Discordance of results 
4B Negative Streptococcus pyogenes
DS, CL, I
 
7B Negative Mycoplasma salivarium
DS, CL
, Mycoplasma spp.
 I
, 
Fusobacterium necrophorum
CL, I
 
8C* Negative Streptococcus pneumoniae
 DS, I
 
Samples marked with * were analyzed by 16S rRNA amplicon sequencing to evaluate the findings of the 
other methods. 
The findings in six samples were evaluated by amplicon sequencing of 16S rRNA gene fragments 
using the Roche 454 pyrosequencing platform (Figure 8). These samples were from all three groups 
of results (concordant, partial concordant and discordant). For four of the samples (patient 4A, 8A, 
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Relative abundance 
8B and 8C) the amplicon sequencing confirmed the findings by the other molecular methods. For the 
remaining two samples, amplicon sequencing revealed additional microorganisms (in patient 6A 
these were Peptoniphilus sp. and Porphyromonas sp., in patient 7A it was Prevotella sp. and Sharpea 
sp.). The findings of Candida albicans and Cladosporium cladosporioides by Ibis T5000 biosensor 
could not be confirmed, since these were not targeted by 16S rRNA gene based methods.  
 
 
 
 
 
 
  
Figure 8: The taxonomic groups identified by 16S rRNA amplicon sequencing. The stacked graph 
illustrates the relative abundance of each taxon (color coded according to the key). 
These results indicate that use of molecular methods may be valuable diagnostic tools for 
identification of microorganisms in NSTIs. 15% of the samples were found to be culture-negative 
although microorganisms could be identified with the molecular methods. Interestingly, all these 
samples originated from patients where other samples taken from different places in the infection 
sites resulted in identification of microorganism by culture. Furthermore, the molecular methods also 
identified microorganisms that were not registered in the culture reports for 20% of the samples, 
which together with the reduced turnaround time that can be obtained by some of the molecular 
methods may be relevant for the fulminant NSTIs. 
5.2 Case: Chronic wounds  
Chronic wounds are a major and ever increasing healthcare problem and a contributing factor in 
hundreds of thousands of annual deaths (Dowd et al., 2008; Sen et al., 2009). There are three major 
types of chronic wounds defined by the predisposing condition of the patient: venous leg ulcers, 
diabetic foot ulcers, and pressure ulcers (Dowd et al., 2008). The wound environment is ideal for 
microbial growth due to tissue necrosis which provides ample nutrients (Bowler et al., 2001).  
Some studies exist where the microbial findings by culture-dependent methods are compared with 
the findings by molecular methods, such as 16S rRNA gene analysis (by fingerprinting and Sanger 
sequencing, cloning and Sanger sequencing, and amplicon sequencing using NGS platforms) and Ibis 
T5000 biosensor. The studies showed that molecular methods detect a greater microbial diversity 
than culture no matter which molecular method was used (Figure 9). The larger diversity found by 
the molecular methods is both due to ability to detect microorganisms that are not found by culture, 
but also because the molecular methods were able to distinguish between different species or genera 
of microorganisms where culture-dependent methods might only be able to identify certain groups or 
families. The number of species found in the studies varied depending on the number of samples 
included in the studies, suggesting that the microbial flora of individual patients varied greatly.  
 
Phylum Identity
Bacteroidetes Porphyromonas  sp.
Prevotella baroniae
Prevotella tannerae
Bacteroides fragilis
Firmicutes Streptococcus pyogenes
Streptococcus pneumoniae
Peptoniphilus sp.
Fusobacteria Fusobacterium necrophorum
Tenericutes Sharpea  sp.
Tericutes Mycoplasma hominis
Mycoplasma  sp.
Key
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Figure 9: Overview of studies where identification of microorganisms by culture-dependent methods is 
compared with various molecular methods. The number of species detected by each method is seen 
(color coded according to the key). Article V, (Hill et al., 2003), (Dowd et al., 2008) and (Tuttle et al., 
2011) are studies of chronic venous leg ulcers, while (Price et al., 2009) and (Frank et al., 2009) are 
studies of chronic wounds with various predisposing conditions. N= the number of wounds included in 
the studies. 
A factor contributing to the lower microbial diversity found by culture-dependent methods may be 
the formation of biofilms within chronic wounds, which is increasingly being appreciated as an 
important part of the pathogenesis. It is hypothesized that the wounds are kept chronic by the 
bacterial burden (Bjarnsholt et al., 2008; Martin et al., 2010). The first indications of presence of 
biofilm was obtained by PNA-FISH studies, where large microcolonies of microorganisms 
surrounded but not penetrated by human host cells (most likely polymorphonuclear neutrophilic 
leukocytes (PMNs)) were observed (Bjarnsholt et al., 2008) (article V). Further studies using 
alginate-specific immunostaining, showed that the microcolonies were imbedded in a self-produced 
alginate matrix (Kirketerp-Moller et al., 2008). Studies using FISH to investigate the distribution of 
microorganisms and host immune cells, have been published (Fazli et al., 2009, 2011), along with 
studies of competition between different species within in vitro biofilms (Malic et al., 2009; Pihl et 
al., 2010). These competition studies showed that Pseudomonas aeruginosa could outcompete other 
microorganisms, especially if the P. aeruginosa strains showed reduced expression of certain 
virulence factors, which has been linked with enhanced persistence in the chronic wound 
environment (Malic et al., 2009; Pihl et al., 2010).  
Physiological conditions can vary spatially within a wound and create diverse microenvironments 
that may support different microbial communities. For instance, the surface of a wound seems to 
support different microbial flora than the deeper wound layers (Fazli et al., 2009; Malic et al., 2009). 
Furthermore, studies investigating the spatial distribution of microorganisms within individual 
wounds using molecular methods have indicated that microbial flora also varies across the entire area 
of the wounds (article V) (Andersen et al., 2007; Wolcott et al., 2009; Price et al., 2011; Wolff et al., 
2011). These studies used sampling of small discrete locations within wounds, as illustrated in Figure 
10. 
Method
Culture
Fingerprinting and Sanger sequencing
Cloning and Sanger sequencing
Amplicon sequencing
Ibis T5000 Biosensor
Key
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Figure 10: Sampling procedure to investigate spatial localization of microorganisms by molecular 
methods. Picture obtained from (Cunningham et al., 2010), and edited to illustrate sampling procedure 
from article V. Samples used by Andersen et al. (2007), Wolcott et al. (2009) and Price et al. (2011) 
included center of the wound (C), and two opposing edges of the wound (e.g. position 3 and 9). 
In addition to showing different microbial flora at discrete sites inside wounds, it was shown that the 
relative abundance of individual microorganisms also varied at different sites in the individual 
wounds (article V) (Wolcott et al., 2009). The findings indicate how important appropriate sampling 
is to fully characterize the global wound ecology. However, an ideal sampling method has not been 
established yet and is a matter of continued debate. It has been suggested that swabs of wound 
surface are inaccurate. Culture-based investigations have shown that the yield of anaerobes in swabs 
are lower than that found by biopsies (Davies et al., 2007) and that anaerobes in the wound beds may 
be implicated in mediation of chronicity of the wounds (Wall et al., 2002; Stephens et al., 2003). A 
study using qPCR to investigate swabs and biopsies taken during the healing process showed that the 
number of microorganisms decreased in biopsy samples as the wounds healed, whereas no significant 
decrease could be found in swab samples, indicating that positive swabs may indicate just the 
presence of colonizing microorganisms (Gentili et al., 2012).  
The identity of microorganisms present in wounds and the effect on wound healing is difficult to 
assess. Studies comparing the microbial communities in healing and non-healing chronic venous leg 
ulcers have been performed using 16S rRNA fingerprinting and Sanger sequencing (Davies et al., 
2004) and 16S rRNA amplicon sequencing and the Ibis T5000 biosensor (Tuttle et al., 2011). 
Although both studies found differences in the incidence of specific microorganisms between the two 
patient groups, the findings in the two studies were not concordant. The evidence from the literature 
on various chronic wounds is that all wounds are colonized with microorganisms, and differentiating 
colonizers from invading microorganisms is difficult. Individual wounds have unique profiles of 
microorganisms, and the spatial distribution of the microorganisms within individual wounds is 
heterogeneous. This suggests that each wound has to be carefully evaluated, with sampling covering 
all of the wound area, and that no single pathogen is likely to be the causative agent of such 
infections. 
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5.3 Case: CF 
“Anyone who reviews the literature on cystic fibrosis and isn’t confused, is confused” 
-Dr. Efraim Racker, 1985  
CF is an intensively studied disease, which has increased the knowledge of the disease and resulted 
in an increase in life expectancy for CF patients. However, the immense literature on the subject can 
also tend to confuse the understanding of the infections that occur in CF patients. The genetic 
disorder that causes CF affects several organs. The most severe effect is on the lungs, and respiratory 
failure accounts for most premature deaths of CF patients (Quinton, 1999; Conese et al., 2003; 
Parsek and Singh, 2003). Nasal and sinus inflammation is a frequent condition in patients with CF 
and most CF patients are thought to have sinus infections (Gysin et al., 2000; Rasmussen et al., 
2012). However, since the symptoms of sinus infections are less problematic than the symptoms of 
lung infections, the reported incidences are relatively low (Mainz et al. 2009; Robertson et al. 2008) 
5.3.1 Lung infections 
The classical understanding of CF pathogens is concerned with a few microorganisms that dominate 
the culture findings. These belong to the Pseudomonas, Staphylococcus, Burkholderia and 
Haemophilus genera, while other microorganisms (including fungus, Gram negatives, 
Achromobacter, Streptococcus and Mycobacterium spp.) are less common findings (Figure 11). 
 
Figure 11: Bacterial genera recovered from CF sputum during 28 years of culture-dependent 
identification at the Southern Alberta Cystic Fibrosis Clinic (Alberta, Canada). The proportional 
abundance of each genus is depicted with solid circles (Sibley et al., 2011). 
The CF patients experience repeated lung infections that eventually develop into chronic infections. 
In the classical view of the development of disease, the key pathogens Staphylococcus aureus, 
Haemophilus influenzae and Streptococcus pneumoniae are considered mainly as causing recurring 
intermittent infections, whereas P. aeruginosa and members of the Burkholderia cepacia complex 
mainly are considered as causes of chronic infections (Høiby, 1982; Gilligan, 1991). It is now 
generally accepted that chronic infections of CF lungs persist due to formation of biofilms. The early 
indications of the involvement of biofilm was the isolation of mucoid strains of P. aeruginosa from 
CF patients (Doggett et al., 1964) and microscopy studies of CF lung tissue showing that the 
microorganisms reside in EPS-enclosed microcolonies within the airway lumen (Lam et al., 1980; 
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Worlitzsch et al., 2002). Since then, the biofilms produced in the lungs of CF, particularly by P. 
aeruginosa, have become one of the most intensively studied clinical biofilms (Costerton et al., 
1999). Findings by FISH suggest that the spatial distribution of P. aeruginosa within sputum depends 
on whether the strain was mucoid or non-mucoid. Aggregated P. aeruginosa cells appear to be 
mainly the mucoid type (Yang et al., 2008). These aggregated microorganisms are protected from the 
phagocytic action of PMNs, leaving the biofilm surrounded by PMNs, which has been shown for in 
vitro biofilms, and confirmed in lung tissue samples by FISH (Bjarnsholt et al., 2009). Establishment 
of biofilms and hence chronic infections may be delayed by administration of aggressive 
antimicrobial therapy, which can eradicate intermittent infections caused by planktonic pathogens. 
However, once a chronic infection has been established it cannot be eradicated (Høiby et al., 2005). 
Various molecular methods have been used to investigate the microorganisms involved in CF lung 
infections. Until 2003 molecular methods were primarily used on isolated microorganisms and aimed 
towards typing of pathogenic strains or detection and identification of specific microorganisms, 
typically isolates that were difficult to identify by phenotypic investigations. Molecular methods are 
still being used on isolates for typing of strains (e.g. Segonds et al., 2009; Grinwis et al., 2010; 
Mortensen et al., 2011; Nicoletti et al., 2011; Waters et al., 2012) and identification of 
microorganisms by methods such as MALDI-TOF MS (Degand et al., 2008; Fernández-Olmos et al., 
2012; Marko et al., 2012; Masoud-Landgraf et al., 2012) and 16S rRNA gene sequencing. 16S rRNA 
gene sequencing has been used in cases of misidentification of isolates or inconclusive culture 
reports. For instance, the phenotypic identification of Gram negative, oxidase-positive rods 
(including non-typical P. aeruginosa) and anaerobes carries a high risk of misidentification due to 
their marked phenotypic diversity (Qin et al., 2003; Wellinghausen et al., 2005; Tunney et al., 2008; 
Kidd et al., 2009; Field et al., 2010). Other cases where 16S rRNA gene analysis has proven useful 
are in the identification of unusual microorganisms such as Inquilinus sp. (Chiron et al., 2005), 
Herbaspirillum sp. (Spilker et al., 2008), Pandoraea sputorum (Pimentel and MacLeod, 2008), 
Segniliparus rugosus (Butler et al., 2007), Brevundimonas diminuta and Ochrobactrum anthropican 
(Menuet et al., 2008). 
Over the past decade, the use of molecular methods without prior isolation by culture, has led to the 
view that CF airways contain complex polymicrobial communities (Zemanick et al., 2011). The early 
studies of diversity in sputum samples relied on clone hybridization or genetic fingerprinting 
methods (van Belkum et al., 2000; Kolak et al., 2003; Rogers et al., 2003, 2004, 2006). Of the 
fingerprinting methods only T-RFLP is still frequently used today (Rogers et al., 2009; Spasenovski 
et al., 2009; Sibley et al., 2011; Stressmann et al., 2011, 2012), but most studies of the microbial 
community in CF lungs use sequencing of the 16S rRNA genes (by cloning and Sanger sequencing 
or amplicon sequencing) (Bittar et al., 2008; Armougom et al., 2009; Guss et al., 2011; Sibley et al., 
2011; Stressmann et al., 2011; van der Gast et al., 2011; Delhaes et al., 2012; Zhao et al., 2012). 
Although it is often stated in the literature that molecular methods identify more species than the 
classical CF pathogens found by culture-dependent methods, few studies directly compare findings 
by culture and molecular methods on samples from the same patients (Figure 12). 
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Figure 12: Comparison of studies where detection of species by culture is compared with various 
molecular methods targeting the 16S rRNA gene. The number of species detected by each method is 
seen (color coded according to the key). The studies by Kolak et al. (2003), Bittar et al. (2008), Guss et al. 
(2011) and Stressmann et al. (2012) were of CF sputum samples, while Article II was of tissue and 
sputum excised from explanted CF lungs. N= the number of samples included in the studies. 
Direct comparison of the results by culture and molecular methods clearly shows that the latter 
identified a larger number of microorganisms. It is, however, possible that this discrepancy can be 
minimized by using more extensive culture approaches (Sibley et al., 2011). Generally, the mean 
number of species per sputum sample is reported to be around 3 fungi (Delhaes et al., 2012) and 5-7 
bacteria (Harris et al., 2007; Bittar and Rolain, 2010; Rogers, Skelton, et al., 2010; Stressmann et al., 
2011; Delhaes et al., 2012). However, some studies have found a higher number of species using T-
RFLP (Sibley et al., 2008), microarrays (Klepac-Ceraj et al., 2010), and amplicon sequencing (Guss 
et al., 2011; Zhao et al., 2012).  
Routine culture-dependent detection of supposed CF pathogens is carried out on sputum and throat 
samples produced by the CF patients. Such secretions are nearly always contaminated by microbes 
from the pharynx and mouth, where aerobic, facultative, and anaerobic bacteria are part of the normal 
flora, but these contaminants are normally filtered from the culture results (Høiby and Frederiksen, 
2000). These types of samples are the most frequently used in the molecular studies of microbial 
communities involved in CF lung infections, and these results are typically not filtered to remove 
possible contaminants, which may explain some of the discrepancies in the results by the two types 
of methods (Goddard et al., 2012). Some authors claim that the potential contamination of sputum 
and throat samples is not significant (Rogers et al., 2006) or that contaminating saliva can be 
removed from the sputum sample by a series of washing steps (Rogers et al., 2006; Guss et al., 
2011). In a study comparing samples from explanted lungs with throat and sputum samples from the 
same patients before lung transplantation, differences in microbial communities were observed. The 
throat and sputum samples contained non-typical microorganisms, which were not found in the 
explanted lungs (Goddard et al., 2012). Likewise, a study using 16S rRNA gene amplicon 
sequencing to study the microbial diversity in chronic obstructive pulmonary disease of non-CF 
patients, indicated that sputum and throat samples were not representative of the lower bronchial 
mucosa flora (Cabrera-Rubio et al., 2012). Further indications of the problems connected with the 
use of sputum samples for investigation of lower airway infection is the finding of a heterogeneous 
distribution of microorganisms in different areas of the lungs, as determined by 16S rRNA gene 
amplicon sequencing of tissue from different areas of CF lungs (Goddard et al., 2012; Willner et al., 
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2012). Investigation of the microorganisms in sputum samples using PNA FISH, have additionally 
shown that the different microorganisms cluster together in distinct, largely monomicrobial 
aggregates (article III) (Figure 13). This further add to the spatial diversity found in the CF lungs, 
and since the monomicrobial aggregates were not found to be in direct physical contact with each 
other the biofilm infections may be monomicrobial despite the overall polymicrobial nature of the 
infection, which can have implications on treatment of CF lung infections.  
 
Figure 13: PNA FISH images of bacterial aggregates in expectorated sputum of non-end stage CF 
patients (article III). The aggregates within the sputum were largely monomicrobial and segregated 
from each other. A: S. aureus (red) and other bacterial species (green), B and C: P. aeruginosa (red), 
and other bacteria (green). 
Visualization of microorganisms in lung tissue have shown that microorganisms are found in 
biofilms in the conductive zone of the lungs, and only rarely in the respiratory zone (where they exist 
as planktonic cells that can be eradicated by the high number of professional phagocytes) (Bjarnsholt 
et al., 2009; Ulrich et al., 2010). The lack of microorganisms in the respiratory zone has been linked 
to the adoption of an aggressive, chronic suppressive antimicrobial treatment strategy, where the 
antimicrobial agents may be able to eradicate the planktonic cells (Bjarnsholt et al., 2009). Use of 
FISH is valuable for analysis of CF samples, since normal microscopy might not be informative for 
the biofilm residing microorganisms that are encountered in the CF lungs (Bjarnsholt et al., 2011). 
To distinguish common CF pathogens in the samples, several FISH probes have been developed 
(Hogardt et al., 2000; Wellinghausen et al., 2006; Brown and Govan, 2007).  
Many of the additional microorganisms identified by molecular methods are anaerobes or species 
that have not previously been isolated from CF sputum, making the list of microorganisms associated 
with lung infection of CF patients ever increasing (as reviewed elsewhere, e.g. Bittar and Rolain, 
2010). The different reports of microorganisms involved in CF lung infection may not be directly 
comparable due to several factors. Firstly, it has been reported that the type of CFTR mutations can 
affect the observed microbial community, due to different effects on the lung environment by 
different mutations (Cox et al., 2010; Klepac-Ceraj et al., 2010). Secondly, the microbial findings in 
different parts of the world may not be comparable due to differences in treatment regimes and 
exposure to different microbes. This has been suggested by differences in detection of P. aeruginosa 
and B. cepacia complex by culture in Toronto, Canada and Copenhagen, Denmark (Johansen et al., 
1998) and supported by investigation of bacterial communities in the lungs of American and British 
CF patients using molecular methods, where the majority of species were uniquely found in one 
geographical location (Stressmann et al., 2011).  
It has been suggested that certain abundant species are core to CF lung infections by adulthood (i.e. 
in chronic lung infections) (Stressmann et al., 2011; van der Gast et al., 2011). In the study by van 
der Gast and coworkers (2011) the core group primarily consisted of species from the oral flora, and 
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P. aeruginosa was the only traditional key CF pathogen assigned to this group, the remaining 
traditional CF pathogens were found to be a part of the satellite group. Although the finding of core 
species may have implications on our understanding of CF, any species present in the CF airways 
might be important. Interestingly, several studies have found a tendency of less complex microbial 
communities in the lung of older or deceased CF patients, which is correlated with deterioration of 
lung function (article II and III) (Cox et al., 2010; Klepac-Ceraj et al., 2010; van der Gast et al., 
2011; Goddard et al., 2012; Stressmann et al., 2012; Willner et al., 2012; Zhao et al., 2012). This 
loss of diversity indicates that remaining microorganisms were competitively dominant and 
extremely well suited to the conditions in the CF lungs due to selection during the course of long-
term infection and antimicrobial selection (Cox et al., 2010; Yang, Jelsbak, et al., 2011; Hogardt and 
Heesemann, 2012). Adaptation of pathogens to the CF lung environment has been studied for 
Burkholderia dolosa (Lieberman et al., 2011), Burkholderia cenocepacia (Madeira et al., 2011), S. 
aureus (Goerke and Wolz, 2004, 2010; McAdam et al., 2011), Stenotrophomonas maltophilia 
(Pompilio et al., 2011) and P. aeruginosa. The latter has been extensively studied, also by advanced 
methods such as genome sequencing (Smith et al., 2006; Yang, Jelsbak, et al., 2011; Rau et al., 
2012) and microarrays (Ernst et al., 2003; Huse et al., 2010; Rau et al., 2010; Warren et al., 2011; 
Yang, Jelsbak, et al., 2011; Yang, Rau, et al., 2011).  
Some concern has been raised whether the microorganisms found by molecular methods are active or 
if detection were due to extracellular DNA or dead cells. This is a concern for use of molecular 
methods in all types of samples, but particularly in the CF lungs, where the disease means that 
material is not cleared quickly (Rogers et al., 2008). Use of reverse transcription and T-RFLP has 
indicated that many of the identified microorganisms were metabolically active, although differences 
between detected microorganisms and metabolically active microorganisms were found (Rogers et 
al., 2005). The results of this study also indicated that although some microorganisms may be present 
in low numbers, they may be highly active, for instance members of the B. cepacia complex (Rogers 
et al., 2005, 2009). It is, however, possible that such methods impair detection of microorganisms 
that are present but fail to grow due to the intense immune response and antimicrobial therapy 
(Goddard et al., 2012). Using propidium monoazide pretreatment it has been shown that DNA from 
nonviable bacteria can influence the microbial flora detected by molecular methods (Rogers et al., 
2008; Rogers, Marsh, et al., 2010; Stressmann et al., 2012). 
Although the main focus of CF research has been on lung infections as a cause for the inflammation 
that results in respiratory failure, it is debated whether inflammation might also be is directly linked 
to the mutations that cause the disease (Machen, 2006; Ulrich et al., 2010).  
5.3.2 Sinus infections 
The microbiology of CF sinuses has primarily been investigated by culture-dependent methods, and 
the most frequently found microorganisms are known CF pathogens (Table 5). 
Studies where the microbial flora of sinuses and lungs (sputum and throat samples) have been 
compared have shown correlation in the identified microorganisms from these two distinct anatomic 
sites (Dosanjh et al., 2000; Holzmann et al., 2004; Roby et al., 2008; Mainz et al., 2009). In younger 
CF patients the correlation tendency is not as strong (Muhlebach et al., 2006; Bonestroo et al., 2010). 
A few pathogens are primarily recovered from only one habitat. From sinuses these include 
coagulase-negative staphylococci, Corynebacterium and Moraxella sp., whereas pathogens more 
frequently recovered from the lungs include fungus and S. maltophilia (Mainz et al., 2009). 
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Table 5: The microorganisms identified by culture in studies of CF sinuses (an x indicates that the 
microorganism was found in at least one case in the study). 
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The findings by Mainz et al., (2009) have been shortened to fit this table; however, the most frequently 
found microorganisms are included here. 
The finding of a correlation between microbial flora in sinuses and lungs indicates that cross 
infection between the upper and lower airway occurs. This has been supported by genetic typing of 
isolates (primarily P. aeruginosa but in some cases also S. aureus isolates) using pulsed field gel 
electrophoresis (Muhlebach et al., 2006; Johansen et al., 2012) and single nucleotide polymorphism 
microarrays (Mainz et al., 2009; Hansen et al., 2012), where genotypically identical isolates were 
found in the sinuses and lungs. The sinuses may act like a protective niche for the microorganisms. 
This is both because the sinuses do not have a PMN dominated inflammation like the lungs (probably 
due to differential immunoglobulin distributions (Johansen et al., 2012)), and the fact that many sinus 
microorganisms are not eradicated by antimicrobial therapy, although the isolates show susceptibility 
towards the antimicrobial agents (Shapiro et al., 1982; Hansen et al., 2012). Development of sinus 
infection early in life and findings of the same species in lung infections later in life suggest that the 
microorganisms migrate from the sinuses to the lower airways (Roby et al., 2008). Furthermore, a 
longitudinal study of genetic and phenotypic profiles (including colony morphology, motility, 
quorum sensing, biofilm formation and antimicrobial susceptibility) of P. aeruginosa isolates from 
sinuses and lungs of CF patients, suggests that the bacteria in the sinuses diversify and evolve into 
phenotypes that are well adapted to the CF lungs. These bacteria intermittently colonize the lungs and 
may ultimately cause chronic lung infection (Hansen et al., 2012). One of the adaptations that occur 
in the sinuses might be the ability to live under anaerobic conditions, since the microenvironments in 
the sinuses shown oxygen depletion due to mucous obstruction of sinuses (Aanaes et al., 2011). The 
left and right sinuses may have different oxygen tension values, which correlates to the finding of 
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different microbial flora (Aanaes et al., 2011) and distinct morphotype populations of strains in the 
two sinuses (Hansen et al., 2012). 
Presence of microorganisms in the sinuses may account for the recurrent lung infections after 
antimicrobial eradication and is a concern for lung transplant patients, since it is possible that the 
lung allograft become re-colonized with pathogens from the sinus reservoir. This has been supported 
by genotyping of isolates before and after lung transplantation which indicated that there is little or 
no difference in the microbial population (Walter et al., 1997). Sinus surgery combined with 
postoperative daily nasal washing may be a way to treat chronic sinus infections and avoid re-
colonization of the lung allografts (Holzmann et al., 2004; Vital et al., 2012), although some authors 
do not find an effect of such treatments (Leung et al., 2008; Osborn et al., 2011). Patients attending 
the Copenhagen CF center are offered sinus surgery to delay or prevent re-colonization of the 
transplanted lung within one year after transplantation.  
The literature contains no studies where the microbial flora of CF sinuses has been directly evaluated 
by broad range PCR-based methods. The findings in article IV indicate that the microbial 
complexity in samples obtained by sinus surgery may be much greater than suggested by culture-
dependent methods (Figure 14).  
 
Figure 14: Overview of the number of species found in the sinuses of 19 Danish CF patients (article IV). 
The microorganisms were either identified only by culture (blue), only in the 16S rRNA gene clone 
libraries (yellow) or by both methods (green). In one case (a) the finding by culture was probably 
misidentified (result was Bordetella bronchiseptica, which has high phenotypic affinity to A. xylosoxidans 
which was found in the clone library). 
Only in approximately half of the cases did culture and 16S rRNA clone libraries identify at least one 
common microorganism and generally the clone libraries identified a more diverse microbial 
community than culture. Although this may indicate that such molecular methods are more sensitive 
than culture-dependent methods, the culture reports did not include species that were deemed to be 
contaminants. Also, since the sample volume was greater for culture-dependent methods than 
molecular methods, it is possible that observed differences stem from variations in spatial 
distribution.  
Although no other studies have investigated the microbial flora of CF sinuses by broad-range PCR 
based methods, there are several studies where such methods have been applied to chronic sinusitis 
samples of non-CF patients. These studies have shown a greater microbial diversity and more 
frequent involvement of fungus and anaerobes by using methods such as specific (multiplex) PCR, 
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16S rRNA gene cloning with Sanger sequencing and the Roche 454 pyrosequencing platform 
compared with culture (Hendolin et al., 2000; Keech et al., 2000; Ramadan et al., 2002; Kalcioglu et 
al., 2003; Paju et al., 2003; Stephenson et al., 2010). Also, studies of non-CF patients were the first 
to show that chronic sinusitis may be caused by biofilm formation, which has implications the 
understanding of sinus infections in both non-CF and CF patients (Cryer et al., 2004; Perloff and 
Palmer, 2004; Ramadan et al., 2005; Sanclement et al., 2005; Sanderson et al., 2006). 
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6 Conclusions and perspectives 
The objective of this PhD project was to evaluate if alternative methods to culture-dependent 
techniques can give relevant information in a clinical setting, and be used as a supplement or 
replacement for culture-dependent methods. Identification by culture-dependent methods have well-
publicized difficulties for some microorganisms, for instance cells exhibiting the effects of 
antimicrobial therapy and might not be suitable for a number of microorganisms due to the limited 
number of conditions used for testing in clinical microbiology.  
Overall, the various alternative methods had different limitations and disadvantages, and their use 
depend on the subject matter of investigation.  
It is possible to quickly screen for pathogens by microarrays, qPCR and Ibis T5000 biosensor. FISH 
can also be used for this purpose, but it might be time consuming to locate microorganisms in clinical 
samples, especially if the abundance is low. The multiplexing capabilities of particularly microarrays 
and Ibis T5000 biosensor mitigate the inherent problem that only targeted species will be detected. A 
further advantage of the Ibis T5000 biosensor is that antimicrobial resistance genes can be detected 
and sequence variability can be analyzed.  
Sequencing of molecular marker genes and indeed entire genomes, allows for identification of 
microorganisms that may not be targeted by the standard culture-dependent methods. Sanger 
sequencing is increasingly outcompeted by NGS, in large part because the requirement of pure target 
DNA molecules makes Sanger sequencing too labor intensive. Furthermore, the ability to perform 
genome sequencing constitutes the ultimate typing method, and will surely take over for MLST and 
other similar subtyping methods in epidemiological studies. Continued developments and 
improvements of NGS platforms is associated with rapidly falling cost and turnaround time, and 
makes it plausible that deep amplicon sequencing and whole genome sequencing will be used in 
clinical microbiology laboratories in the near future.  
A problem of molecular methods is the requirement of unbiased nucleic acid extraction, which is 
currently not possible. This is not an issue using microscopy-based techniques, where the 
microorganisms can be observed directly within the clinical sample, though the detection limit is 
generally high. Microscopy can be used to obtain clinically relevant information and is for instance 
the only sure way to establish presence of biofilms. 
Molecular methods were found to add value to microbial analysis of all the infection types 
investigated in this thesis. 
For NSTIs it was possible to identify microorganisms despite administration of antimicrobial agents. 
Although positive culture results were confirmed by the molecular methods, additional species were 
generally also found, and uncommon findings were made. By using a broad spectrum of molecular 
methods, it was found that various methods might give differing results, and indicated that direct 
Sanger sequencing may be more inclined to fail in identifying the microorganisms that were truly 
present. The infected tissue from NSTI patients were found to contain few detectable metabolically 
active bacteria, but showed high amount of inflammatory cells and coagulated blood, indicating an 
active immune responses. The more rapid diagnosis that can obtainable by some of the used 
molecular methods is of clinical importance in fulminant infections such as NSTI (article I). 
For chronic CF lung infections the use of molecular methods on explanted lung tissue indicated the 
infections in end-stage patients were dominated by a single species and that culture analysis of 
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sputum samples could identify the dominant microorganisms. Comparison of the findings in 
transplanted end-stage patients with non-end-stage patients indicated a link between low microbial 
diversity and high pathogenicity. Spatial investigations of sputum from the chronically infected, but 
non-end-stage patients showed that although the lung infections were polymicrobial, the associated 
biofilm aggregates were monomicrobial and spatially segregated from other species (article II and 
III). The sinuses of CF patients are generally also infected, and the microorganisms residing in the 
sinuses have been implicated in the recurrent lung infections after successful antimicrobial treatment, 
and establishment of lung infections in lung-transplanted CF patients. By using molecular methods a 
large microbial diversity was found in the sinuses, which included common CF pathogens, 
environmental species and anaerobes. Comparatively the diversity found by culture-dependent 
methods was low. The microorganisms detected by the molecular methods were probably live cells 
(since DNA had been extracted using MolYsis pretreatment), but the clinical relevance of the diverse 
microbial communities in the sinuses is presently unclear (article IV). 
Using molecular methods to investigate the microbial communities in chronic venous leg ulcers 
further underlined the ability of the methods to identify a greater diversity than culture-dependent 
methods, but again indicated that different methods may give different results. Interestingly, by 
sampling different areas inside two wounds it was found that the microbial communities in these 
areas varied. Furthermore, it was shown that the abundance of individual species also varied in the 
different areas. This finding has direct implications on the sampling procedure used for such wounds, 
since a biopsy taken from a single location in the wound probably does not represent the true 
microbial community (article V). 
In an exploratory study of suspected prosthetic joint infections, approximately two thirds of the cases 
gave concordant results by culture-dependent and molecular methods. This was primarily caused by 
concordant negative results. In the remaining cases molecular analysis generally identified 
microorganisms that could not all be found by culture. One of the reasons for discrepancy was that 
incubation time was insufficient for growth of fastidious microorganisms such as P. acnes. 
Visualization of samples from prosthesis surface indicated that biofilm formation may be involved in 
prosthetic joint infections, which could influence the ability to detect microorganisms by culture-
dependent methods (article VI). 
This PhD project has shown that molecular methods can be used to derive information that is relevant 
in the clinical setting and may impact the outcome for patients. The findings have had a direct 
influence in the clinical setting, both by indicating that single biopsies from chronic wounds is not a 
suitable sampling method and culture-dependent analysis of prosthetic joint infections should be 
extended to allow for growth of for example P. acnes. The studies conducted in this PhD have also 
contributed in convincing medical professionals of the added value that can be gained by use of 
molecular methods. What has also become clear is that the various molecular methods can yield 
different results, and that further studies are needed in order to determine a universal method for 
identification of microorganisms in infections.  
For the time being the majority of microorganisms in the clinical microbiology departments will 
continue to be identified using culture-dependent methods, as these are readily available, often 
adequate and allows for antimicrobial susceptibility testing. The latter is a crucial point, and huge 
incentive to continue the use of culture-dependent methods. Although it is possible to predict 
potential for antimicrobial resistance based on presence of resistance genes, this might not be 
informative about the susceptibility of the microorganisms.  
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From a research standpoint the possibility of investigating the entire microbial community in depth is 
highly desirable in order to gain a complete understanding of the infections. For this purpose the 
potential of performing in-depth sequencing of the metagenomes is highly relevant, and will 
increasingly become available as the cost of massively parallel sequencing continues to decrease. 
However, from a clinical standpoint the focus is primarily on the treatment of infections, and it is 
therefore highly possible that the best method will ultimately be a combination of culture-dependent 
antimicrobial susceptibility testing and molecular analysis.  
While the focus of this PhD project has been on the ability of various methods to detect and identify 
the microorganisms in clinical samples, it is clear that the understanding of the role multifarious 
microbial communities in infections is lagging behind. The potential of performing metagenomic, 
metatranscriptomic and metaproteomic analysis might offer insights into the mechanisms that are 
involved in progression of disease and the interplay between microorganisms and the human host. It 
is possible that the future of clinical microbiology does not lie with identification of microbial 
species, but rather with identification and detection of particular traits, be it antimicrobial resistance 
or virulence profiles. 
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Abstract 
Necrotizing soft tissue infections (NSTIs) is a group of infections of all soft tissues involving necrosis of the 
afflicted tissue. NSTI is potentially life threatening due to major and rapid destruction of tissue and potential 
association of septic shock and organ effect or failure. The gold standard for identification of involved 
pathogens is culture; however molecular methods for identification of microorganisms may provide a more 
rapid result and be able to identify additional microorganisms that are not detected by culture. 
In this study, tissue samples (n=20) obtained after debridement of 10 NSTI patients were analyzed by standard 
culture, peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH) and different molecular methods. 
The molecular methods included analysis of microbial diversity by 1) direct rRNA gene Sanger sequencing 2) 
construction of near full-length 16S rRNA gene clone libraries (or deep 454-based pyrosequencing) and 3) the 
Ibis T5000 biosensor. Furthermore, quantitative PCR (qPCR) was used to verify and determine the relative 
abundance of Streptococcus pyogenes in samples. 
For approximately half the samples it was possible to identify microorganisms by culture, although some 
samples did not result in growth presumable due to administration of antimicrobial therapy. The various 
molecular methods identified microorganisms in all samples, and frequently detected additional 
microorganisms compared to culture. Although the various molecular methods generally gave concordant 
results, our results seem to indicate that direct Sanger sequencing may misidentify or overlook 
microorganisms that can be detected by other molecular methods. 
Half of the patients were found to harbor S. pyogenes, but several atypical findings were also made including a 
monomicrobial infection by Acinetobacter baumannii and Streptococcus pneumoniae, and a polymicrobial 
infection by fungi, mycoplasma and Fusobacterium necrophorum. The faster turnaround time that is offered 
by some molecular methods makes their use attractive for identification of microorganisms, especially for 
fulminant life-threatening infections such as NSTI.  
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Introduction 
The spectrum of diseases referred to as soft tissue infections is diverse. Their common characteristic is that 
they involve infection of the skin, subcutaneous tissue, fascia or muscle (Bowler et al., 2001). The infections 
range from common superficial epidermal infections to potentially life threatening but rare cases of 
necrotizing soft tissue infections (NSTI) (Stevens et al., 2005). The incidence of NSTI has been estimated to 
be 4 cases per 100,000 person-years in the USA (Ellis Simonsen et al., 2006); thus, an average practitioner 
will only see one or two cases during their career (Anaya and Dellinger, 2007; Sarani et al., 2009), and may 
therefore not be sufficiently familiar with the disease to ensure a rapid diagnosis and appropriate treatment 
(Sarani et al., 2009). Treatment of NSTI involves immediate aggressive surgical debridement and 
administration of intravenous broad-spectrum antibiotics. Some centers also use systemic administration of 
non-specific immunoglobulin as well as hyperbaric oxygen treatment. Establishing the diagnosis can be a 
challenge in managing NSTI, because the early signs are non-specific and include local erythema and swelling 
with warmth and pain out of proportion to physical findings (Wong et al., 2003; Sarani et al., 2009). As the 
disease progress bullae filled with serous fluid are formed, and eventually large hemorrhagic bullae, skin 
necrosis, fluctuance, crepitus and sensory and motor deficits become apparent (Wong et al., 2003; Stevens et 
al., 2005). Despite many advances in the understanding of NSTI and great improvements in medical care, the 
mortality associated with NSTI remains high (Stevens et al., 2005; Sarani et al., 2009). Different mortality 
rates have been reported, but are generally in the range of 16-24% (Wong et al., 2003; Anaya and Dellinger, 
2007; Golger et al., 2007).  
The etiology of necrotizing fasciitis is variable and not fully understood. In some cases an antecedent 
penetrating injury is present (such as skin trauma, varicella, and burns) (Cunningham, 2000; Wong et al., 
2003; Olsen and Musser, 2010). The skin trauma may be caused by surgery or may even be caused by a trivial 
event such as an insect bite, scratch, or abrasion (Singh et al., 2002; Hasham et al., 2005). In many cases 
however, no identifiable cause can be found (Cunningham, 2000; Singh et al., 2002; Wong et al., 2003; 
Johansson et al., 2010; Olsen and Musser, 2010). In these cases it is hypothesized that necrotizing fasciitis 
may result from hematogeneous seeding from a reservoir in the oropharynx or other anatomic site (Kihiczak et 
al., 2006; Olsen and Musser, 2010). Most patients who develop necrotizing fasciitis have pre-existing 
conditions that render them susceptible to infection, including diabetes mellitus, advanced age, immune 
suppression, peripheral vascular disease, obesity, smoking, drug and alcohol misuse (Wong et al., 2003; 
Hasham et al., 2005; Anaya and Dellinger, 2007; Angoules et al., 2007; Sarani et al., 2009). The necrotizing 
changes associated with NSTI lead to devitalization of the infected tissue, which provides a suitable 
environment for further microbial growth, setting the stage for major and rapid destruction of tissue (Bowler et 
al., 2001; Stevens et al., 2005). Infection can spread as fast as 1 inch per hour with little overlying skin change 
(Sarani et al., 2009). It is hypothesized that rapid tissue destruction and severe pain associated with NSTI is 
caused by the interaction of microorganisms and their toxins with the human coagulation system, leading to 
hypercoagulation, vascular occlusion and microvascular thrombosis (Bryant, 2003). The resulting poor tissue 
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perfusion also has implications on the treatment strategy, since the antibiotic concentration at the infection site 
may be insufficient (Johansson et al., 2010).  
Historically NSTI has been classified into specific types based on anatomic location or microbial findings. 
Based on bacteriology, two types of infections have been defined. Type-I infections are polymicrobial 
synergistic infections (usually caused by non-group-A streptococci, aerobic organisms and anaerobic 
organisms) and usually occur in immunocompromised hosts. Type-II infections are usually caused by 
Streptococcus pyogenes alone or with staphylocci and tend to occur in patients with no underlying 
comorbidities. This type of infection might be associated with toxic shock syndrome (Sarani et al., 2009). A 
third type has been suggested, although it has not been universally agreed on, caused by marine vibrios, and is 
usually associated with exposure to seawater or marine animals (Wong et al., 2003; Sarani et al., 2009). 
However, it has been suggested that such classifications lead to undue complication of the issue. It is argued 
that the most important information to be established is presence of a necrotizing component, distinguishing 
NSTI from a milder condition such as cellulitis that should respond to antibiotics alone (Elliott et al., 1996; 
Singh et al., 2002; Hasham et al., 2005; Stevens et al., 2005; Anaya and Dellinger, 2007). On the other hand, 
the correct identification of the microorganisms involved has important implications on the antibiotic 
treatment since S. pyogenes or Clostridium perfringens need different treatment modalities (Kaul et al., 1997; 
Cawley et al., 1999; Stevens et al., 2005) than for example methicillin-resistant Staphylococcus aureus 
(Miller et al., 2005), or Streptococcus pneumoniae (Kwak et al., 2002). 
The microbial communities involved in NSTI have previously only been investigated by culture-dependent 
methods. It is, however, possible that additional microorganisms, which may not be detectable by standard 
cultural methods, are involved in the infections as recent studies of numerous infectious conditions using 
molecular diagnostics have revealed that many of what were once thought to be monomicrobial infections are 
in fact polymicrobial (Melton-Kreft et al., In Press; Hall-Stoodley et al., 2006; Ehrlich et al., 2010; Costerton 
et al., 2011; Stoodley, Ehrlich, et al., 2011). Presently, various molecular methods are available that may be 
able to identify additional microorganisms and offer a more rapid identification of microorganisms than 
routine cultural methods. Since the various NSTI-causing microorganisms may require different antibiotics, 
the initial empiric antimicrobial treatment may need to be subsequently modified to target the infecting 
microorganisms. Because of the rapid progression of the disease it is of paramount importance that the 
etiologic pathogens can be rapidly identified. In this study, we investigated several molecular methods for 
identification of microorganisms, including the Ibis T5000 biosensor, quantitative polymerase chain reaction 
(qPCR) and 16S rRNA gene analysis by direct sequencing, near full length 16S rRNA clone libraries and 454 
pyrosequencing. These findings were then compared to those of routine cultural methods.   
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Methods 
Patients and samples 
Samples in this study were obtained from NSTI patients by debridement of the infected area, performed at 
Rigshospitalet (Copenhagen, Denmark). A total of 20 samples from 10 patients were included (Table 1). The 
debrided tissue were immediately transported to the Department of Clinical Microbiology, Rigshospitalet 
(Copenhagen, Denmark), where each sample were divided into three subsamples for standard culture 
experiments, molecular analysis and PNA FISH experiments. The samples for molecular analysis and FISH 
experiments were transferred to tubes containing glycerol or ethanol respectively, and kept frozen until 
analysis. 
Culture 
All culture experiments were performed at the Department of Clinical Microbiology at Rigshospitalet. All 
biopsies were analyzed by Gram-staining, and culture. Both aerobic and anaerobic conditions were used. 
Biopsies were plated on brain heart infusion agar (BHIA, SSI, Copenhagen Denmark), coagulated agar, and 
5% horse blood agar (SSI) for culture in a 5% CO2 atmosphere. Aerobic conditions included plating on 
modified Conradi-Drigalski (“Blue plates”, SSI), in serum buillon, in thioglycollate media, on tellurite agar 
(SSI) in a normal atmosphere. 37 Colonies were further identified by use of Matrix-assisted laser desorption-
ionization time of flight mass specroscopy (MALDI-TOF MS), Bruker, Bremen, Germany). Resistance 
patterns were analyzed by disc diffusion test on blood agar (SSI) using Neosensitabs (Rosco Diagnostica, 
Taastrup, Denmark). 
DNA extraction 
DNA was extracted from samples as described previously (Stoodley, Conti, et al., 2011). Briefly, the tissue 
samples were cut into smaller pieces under sterile conditions. Approximately 1 mm
3
 of tissue was transferred 
to a microcentrifuge tube containing tissue lysis buffer (ATL, Qiagen) and 20 mg/mL
 
proteinase K (Qiagen). 
The sample was incubated at 55 °C until visual inspection indicated that lysis was achieved. 100µL 
Zirconia/Silica Beads mixture (50 µL of 0.1 mm diameter, Biospec, PN: 11079101z and 50 µL of 0.7 mm 
diameter, Biospec, PN:11079107zx) were added to the microcentrifuge tube and the sample was homogenized 
for 10 min at 25 Hz using a Qiagen Tissuelyser (Model MM300, cat# 85210). DNA from the lysed samples 
was extracted using the Qiagen DNeasy Tissue kit, according to the manufacturer’s protocol. The DNA was 
eluded in 200 µL AE buffer (10 mM Tris·Cl; 0.5 mM EDTA, pH 9.0). 
Direct rRNA gene Sanger sequencing 
PCR was performed with primers that targeted the first 500 bases of the bacterial 16S rRNA gene or the D2 
region of the fungal 28S rRNA gene. The resulting PCR products were sequenced using the MicroSeq® 500 
kit (Applied Biosystems, Carlsbad, California) according to the manufacturer’s guidelines. The resulting DNA 
sequences were compared to the sequence library included in the MicroSeq® ID analysis software. In cases 
where sequencing resulted in mixed chromatograms due to 16S rRNA gene products from multiple species, 
these chromatograms were analyzed using RipSeq Mixed at www.ripseq.com.  
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Construction and analysis of clone libraries 
Clone libraries were constructed for near full length 16S rRNA genes (E. coli position 26-1390) and sequences 
were obtained as described previously (Rudkjøbing et al., Unpublished; Xu et al., 2012). Briefly, PCR 
amplicons of near full-length 16S rRNA genes were cloned using the TOPO TA Cloning ® kit (Invitrogen) 
according to the manufacturer’s instructions. Plasmid purification and sequencing was performed by 
Macrogen Inc. (Korea) using M13F primer (and M13R primer in some cases). Manual refinement of 
sequences and construction of consensus sequences were done in CLC Main Workbench (CLC bio, Aarhus, 
Denmark). Sequences were checked for chimeras using the Mallard software package (Ashelford et al., 2006), 
aligned using SINA Web Aligner (Pruesse et al., 2007) and imported into the ARB software package (Ludwig 
et al., 2004) for taxonomic lineage assignment, using the non-redundant (NR) SSU Ref database from SILVA 
Release 106 as reference database. Operational taxonomic units (OTUs) were constructed across all patient 
samples for clones having a sequence similarity of more than 97% since these sequences are typically assigned 
to the same species. One clone from each OTU was sequenced with both M13F and M13R primers. The 
resulting consensus sequences and their closest relatives in the database were selected to construct 
phylogenetic trees using neighbor joining, maximum parsimony and maximum likelihood methods. The non-
redundant, near full-length 16S rRNA gene sequences, representing each OTU obtained in this study, were 
deposited in GenBank under the accession numbers (not yet submitted).  
454-pyrosequencing 
454-based pyrosequencing was performed largely as described previously (Mussmann et al., 2007). Briefly, 
bar-coded FLX-titanium amplicon pyrosequencing of the V2–V3 region of the 16S rRNA gene was performed 
using the 27F and 338R primers. The DNA fragments were amplified using Platinum Hi-Fi taq polymerase 
(Invitrogen) with 800 µM dNTP, 2 mM MgCl2 and 400 nM of each primer. To each reaction 5 µL of template 
DNA was added, and the volume was adjusted to 50 µL. The PCR incubation conditions were 94°C for 2 min 
followed by 30 cycles of 94 °C for 30 s, 55 °C for 30 s, and 68 °C for 60 s, with a  final extension at 72 °C for 
7 min. Tag-encoded FLX amplicon pyrosequencing analyses utilized the Roche 454 FLX instrument with 
titanium reagents and titanium procedures (Roche). 
Analysis of 16S rRNA gene amplicon sequences was performed using Quantitative Insights Into Microbial 
Ecology (QIIME v.1.3.0) pipeline (Caporaso et al., 2010). The sequencing data was processed initially with 
AmpliconNoise (Quince et al., 2011) to remove noise. Then the QIIME pipeline separates the sequences into 
individual specimen communities based on the unique 5’ barcode sequence and utilizes a suite of external 
programs to make taxonomic assignments and estimate phylogenetic diversity. These data were used to 
generate taxonomic summaries. The default settings in QIIME were employed for analysis, except that the 
sequences were grouped into operational taxonomic units using 99% sequence similarity for clustering; 
taxonomic assignments were done using Greengenes taxonomy (DeSantis et al., 2006).  
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Ibis T5000 assay  
An aliquot of each DNA extract was loaded into each of 16 wells of an Ibis 96-well BAC (bacteria, antibiotic 
resistance genes, candida) detection plates (Abbott Molecular) and processed as described previously (Tuttle 
et al., 2011). Briefly, PCR amplifications were carried out, and the resulting PCR products where then desalted 
in a 96-well format and sequentially electrosprayed into the TOF MS as described by the manufacturer. The 
spectral signals were processed to determine the mass of each strand of the PCR products, which in turn were 
used to derive the base compositions that were then compared to the Ibis database to obtain species level 
determinations for all microorganisms (Ecker et al., 2008). 
Quantitative PCR 
Quantification of S. pyogenes (Dawson et al., 2009) and 16S rRNA genes (Suzuki et al., 2000) was performed 
using hydrolysis probe chemistry. The S. pyogenes assay is commercially available from Biosearch 
Technologies (Novato, CA). For each sample duplicate 25 µL reactions were run, each containing: 12.5 µL 
Brilliant® qPCR Master mix (Agilent Technologies, Santa Clara, California), 25 µg BSA (Sigma-Aldrich, 
Brøndby, Denmark), appropriate concentration of primers and TaqMan® probes (S. pyogenes: 400 nM 
primers and 100 nM probe, 16S rRNA: 900 nM primers and 200 nM probe), 0.75 µM ROX reference dye 
(Agilent Technologies) and 2 µL of template DNA. Measurements were obtained by absolute quantification 
using genomic DNA isolated from S. pyogenes (DSM 20565) and P. aeruginosa (DSM 1253) for total bacteria 
quantification. The number of isolated genomes was calculated based on DNA concentration (Quant-iT™ 
dsDNA Assay Kit (Invitrogen)) and genome size estimated to be 1.8Mbp for S. pyogenes and 6.5 Mbp for P. 
aeruginosa (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi). Dilution series of the genomic DNA covered a range 
of 10
6
-10
0
 genome copies. Reactions were run on an Mx3005P (Agilent Technologies) with the following 
program: 10 min at 95 °C, followed by 40 cycles of 30 s at 95 °C, 1 min at 60 °C. 
Analysis of quantitative data 
The number of gene copies measured by qPCR was converted to number of CFU per gram sample 
using C   g 
Cmeasured Cgenome ( total  used )
msample
  . Here Cmeasured is the number of copies measured and 
Cgenome is the number of gene copies in the genome of one CFU. The standard deviation of all measurements 
above the detection limit of the assays was calculated. For samples where more than one bacterium could be 
quantified, a two tailed T-test was used to provide a hypothesis test of the difference between population 
means. A statistical value of ≤ 0.05 was considered significant. 
Visualization of samples 
The samples were prepared for visualization by imbedding in paraffin, which was sectioned (4 μm) and 
mounted on microscope slides. Before staining or hybridization, the slides of five randomly selected samples 
(patient 4A, 6A, 8A, 8C and 9B) were deparaffinized by using 2x 5 min xylene, 2x 3 min 99.9% EtOH, 2x 
3min 96% EtOH, and washed 3x 3 min in sterile water. The de-paraffinized NSTI sections were analyzed by 
FISH using PNA probes (Stender, 2003). A mixture of fluorescein isothiocyanate (FITC)-labeled S. aureus-
specific PNA probe and Texas Red-labeled universal bacterium PNA probe both in hybridization solution 
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(AdvanDx, Inc., Woburn, MA) was added to each section
 
and hybridized in a PNA FISH Workstation at 55°C 
for 90 min covered by a lid (Bjarnsholt et al., 2009).The slides were washed for 30 min. at 55°C in Wash 
Solution (AdvanDx).
 
200 µl of DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) (Life technologies, 
Paisley, Scotland) was added and incubated in darkness for 15 minutes at RT. The sample was then washed 
twice with PBS. Once dry, 20 µl Prolong Gold (Life technologies) was added and a cover slip was added. To 
fix the coverslip, a small amount of clear nail polish was brushed on each side. The entire PNA FISH 
procedure required approx.
 
2.5 h. Slides were investigated using a LSM 710 confocal laser scanning 
microscope (Zeiss, Germany).  
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Results 
Identification of microorganisms by routine culture 
The findings by routine culture at the Department of Clinical Microbiology, Rigshospitalet (Copenhagen, 
Denmark), mostly revealed monomicrobial infections of the surgical samples (in 7 of the 10 patients) (Table 
2). These monomicrobial infections were primarily caused by streptococci (71% of the monomicrobial 
infections), specifically S. pyogenes, S. pneumoniae and non-hemolytic streptococci. The remaining 
monomicrobial culture findings were identified as Acinetobacter baumanii (patient 3) and fungal infection 
(patient 7). Furthermore, two patients were found to harbor more than one microorganism (patients 5 and 6), 
where Bacteroidees fragilis with Clostridium paraputrificum and S. pyogenes with Escherichia coli were 
found. One fourth of the samples investigated by culture did not result in growth of microorganisms. Three of 
these surgical samples originated from patients where other samples taken from the site of infection resulted in 
growth of microorganisms. The remaining culture-negative samples originated from a patient, where none of 
the samples resulted in growth of microorganisms (patient 10). 
Identification of microorganisms by molecular methods 
Generally, the molecular methods confirmed the cultural findings (Table 2). However, using the multiple 
molecular methods, microorganisms were found in all samples including those that were culture-negative, and 
in most culture-positive cases additional microorganisms were identified by the molecular methods (Table 3). 
Overall, the different molecular methods gave largely concordant results, although the results obtained for 
patient 10 was difficult to interpret since the various methods gave differing results. 16S rRNA clone libraries 
were not constructed for six of the samples, instead deep 454-based pyrosequencing of 16S rRNA gene was 
performed (Figure 1). For four of the samples (patients 4A, 8A, 8B and 8C) the deep sequencing confirmed 
the findings by the other molecular methods. For the remaining two samples, deep sequencing confirmed the 
other molecular diagnostics and also revealed additional microorganisms (in patient 6A these were 
Peptoniphilus sp. and Porphyromonas sp., in patient 7A Prevotella sp. and Sharpea sp. were additionally 
found). In two of the samples some of the findings detected by a single molecular method were not confirmed 
by the 454 pyrosequencing (in sample 4A this was Streptococcus didelphis detected by the Ibis T5000 
Biosensor, and in sample 6A it was staphylococci by the Ibis T5000 Biosensor and Mycoplasma hominis by 
direct Sanger sequencing). Of the used molecular methods only the Ibis T5000 biosensor could identify 
Candida albicans in sample 7B and Cladosporium cladosporioides in sample 6A, since this was the only 
method not entirely based on the bacterial 16S rRNA gene. 
Verification of findings by qPCR 
The findings of S. pyogenes by molecular methods could generally be confirmed by qPCR (Figure 2). Based 
on the measurements of bacterial 16S rRNA genes, S. pyogenes was the dominant microorganism in most of 
the samples, except 6A and 7B.   
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Visualization of samples 
Of the five randomly selected NSTI samples investigated by FISH and DAPI staining, only two were found to 
have detectable amounts of bacterial cells (Figure 3). The observed bacteria were located in clusters. 
Generally, the areas of tissue destruction were not found to contain detectable bacterial cells, but large 
amounts of inflammatory stained with DAPI. 
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Discussion 
NSTI is a serious, potentially lethal condition induced by microorganisms. The gold standard for identification 
of microorganisms involved in NSTI is culture and a number of studies have described microbiological 
findings during NSTI. However, newer molecular techniques may provide more rapid results with the added 
benefit of being able to provide additional information relating to the detection of unculturable organisms. 
Therefore, the present study was designed to investigate the potential of adding molecular diagnostics to 
cultural studies in the diagnosis of NSTI. For the majority (15 of 20: 75%) of samples included in this study, 
pathogens could be identified by culture (Table 2) with monomicrobial infections caused by S. pyogenes being 
the most frequently finding, although one patient (patient 6) was found to harbor additional microorganisms. 
The incidence of monomicrobial S. pyogenes NSTIs is higher in this study than reported elsewhere, with an 
accordingly decreased incidence of polymicrobial infections (Elliott et al., 2000; Wong et al., 2003; Levine 
and Manders, 2005; Sarani et al., 2009).  
For all samples three different molecular methods were used to identify microorganisms: 1) direct rRNA gene 
Sanger sequencing; 2) construction of 16S rRNA gene clone libraries and Sanger sequencing (or 454-based 
16S rRNA gene pyrosequencing in samples 4A, 6A, 7A, 8A, 8B and 8C); and 3) the Ibis T5000 Biosensor. 
Although all of the molecular methods generally provided concordant results, there were some cases where a 
microorganism was only detected by one of the three methods (Table 3). Only microorganisms found by at 
least two molecular methods were considered to be present in the sample, with the exception of fungal species 
which were only found by the Ibis T5000 biosensor, since these were not targeted by 16S rRNA gene based 
methods. For a single patient (patient 10) the various molecular methods gave discrepant or negative results. 
Since the confidences of the Ibis T5000 biosensor results were generally low (< 0.72) as was the number of 
genomes/well (data not shown) the results may be contaminants or background, which would correspond with 
the inability to construct clone libraries due to negative PCR. Discrepancies in results were most often caused 
by direct Sanger sequencing, which misidentified or missed the microorganisms that could be found by the 
other two molecular methods. Since the DNA molecules in the direct Sanger sequencing reactions are 
competing for the same reagents it is possible that microorganisms present in low quantities cannot be 
identified by this method. Furthermore the Ripseq algorithm used for interpretation of mixed chromatograms 
has only been validated in samples containing up to three different species (Kommedal et al., 2008), which 
may explain the less complex communities that are being found by direct Sanger sequencing. Although these 
considerations might explain some of the discrepant results, it does not explain the cases of misidentifications. 
The fact that all misidentifications by direct Sanger sequencing is identified as the same species (S. pyogenes) 
indicates that the results are based on contamination, potentially during the PCR setup in order for the DNA 
sequences from this species to outcompete the DNA from the microorganisms within the sample.  
By the molecular methods microorganisms could be identified in all samples (with the exception of samples 
from patient 10), including those where no growth was observed by culture. Overall, there were a total of 17 
samples where culture and molecular methods were in agreement, giving either concordant (13 samples) or 
partially concordant results (four samples). In the remaining cases the disagreement between culture and 
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molecular methods were caused by lack of growth, which was most likely caused by antibiotic therapy, since 
other samples taken from patients earlier in the course of disease did show growth of microorganisms (Table 
2). The partial concordance is caused by finding of a greater diversity by molecular methods compared to 
culture (Table 2 and 3), which is consistent with similar comparative studies of other clinical conditions 
evaluating microbial detection methods (Jacovides et al., In Press; Yun et al., Submitted for publication; 
Stoodley et al., 2008; Kathju et al., 2009; Gallo et al., 2011; Stoodley, Ehrlich, et al., 2011).  
An interesting aspect of the 454 pyrosequencing results is their reportedly quantitative nature. When the deep 
sequencing results for sample 6A are compared to the culture results, it is seen that culture only identified 
pathogens that were found in low abundance by 454 pyrosequencing; S. pyogenes and E. coli constituted >2% 
and >1% respectively of the total number of sequences. The Ibis T5000 Biosensor also has a capacity for 
generating quantitative results due to an internal calibration standard. According to the Ibis T5000 biosensor, 
S. pyogenes and E. coli constituted 42% and 30% respectively of the total number of genomes found per well, 
which is more than expected based on the culture results. By qPCR, the presence of S. pyogenes was 
quantified and related to the total number of bacteria in the sample (estimates of cell numbers based on 16S 
rRNA gene measurements). Based on these qPCR results S. pyogenes appear to be the dominant pathogen in 
the samples where the pathogen was found by other methods, except samples 6A and 7B, where the total 
number of bacteria seemed to exceed the number of S. pyogenes. In these samples were contained a larger 
number of different species, which supports the findings by qPCR. The high relative abundance of S. pyogenes 
in sample 6A, seems to be in agreement with the quantitative results by the Ibis T5000 Biosensor, but not the 
454 pyrosequencing data. An unexpected finding by qPCR was the presence of S. pyogenes in relatively high 
abundance in sample 7B, since the pathogen was not found in the sample by any other method. The use of 
qPCR furthermore seems to support our criteria of detection of bacteria by at least two methods, since S. 
pyogens could not be quantified in samples 3A, 5A, 10A and 10B where direct Sanger sequencing had 
indicated the presence of the pathogen (data not shown). 
Using FISH it was possible to detect bacteria in 2 out of 5 samples of debrided tissue from the NSTI patients. 
Interestingly, the areas of damaged tissue were found to contain large amounts of DAPI stained DNA. Based 
on the morphology this was likely inflammatory cells, which would be possible to determine in future studies 
using specific immunostaining. The general the lack of detection of bacterial cells but observation of high 
amounts of inflammatory cells may indicate that the tissue damage might in large part be mediated by the host 
immune system. However, it is also possible that lack of bacterial detection in the debrided tissue is due to 
successful antimicrobial treatment and that the vast majority of causative pathogens have rendered 
metabolically inactive prior to debridement of tissue. This seems plausible since the majority of patients in this 
study survived the NSTI. It is also possible that the microorganisms have moved on to other tissue areas after 
having destroyed the tissue that is investigated here. We cannot, however, preclude that pathogens were 
present in the tissue but not detected due problems during transport and storage of samples for FISH or 
because they were present in concentrations below the limit of detection for PNA FISH.  
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The polymicrobial findings in this study included Escherichia coli, streptococci and the anaerobes Bacteroides 
fragilis, Fusobacterium spp. and Clostridium spp. These findings correspond with bacteria previously reported 
to be present in polymicrobial NSTIs (Elliott et al., 2000; Kihiczak et al., 2006; Pandey et al., 2009). 
Furthermore, fungal NSTI due to Candida albicans have also been reported (Elliott et al., 2000; Wong et al., 
2003). The detection of Mycoplasma spp. in polymicrobial NSTI (patient 7 by all molecular methods), is to 
the best of our knowledge unique. However, animal studies have shown that ulcerative dermal necrosis can be 
induced in mice by Mycoplasma arthritidis (Cole et al., 1985). Mycoplasmas are associated with the mucosa 
and residing primarily in the respiratory tract and rarely penetrating the submucosa except in cases of 
immunosupression or instrumentation. The lack of cell wall makes the mycoplasmas very sensitive to 
environmental conditions and isolation of mycoplasmas is complicated due specific nutrient requirements and 
lack of a single optimal media formulation (Waites and Taylor-Robinson, 2011), which may explain why they 
have not been isolated in NSTI patients before. Interestingly, the localization of infection in patient 7 where 
mycoplasmas were detected was the neck, which corresponds with the association of mycoplasmas with the 
respiratory tract. It is possible that repeated surgical revision of the patient is the cause for the finding of 
mycoplasmas, and that they may not be playing an etiological role in the NSTI pathogenesis. 
Monomicrobial infections by other species such as A. baumannii (patient 3) and S. pneumoniae (patient 8) are 
unusual findings. However, A. baumanii is an emergent pathogen and has increasingly been recognized as a 
prevalent and significant nosocomial pathogen associated with sepsis, wound infections, and pneumonia 
(Charnot-Katsikas et al., 2009). A. baumannii and other Acinetobacter sp. have been described as participants 
in polymicrobial NSTIs (Anaya and Dellinger, 2007; Angoules et al., 2007; Guerrero et al., 2010) and several 
reports have identified A. baumanniias the sole agent in NSTIs. (Liu et al., 2005; Charnot-Katsikas et al., 
2009; Corradino et al., 2010; Sullivan et al., 2010). The increased prevalence of A. baumannii coupled with its 
increasing resistance to even the most-broad-spectrum antibiotics, means that NSTI infections caused by this 
pathogen may become an increasing problem (Charnot-Katsikas et al., 2009). S. pneumoniae is a common 
pathogen implicated in community-acquired pneumonia, sinusitis, otitis media and meningitis, which displays 
enormous heterogenetiy with respect to phenotype and pathogenicity (Forbes et al., 2008; Hall-Stoodley et al., 
2008). However, NSTI due to S. pneumoniae is rare and has primarily been reported in cases where patients 
were immunosuppressed or had other underlying conditions (Ballon-Landa et al., 2001; Frick and Cerny, 
2001; Kwak et al., 2002; Imhof et al., 2003; Dawar et al., 2008; Park et al., 2011), which does not correspond 
to the patient history in this case (Table 1). 
The realization that many pathogens can cause NSTIs, and that no specific combination of species are found in 
all cases means that clinicians should be prepared to treat any combination of microbial pathogens (Elliott et 
al., 2000; Anaya and Dellinger, 2007). Although appropriate antimicrobial treatment cannot cure NSTI, it can 
help during the acute phase of the infection (Anaya and Dellinger, 2007), which highlights the importance of 
rapid and comprehensive identification of the pathogens involved. 
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In conclusion, most of the microorganisms found in this study have previously been described in NSTIs. 
However, several atypical findings were made with the aid of the molecular diagnostis including 
monomicrobial infections by A. baumannii and S. pneumoniae and a polymicrobial infection including 
mycoplasma. The detection of mycoplasma was consistent across all samples from the affected patient and 
across the various molecular methods and therefore strongly suggests that the culture results represent false-
negatives. The culture reports from the Department of Clinical Microbiology only included microorganisms 
known as potential human pathogens, which may contribute to the finding of a larger microbial diversity by 
molecular methods. The fact that all microorganisms identified by culture were also identified by molecular 
methods indicates that these would be suitable alternatives for rapid identification of NSTI pathogens. The 
much faster turnaround time for the diagnostic molecular methods (Ibis and qPCR) makes the use of these 
methods attractive for pathogen identification in diseases that have rapid progression such as NSTI. However 
the use of molecular methods may increase the risk of identifying colonizers or contaminants to a higher 
degree. Based on the findings in this study, the Ibis T5000 biosensor appears to be the best of the molecular 
methods, but it has not yet been FDA approved for routine use in clinical practice. A problem with the 
molecular methods is that antimicrobial susceptibility testing cannot be performed, however the Ibis T5000 
biosensor has the ability to detect some resistance genes, and did in fact detect the mecA gene in sample 6A 
where staphylococci were identified (data not shown). Furthermore, if an organism is not cultured it can never 
be examined for antibiotic sensitivity, thus speciating molecular diagnostics that incorporate antimicrobial 
resistance gene determinants such as the Ibis T5000 are an attractive alternative to culture, particularly when a 
rapid answer is needed as in NSTIs.  
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Table 2: Microorganisms detected by routine culture methods in surgical and other (often previous) 
samples from NSTI patients. In many cases the findings by culture could be confirmed by the molecular 
methods (), or the molecular methods identified additional microorganisms (*). 
 Other samples Surgical samples 
Patient  Culture Sample Culture Molecular methods 
1 - A Streptococcus pyogenes  
  B Streptococcus pyogenes  
  C Streptococcus pyogenes  
  D Streptococcus pyogenes  
2 Streptococcus pyogenes (blood culture) A Streptococcus pyogenes  
  B Streptococcus pyogenes  
3 No growth A Acinetobacter baumannii 
(Gram positive cocci in 
chains by light microscopy) 
*
 
4 Streptococcus pyogenes and CNS (Gram 
negative rods by light microscopy) 
A Non-hemolytic streptococci  
 B No growth * 
5 - A Bacteroides fragilis, 
Clostridium paraputrificum 
* 
6 Streptococcus pyogenes, 
Staphylococcus aureus and 
Enterobacteriaceae 
A Streptococcus pyogenes, 
Escherichia coli 
* 
7 Fusobacterium necrophorum A Fungus * 
  B No growth * 
8 Streptococcus pneumoniae A Streptococcus pneumoniae  
  B Streptococcus pneumoniae  
  C No growth  * 
9 Streptococcus pyogenes A Streptococcus pyogenes  
  B Streptococcus pyogenes   
10 Staphylococcus aureus  A No growth  
 B No growth  
- Indicates that no previous samples were taken for culture. 
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Key
Figures 
Figure 1: Taxa identified by pyrosequencing. The stacked graph illustrates the relative abundance of each 
taxon identified by pyrosequencing from the six samples (color coded according to the key).   
22 
 
Figure 2: Results by taqman qPCR for S. pyogenes (grey) and the 16S rRNA gene of all bacteria (black) given 
as CFU/mg sample.  
 
  
23 
 
Figure 3: Visualization of NSTI samples where microorganisms could be detected. Frame (A) show an 
overview of sample 9B, where DAPI stained nucleic acid (blue) and coagulated blood (orange, indicated by 
red arrow) can be seen in the tissue. The black areas in the tissue is fat cells (defined areas), but also areas of 
tissue destruction (green arrow). Frame (B) and (C) show 63x magnification of samples where bacterial cells 
could be detected by the universal bacterium PNA probe (scalebar represents 15 µm). Frame (B) shows 
sample 9B where bacterial cells could be detected (white arrow) among DAPI stained DNA and coagulated 
blood. Frame (C) show a large cluster of bacterial cell in sample 8A. 
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Patients suffering from cystic fibrosis (CF) develop chronic lung infection. In this study, we investigated the
microorganisms present in transplanted CF lungs (n  5) by standard culturing and 16S rRNA gene analysis.
A correspondence between culturing and the molecular methods was observed. In conclusion, standard
culturing seems reliable for the identification of the dominating pathogens.
Cystic fibrosis (CF) is the most common lethal autosomal
recessively inherited disorder of Caucasians. Although several
organs are affected, the most severe effect is observed in the
lungs, which is the major cause of deaths of patients (5). Here,
genetic alterations of the chloride channel in epithelial cells
lead to dehydration of the airway mucus, increasing its viscos-
ity. This means that the cilia are unable to transport the mucus
in which inhaled material and, importantly, bacteria are en-
trapped, enabling microorganisms to colonize and establish
infections within the mucus (9). In the early stages of CF,
intermittent colonizations occur, which can be treated with
antibiotics (10). Establishment of chronic infection occurs over
time and is characterized by the formation and establishment
of bacterial aggregates (the so-called biofilms) (1, 5). Forma-
tion of biofilm is problematic since not only does this afford
protection against the different components of the host de-
fense in the lungs but the bacteria also become extremely
tolerant to antibiotics (1, 4, 5). Most pathogenic bacteria are
easily diagnosed by standard culture-based techniques; how-
ever, many less well recognized bacteria can be difficult to
culture due to their growth requirements or being very slow
growing or not growing at all if the patient has been treated
with antibiotics. In these cases, the standard culture techniques
may fail to detect these bacteria and detect only the more
readily culturable bacteria (14). In the CF centers in Denmark,
an intensive antibiotic treatment strategy has been shown to
prolong the life expectancy of the CF patients (10). In recent
studies, the chronically infected lungs of CF patients have been
observed to harbor multiple species (19, 21). However, the
strict antibiotic strategy employed in Denmark has led to only
a small variety of microorganisms being found in the lungs of
CF patients, compared to what is found in other studies (8, 18,
23). In a previous study, we applied fluorescence in situ hybrid-
ization (FISH) using peptide nucleic acid (PNA) probes to
investigate the spatial distribution of Pseudomonas aeruginosa
in the lungs of end-stage Danish CF patients by using both
general and specific probes and found P. aeruginosa to be
present alone (1). The end stage is defined as the time when
the lungs are destroyed and the lung function is reduced to an
extent where lung transplantation is required for the patient to
survive (3).
In the present study, we investigated the true microbiota of
the end-stage CF lung by investigating fresh samples directly
from explanted lungs of Danish CF patients undergoing dou-
ble lung transplantations. This was to avoid possible contami-
nation by the patient’s oral and pharyngeal flora during expec-
toration of sputum, which is the typical type of sample
investigated in CF studies.
We included 34 lung tissue and mucopurulent pus/sputum
samples excised directly and sterilely from the lungs of five
Danish end-stage CF patients undergoing double lung trans-
plantation at Rigshospitalet (Copenhagen, Denmark). The
lungs were collected with the consent of the patients and in
accordance with the biomedical project protocol (KF-
01278432) approved by the Danish Council of Ethics. To in-
vestigate the microorganisms of the true microbiota present
within the lungs of the patients, both standard culturing and
16S rRNA gene analysis were performed. All culture experi-
ments were performed at the Department of Clinical Micro-
biology, Rigshospitalet (Copenhagen University Hospital,
Denmark), according to standard protocols (2). All samples
were incubated both aerobically and anaerobically. Aerobic
culturing was performed on blood agar, chocolate agar, and
eosin-methylene blue (EMB) agar with an incubation time of
up to 1 week. Anaerobic culturing was performed on blood
agar and chocolate agar, using an atmosphere of 7% CO2 and
7% H2 in N2 for up to 2 weeks.
Before extraction of DNA for 16S rRNA gene analysis,
samples were lysed by proteinase K (40 l) and ATL buffer
(360 l) from the DNeasy blood and tissue kit (Qiagen, Co-
penhagen, Denmark) for each 500 mg of tissue and incubated
overnight at 56°C. The samples were then centrifuged at 13,000
* Corresponding author. Mailing address: Department of Interna-
tional Health, Immunology and Microbiology, University of Copenha-
gen, DK-2100 Copenhagen, Denmark. Phone: 4535457774. Fax:
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rpm for 1 min, and DNA was extracted using the FastDNA
Spin kit for soil (MP Biomedicals, Illkirch, France) according
to the manufacturer’s protocol (revision 6560-200-07DEC);
starting from step 6, DNA was eluted with 60 l diethyl pyro-
carbonate (DEPC)-treated water. Nearly full-length 16S
rRNA genes were amplified as described in the literature (22),
using two different combinations of universal bacterial primers:
26F (5-AGAGTTTGATCCTGGCTCAG-3) with either
1390R (5-GACGGGCGGTGTCTACAA-3) or 1492R (5-T
ACGGYTACCTTGTTACGACTT-3) (15). The resulting 16S
rRNA gene fragments were pooled and purified using Nucleo-
spin Extract II columns (Macherey-Nagel, Düren, Germany).
The PCR products were cloned into a pCR4-TOPO vector,
transformed into One Shot Top 10 chemically competent Esch-
erichia coli cells (Invitrogen, Carlsbad, CA), and incubated
overnight at 37°C on LB agar plates containing 50 g/ml
kanamycin and 50 g/ml X-Gal (5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside). Either plasmids were purified using
the Illustra TempliPhi DNA amplification kit (GE Healthcare,
Brøndby, Denmark) and sequenced commercially by Macro-
gen (South Korea), or plasmid purification was performed by
Macrogen before sequencing. Sequences were obtained using
FIG. 1. Maximum likelihood tree of the sequences in the clone libraries with their closest relatives. The OTUs from the clone libraries from
the five patients are given with the numbers of sequences in parentheses. The out-group (consisting of 24 sequences of the Chloroflexi phylum) was
set as the root, not shown in the figure. The scale bar represents a 10% deviation of sequence. Asterisks indicate sequences where identification
by BLAST search gave different results. The identities of microorganisms found by culturing are highlighted by a box; these are also the clones
most often identified in the respective clone libraries.
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the M13F primer (5-GTAAAACGACGGCCAGT-3) and
checked for chimeric sequences with the program Bellerophon
(12), using the Huber-Hugenholtz correction and a window
size of 300 nucleotides. The BlastN function in the NCBI
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used for
initial identification of closest relatives with standard parame-
ter settings, except that the database was set to the nucleotide
collection (nr/nt).
Alignment of the sequences was performed using the SILVA
web aligner (17) with default settings and refined manually in
ARB (16). The sequences from the 34 clone libraries were
compiled into overall libraries for each of the 5 patients; within
these, the sequences were grouped into operational taxonomy
units (OTUs) if they had a sequence similarity of more than
97% (13). Representative clones for all OTUs were also se-
quenced using the M13R primer (5-GCGGATAACAATTT
CACACAGG-3) in order to obtain consensus sequences cov-
ering the entire length of the fragments. Consensus sequences
representing the different OTUs and their closest relatives in
the nonredundant SSU Ref database from SILVA release 104
were used for calculation of trees by distance matrix, parsi-
mony, and maximum likelihood approaches using default set-
tings in the ARB software but omitting hypervariable regions
of the gene. Twenty-four out-group sequences from the phy-
lum Chloroflexi were added to the tree calculations.
Culture analysis showed the presence of monospecies infec-
tion in the lungs of four patients, and two bacterial species
were found for the last patient (patient 4). No growth of an-
aerobic bacteria was observed. The isolated bacteria were P.
aeruginosa, Stenotrophomonas maltophilia, or Achromobacter
xylosoxidans (Table 1), and the same result was found on all
types of media used. The 5 patients expectorated sputum just
prior to their lung transplantation. The culture analysis of this
sputum revealed the exact same bacteria as those found by the
culture analysis from the explanted lungs (not shown). The
initial identification of clone library sequences (as determined
by BLAST search) showed that the organisms found by culture
analysis were present in high numbers in the clone libraries
(Table 1). The phylogenetic trees (neighbor joining, maximum
parsimony, and maximum likelihood) were constructed to vi-
TABLE 1. Overview of bacteria found in the explanted lung samples by culturing and 16S rRNA gene analysis
Patient Culturing
16S rRNA gene analysis
Species (BLAST)a OTU No.b
Patient 1 Achromobacter xylosoxidans Achromobacter xylosoxidans 1 115
Uncultured bacterium 2*c 3
Burkholderia fungorum 3 2
Uncultured bacterium 4* 2
Bacillus cereus 5 1
Uncultured Flavobacterium 6* 1
Uncultured bacterium 7* 1
Uncultured bacterium 8* 1
Uncultured bacterium 9* 1
Uncultured bacterium 10* 1
Patient 2 Pseudomonas aeruginosa Pseudomonas aeruginosa 1 118
Lactobacillus mucosae 2 1
Patient 3 Pseudomonas aeruginosa Pseudomonas aeruginosa 1 406
Uncultured Bacteroidetes bacterium 2 27
Stenotrophomonas maltophilia 3 11
Uncultured bacterium 4* 3
Uncultured bacterium 5* 2
Uncultured Saprospiraceae bacterium 6 1
Uncultured Bacteroidetes bacterium 7 1
Uncultured bacterium 8* 1
Uncultured bacterium 9* 1
Uncultured bacterium 10* 1
Patient 4 Pseudomonas aeruginosa Pseudomonas aeruginosa 1 191
Stenotrophomonas maltophilia Stenotrophomonas maltophilia 2 6
Uncultured bacterium 3 2
Uncultured betaproteobacterium 4 1
Uncultured betaproteobacterium 5* 1
Uncultured betaproteobacterium 6 1
Polaromonas sp. 7 1
Uncultured bacterium 8* 1
Uncultured bacterium 9 1
Patient 5 Achromobacter xylosoxidans Achromobacter xylosoxidans 1 440
Stenotrophomonas maltophilia 2 1
a The species found by 16S rRNA gene analysis is given by the closest relatives of the bacterial OTUs in clone libraries for the patients.
b The number of sequences that make up the OTUs.
c Asterisks indicate clones where the identification by BLAST differed from the identification made by phylogenetic analysis.
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sualize the phylogenetic relationship of the microorganisms
and showed congruent topology (the maximum likelihood tree
is shown in Fig. 1). The locations of the sequences in the tree
confirmed the result of the BLAST search and in several cases
gave identification of sequences that had been determined to
be uncultured bacteria by BLAST search, as indicated by as-
terisks in Table 1 and Fig. 1. This is due to the fact that, unlike
the BLAST tool at NCBI, only quality-checked sequences were
used in the ARB database used. Another factor is that, in
ARB, the secondary structure of the 16S rRNA gene was taken
into account. Some of the bacteria identified in the clone
libraries have previously been associated with cystic fibrosis,
such as Stenotrophomonas maltophilia (6, 7, 20), Burkholderia
fungorum (6, 19), and Streptococcus sp. (13), but the clinical
relevance of these bacteria and others found in small amounts
in the samples is unknown (2, 11). Compared to the results
obtained by culture analysis, the 16S rRNA gene analysis
showed a greater diversity of bacteria, with sequences distrib-
uted into 4 phyla: Proteobacteria, Bacteroidetes, Actinobacteria,
and Firmicutes. As the bacteria found by culturing were also
represented by the highest numbers of sequences in the clone
libraries, it is very likely that these bacteria were dominant in
the lung. We are currently investigating this thoroughly by
FISH and quantitative PCR.
The results presented here correlate with results that we
have previously published (1) that the end-stage CF lung har-
bors relatively few bacterial species that could be identified by
culturing. However, this might not represent the other levels of
chronic infection in the CF lungs. In fact, many of the non-
end-stage CF patients at the Copenhagen CF Clinic harbor
several species in their lungs, which should also be investigated
further.
Nucleotide sequence accession numbers. The nonredundant,
nearly full-length 16S rRNA gene sequences representing each
OTU obtained in this study were deposited in GenBank under
the accession numbers JN802672 to JN802704.
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Abstract
Patients suffering from cystic fibrosis (CF) develop chronic lung infections
because of highly viscous mucus, where bacteria can form biofilms. In this
study, we investigated the microorganisms present in the lungs of end-stage
and non-end-stage patients using standard culturing techniques and molecular
methods. Tissue and sputum samples (n = 34) from explanted lungs of five
end-stage patients were examined along with routine expectorates (n = 15)
from 13 patients with non-end-stage CF, representing earlier stages of chronic
lung infections. Previously, using peptide nucleic acid (PNA) fluorescence
in situ hybridization (FISH), we have shown that Pseudomonas aeruginosa was
the sole pathogen in end-stage CF lungs (Pediatr Pulmonol 2009, 44: 547). In
this study, this tendency was supported by the results of real-time PCR, con-
firming previous results obtained by standard culturing and 16S rRNA gene
analysis (J Clin Microbiol 2011, 49: 4352). Conversely, the non-end-stage
patients were found to harbor several species by culturing. PNA FISH con-
firmed heterogeneous microbiota and showed that the bacteria were located in
monospecies aggregates with no apparent physical interaction between the dif-
ferent microcolonies. In conclusion, standard culturing identifies the dominat-
ing pathogens, which seem to reside in monospecies microcolonies. The
possibility of signaling between the distinct microcolonies still has to be veri-
fied and elucidated.
Introduction
Cystic fibrosis (CF) is the most common lethal autosomal
recessively inherited disorder of Caucasians. The genetic
defect leads to a decrease in epithelial chloride secretion
and an increase in sodium absorption and as such affect
several organs. The most severe effect is on the lungs, where
the airway mucus becomes dehydrated, increasing its
viscosity. Normally, the mucus entraps bacteria and other
foreign material, which is then transported by cilia for
mechanical clearing, for example, by coughing. In patients
with CF, the cilia are unable to transport the highly viscous
mucus, making it a reservoir for inhaled bacteria (Boucher,
2004). The airway microbiology of patients with CF
changes over time; early in life, intermittent acute infec-
tions of many different bacteria occur, the most common
being Haemophilus influenzae, Staphylococcus aureus,
Streptococcus pneumonia, Pseudomonas aeruginosa, the
Burkholderia cepacia complex, and Stenotrophomonas
maltophilia. Of these pathogens, H. influenza, S. aureus,
and P. aeruginosa are predominant (Gilligan, 1991; Saiman,
2004). The viscous mucus enables microorganisms to
establish chronic infections characterized by the formation
and establishment of bacterial aggregates (the so-called bio-
film) (Costerton et al., 1999; Bjarnsholt et al., 2009). Up to
80% of young CF adults are chronically infected
with P. aeruginosa (Gillian, 1991; Bjarnsholt et al., 2009),
but other species, like Achromobacter xylosoxidans, are
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increasingly detected as a cause of chronic infections
(Rønne Hansen et al., 2006). The mucus of a chronically
infected patient contains an abundance of microcolonies,
alginate, and some planktonic bacteria, and a continuous
recruitment of polymorphonuclear neutrophils (PMNs)
occurs. Despite the abundance of PMNs, the bacteria per-
sist for decades, and the constant neutrophil-dominated
inflammation leads to lung tissue destruction and
reduced respiratory function in the patient (Bjarnsholt,
2009; Moser et al., 2009). At some point the lung function
is reduced to an extent where lung transplantation is
required in order for the patient to survive, this is called
the end-stage of the disease. Without transplantation, the
disease leads to premature deaths of the patients (Braun &
Merlo, 2011).
Formation of bacterial biofilms in the CF lung is prob-
lematic as the bacteria are protected from the host
immune system and become extremely tolerant to antibi-
otics, which explains why the chronic infections cannot
be eradicated (Costerton et al., 1999; Conese et al., 2003;
Bjarnsholt et al., 2009). The intermittent colonizations,
however, can be treated successfully with antibiotics. In
Denmark, an aggressive antibiotic treatment strategy has
been employed, and the onset of the chronic infection
has been postponed for decades, prolonging the life
expectancy of the patients (Høiby et al., 2005).
We have previously studied spatial distribution of
P. aeruginosa in the lungs of Danish patients with end-
stage CF using both general and specific peptide nucleic
acid (PNA) probes for fluorescence in situ hybridization
(FISH) (Bjarnsholt et al., 2009). Recently, we investigated
the true microbiota in the lungs of patients with end-
stage CF by examining fresh samples from explanted
lungs using culturing and 16S rRNA gene analysis, and
the results indicated that culturing could identify the
organisms that were dominant in the 16S rRNA gene
libraries (Rudkjøbing et al., 2011). In this study, we inves-
tigated whether P. aeruginosa in fact dominates in the
lungs of these patients by quantifying these by real-time
PCR. As in our previous PNA FISH studies, we also
investigated sputum samples from chronically infected
non-end-stage patients using culturing and PNA FISH to
compare different stages of chronic lung infection.
Materials and methods
Patients and samples
Samples included in this study were obtained from a
group of Danish patients with end-stage and non-end-
stage CF. Samples from five patients with end-stage CF
(34 lung tissue and mucupurulent pus/sputum samples
excised from explanted lungs), as described elsewhere
(Rudkjøbing et al., 2011), were investigated by real-time
PCR. Samples from 13 Danish patients with non-
end-stage CF (15 sputum samples) were obtained during
bacteriology examinations as part of the routine diagnos-
tics. These patients ranged from nonchronic infected to
chronic infected for up to 34 years with P. aeruginosa.
The samples were investigated using standard culturing
and also prepared for PNA FISH visualization by fixation
in PBS with 4% paraformaldehyde and imbedding in
paraffin, which was sectioned (4 μm) and mounted on
glass slides. The end-stage lungs were collected with the
acceptance of the patients and in accordance with the
biomedical project protocol (KF-01278432) approved by
the Danish scientific ethical board.
Culture experiments
All culture experiments were performed at the Depart-
ment of Clinical Microbiology, Rigshospitalet (Copenha-
gen, Denmark) according to standard protocols. All
samples were investigated using our routine CF media
and culture conditions, as described by (Bjarnsholt et al.,
2011). Sputum samples were not subjected to anaerobic
culture because of heavy growth of the normal anaerobic
flora from the mouth (Bjarnsholt et al., 2011).
DNA extraction efficiency – spiking experiment
DNA was extracted from the samples of patients with
end-stage CF, as described previously (Rudkjøbing et al.,
2011). The efficiency of this DNA extraction method was
evaluated by spiking known amounts of S. aureus (DSM
6148) cells to a lung tissue sample. Staphylococcus aureus
was chosen as model organism, as Gram-positive cells
often pose the biggest challenge to DNA extraction. The
tissue was digested by proteinase K solution (40 μL pro-
teinase K and 360 μL ATL buffer from DNeasy® Blood &
Tissue kit; Qiagen), followed by homogenization.
Degraded tissue was divided into five fractions, to which
five different amounts of S. aureus cells grown in LB
media were added (25 000, 7500, 1500, 300 cells, and 0).
Cell concentration was determined using a 4′,6-diamidino-
2-phenylindole (DAPI) solution (1 mg mL−1) for staining
cells filtrated onto a polycarbonate filter and inspected
under a Carl Zeiss Axioskop 2 Plus epifluorescence
microscope using a 100 times oil immersion lens. After
addition of cells, 20 μL proteinase K and 200 μL ATL
buffer were added to each sample and incubated for 2 h.
The samples were homogenized and divided into three
equally sized subsamples (only two subsamples for the
samples with highest and lowest concentration of added
cells), from which DNA was extracted according to (Rud-
kjøbing et al., 2011). The quantity of S. aureus cells was
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measured using real-time PCR, targeting the nuc gene of
S. aureus according to (Hein et al., 2001). Measurements
were taken in triplicate, and comparison of subsamples
with equal amounts of added cells was made (data not
shown).
Real-time PCR
The concentration of P. aeruginosa was determined by real-
time PCR, targeting oprL gene (Jaffe et al., 2001), and
hydrolysis probe-based real-time PCR, targeting the ecfX
gene (Anuj et al., 2009). Also, the total content of bacteria
was quantified using bacterial primer 341F and universal
primer 907R (Skovhus et al., 2004). Measurements were
obtained by absolute quantification using genomic DNA
isolated from P. aeruginosa (DSM 1253) and Escherichia
coli (DSM 30083) for total bacteria quantification. The
number of isolated genomes was calculated based on DNA
concentration (Quant-iT™ dsDNA Assay kit; Invitrogen)
and genome size estimated to be 6.5 Mbp (http://img.jgi.
doe.gov/cgi-bin/pub/main.cgi). Dilution series of the geno-
mic P. aeruginosa DNA covered a range of 106–10−2 gen-
ome copies and 107–100 genome copies for E. coli.
Triplicate 25 μL SYBR-based real-time PCR reactions
were run containing: 12.5 μL Brilliant® II SYBR® Green
REAL-TIME PCR Master mix (Stratagene), 1 μg μL−1
BSA (New England Biolabs), 400 nM of both forward
and reverse primer, 38 nM ROX reference dye (Strata-
gene), and 5 μL of sample, standard, or control. Reac-
tions were run on Mx3005P (Stratagene) with 10 min at
95 °C, 40 cycles of 30 s at 95 °C, 1 min at 60 °C, 1 min at
72 °C, and 15 s at 82 °C (data capture), and finally melt-
ing profile analysis (57–95 °C). For the general bacteria
assay, the program was 10 min at 95 °C, 40 cycles of 30 s
at 95 °C, 1 min at 56 °C, 30 s at 72 °C, and 20 s at 80 °C
(data capture), and finally melting profile analysis. For
the hydrolysis probe-based real-time PCR triplicate 25 μL,
reactions were run containing: 12.5 μL Brilliant® II
QPCR Master mix (Stratagene), 1 μg μL−1 BSA (New
England Biolabs), 1 μM of both primers, 200 nM hydro-
lysis probe, 38 nM ROX reference dye (Stratagene), and
5 μL of sample, standard, or control. The reactions were
run with 10 min at 95 °C, 50 cycles of 30 s at 95 °C, and
1 min at 60 °C (data capture). The gene measurements
were converted into a measure of DNA content, assuming
nucleotide base pair weight of 660 Da, that all bacteria in
the samples have the same genome size as P. aeruginosa
and contain the same number of 16S rRNA gene copies
in the genome (total of four).
The products of a selected number of experiments were
verified on a 2% agarose gel by gel electrophoresis. The
specificity of the assays targeting P. aeruginosa was con-
firmed by cloning amplicons into pCR®4–TOPO® plas-
mid, sequencing, and BLAST search (http://blast.ncbi.nlm.
nih.gov/Blast.cgi).
DNA quantification
DNA content of the lung samples from patients with
end-stage CF was quantified using the Picogreen assay
(Invitrogen). Briefly, standards of Lambda DNA (Invitro-
gen), ranging from 0 to 1000 pg μL−1, were prepared,
and 50 μL of the standards and of the diluted DNA sam-
ples were added to a black, solid 96-well microtiter plate
(Cayman). Fifty microlitres of Picogreen diluted accord-
ing to the manufacturer's instructions was added to the
plate. Fluorescence was measured using Infinite® M1000
plate reader (Tecan) with excitation of 480 nm, emission
of 524 nm, and a gain of 159.
Statistical analysis
The gene copy numbers measured by real-time PCR were
normalized to two factors, in order to estimate whether
the mean reported is the true mean, the relative expres-
sion was calculated along with the standard error of the
relative expression (Jacobs & Dinman, 2004). To compare
the number of genes quantified by the two real-time PCR
assays targeting P. aeruginosa, the paired samples t-test
was used on the mean values of triplicate measurements,
both normalized to DNA content and bacterial content in
PASW Statistics program (formerly SPSS Statistics). This
provided a hypothesis test of the difference between pop-
ulation means for pairs of samples, and a statistical value
of ≤ 0.05 was considered significant.
PNA FISH
Before staining or hybridization, the paraffin was
removed from the samples using 2× 5 min xylene,
2× 3 min 99.9% EtOH, 2× 3 min 96% EtOH and washed
3× 3 min in sterile water. The de-paraffinized sputum
sections were analyzed by FISH using PNA probes
(Stender, 2003). A mixture of Texas Red-labeled P. aeru-
ginosa-specific PNA probe and fluorescein isothiocyanate
(FITC)-labeled universal bacterium PNA probe or FITC-
labeled S. aureus-specific PNA probe and Texas Red-
labeled universal bacterium PNA probe both in hybridiza-
tion solution (AdvanDx, Inc., Woburn, MA) was added
to each section and hybridized in a PNA FISH Worksta-
tion at 55 °C for 90 min covered by a lid (Bjarnsholt et al.,
2009). The slides were washed for 30 min at 55 °C in
Wash Solution (AdvanDx). Vectashield mounting media
with DAPI (Vector laboratories, Burlingame, CA) were
applied, and a cover slip was added to each slide. The
entire PNA FISH procedure required approx. 2.5 h. Slides
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were investigated using a LSM 710 confocal laser scan-
ning microscope (Zeiss, Germany).
Results
Patients with end-stage CF
From previous investigations of the five end-stage patients,
it was found that P. aeruginosa was hardly detectable in
clone libraries constructed for two patients (patients 1 and
5), whereas they were dominant in three patients (patients
2–4). Generally, it was found that 1–2 bacteria dominated
the clone libraries, but the presence of other bacteria from
up to four different phyla could be identified (Rudkjøbing
et al., 2011). To determine whether the dominance in the
clone library was caused by dominance of the pathogen in
the sample or by an artifact in the construction of the
libraries, real-time PCR experiments were performed. Only
the results from samples with P. aeruginosa genes above
the limit of detection are shown. The samples from the
patients varied greatly in size, and therefore the gene mea-
surements were normalized before comparison. Measure-
ments were normalized both to the total bacterial content,
which was quantified by targeting their 16S rRNA genes
(Table 1) and to the total concentration of the extracted
DNA (Table 2). The two P. aeruginosa assays generally
gave differing results, with the assay targeting the ecfX
gene always measuring the highest number (as indicated
by the means given in Tables 1 and 2). A paired samples
t-test revealed that the difference in measurements by the
two assays was statistically significant. Normalization of
P. aeruginosa to the number of bacteria in samples gener-
ally showed that the number of P. aeruginosa cells (based
on measurements of both ecfX and oprL genes) was higher
than the number of bacterial cells (based on 16S rRNA
gene measurements) (Table 1). Although this is not realis-
tic (see Discussion), it indicates that P. aeruginosa is
highly abundant in the samples. The normalization of
P. aeruginosa and bacteria to the total DNA concentration
showed that these constituted only a small percentage of
the extracted DNA (Table 2). The abundance of P. aerugin-
osa was found to vary considerably between the patients
and also between the different samples from a single
patient, which is to be expected based on our previous
findings of a heterogeneous distribution of microcolonies.
Samples from patients 1 and 5 generally did not contain
quantifiable amounts of P. aeruginosa (not shown), which
corresponded to our previous results using 16S rRNA gene
analysis and culturing (Rudkjøbing et al., 2011). Only a
single sample from patient 1 contained P. aeruginosa genes
above the limit of detection, and the normalized results
show that P. aeruginosa constituted a very small percent-
age of all bacteria present (Table 1).
Non-end-stage patients
Culture analysis
The culture analysis of the non-end-stage sputum sam-
ples showed a variety of bacteria, ranging from 1 to 3
different CF-related microorganisms identified in each
sample. The organisms identified were as follows:
Mucoid and nonmucoid P. aeruginosa, H. influenzae,
S. aureus, S. maltophilia, B. cepacia, Candida species,
and Aspergillus species. Compared to culture analysis of
end-stage patients, this is a relatively large diversity
(Table 3).
Table 1. Real-time PCR measurements of the oprL and ecfX genes of
Pseudomonas aeruginosa in samples from patients with end-stage CF.
Measurements are normalized to the total number of bacteria, with
the standard error of the relative expression (as percentage of the
standard error values)
oprL ng per ng
DNA (%)
ecfX ng per ng
DNA (%)
End-stage patient 1
3 tissue 0.029 ± 18 0.608 ± 4
End-stage patient 2
1 tissue 256 ± 6 9300 ± 7
2 tissue 380 ± 8 –
3 tissue 130 ± 17 5940 ± 13
End-stage patient 3
1 sputum – –
2 sputum – –
3 sputum 1150 ± 7 3930 ± 8
4 sputum 2640 ± 11 11 000 ± 12
5 sputum 787 ± 7 2910 ± 9
1 tissue 1040 ± 6 2000 ± 7
2 tissue 3760 ± 10 9620 ± 9
3 tissue – –
4 tissue 504 ± 7 525 ± 15
5 tissue 174 ± 16 394 ± 8
End-stage patient 4
1 tissue 1160 ± 7 3050 ± 5
2 tissue 38.1 ± 30 58.0 ± 10
3 tissue 705 ± 4 617 ± 9
4 tissue 42.3 ± 6 113 ± 6
4 sputum – –
Mean 651 2600
Significance value* 0.011
‘–’ Indicates that data could not be given. For sample 2 tissue from
end-stage patient 2, this was caused by lack of DNA extract. For the
rest, it was not possible to normalize the measured P. aeruginosa
genes because the 16S rRNA assay could not detect the target gene.
*The significance value calculated by paired samples t-test is below
0.05, indicating that the difference between mean value observed for
the two assays targeting P. aeruginosa genes is statistical significant.
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FISH
To investigate the spatial distribution of species in
patients with CF chronically infected with more than one
species, we applied general and specific PNA FISH visual-
ization to sputum samples of patients with non-end-stage
CF (representative selection shown in Fig. 1). Examining
these spatial observations, we were not able to observe
any direct interaction between microcolonies of different
species. No mixing took place at least between P. aerugin-
osa (red) and other bacterial species (green) (Fig. 1a, c,
and d) or S. aureus (red) and other bacteria (green)
(Fig. 1b). We have previously described this segregation
of species for chronic infections (Burmølle et al., 2010).
Even though the lung infection status of the patients ran-
ged from nonchronic to 34 years of chronic, we could
not detect any difference in the spatial distribution of
biofilms and species.
Discussion
In the present study, we investigated the true microbiota
involved in different stages of chronic infection of CF
lungs. The normal type of sample investigated in CF studies
is sputum that has been expectorated by the patients, and
this is also the sample used in routine diagnostics where
standard culturing is employed. It is, however, possible that
these samples contain oral or oropharyngeal contamination
(Bjarnsholt et al., 2011), which may be particularly prob-
lematic in respect to culturing as it becomes difficult to dis-
tinguish pathogens from contaminating organisms. Some
authors claim that the potential contamination is not sig-
nificant (Rogers et al., 2006) or that contaminating saliva
can be removed from the sputum sample by a series of
washing steps (Rogers et al., 2006; Guss et al., 2011). To
avoid this disputed point, the samples included in this
study were either from explanted lungs (end-stage
patients), which were investigated by culture analysis and
PCR-based approaches, or expectorated sputum samples
(non-end-stage patients), which were investigated by cul-
ture analysis and FISH. The visualization by FISH makes it
possible to determine whether the bacteria are integrated in
the sample, which minimizes the risk of observing contam-
inating microorganisms. At present, only few publications
are available where direct sampling of lung tissue is used,
although this allows for a more specific characterization of
microbiota than other sampling methods (Rudkjøbing
et al., 2011; Willner et al., 2011).
The use of molecular methods for the identification of
bacteria has revealed that the complexity and microbial
diversity of many samples is greater than that found by
culturing. This is partly due to the fact that culturing
requires assumptions to be made regarding which species
will be present so that appropriate media can be used
(Rogers et al., 2006; Guss et al., 2011). In a previous
study, we compared culturing and 16S rRNA gene analy-
sis on samples from patients with end-stage CF. In all
cases, culture analysis identified the organism that was
the most frequently represented clone in the clone
libraries, but other bacteria in low abundance with
unknown clinical relevance were also found (Rudkjøbing
et al., 2011). The real-time PCR measurements confirmed
that P. aeruginosa (the clone most frequently found in
clone libraries from the three patients) was in fact the
dominant bacteria in the lungs and not due to an artifact
in the construction of the clone libraries (Table 1). The
finding of a few dominating bacteria (1 or 2) in the CF
Table 2. Real-time PCR measurements of the oprL and ecfX genes of
Pseudomonas aeruginosa and the 16S rRNA gene of Bacteria in
samples from patients with end-stage CF. Measurements are
normalized to the total mass of DNA extracted from samples, with
the standard error of the relative expression (as percentage of the
standard error values)
16S rRNA
ng per
ng DNA (%)
oprL
ng per
ng DNA (%)
ecfX
ng per ng
DNA (%)
End-stage patient 1
3 tissue 0.200 ± 4 0.00006 ± 17 0.001 ± 2
End-stage patient 2
1 tissue 0.006 ± 4 0.016 ± 4 0.580 ± 7
2 tissue 0.001 ± 4 0.002 ± 8 –
3 tissue 0.012 ± 7 0.016 ± 16 0.734 ± 11
End-stage patient 3
1 sputum ND 0.041 ± 11 0.090 ± 8
2 sputum ND 0.129 ± 9 1.171 ± 6
3 sputum 0.035 ± 7 0.406 ± 8 1.391 ± 9
4 sputum 0.024 ± 11 0.554 ± 3 2.306 ± 6
5 sputum 0.077 ± 7 0.422 ± 1 1.562 ± 5
1 tissue 0.001 ± 4 0.011 ± 6 0.021 ± 7
2 tissue 0.003 ± 9 0.101 ± 5 0.259 ± 4
3 tissue ND 0.005 ± 14 0.011 ± 15
4 tissue 0.060 ± 7 0.305 ± 5 0.317 ± 14
5 tissue 0.010 ± 7 0.018 ± 14 0.040 ± 4
End-stage patient 4
1 tissue 0.012 ± 5 0.137 ± 5 0.360 ± 2
2 tissue 0.018 ± 11 0.007 ± 29 0.010 ± 3
3 tissue 0.038 ± 4 0.266 ± 3 0.233 ± 9
4 tissue 0.027 ± 6 0.011 ± 4 0.030 ± 4
4 sputum ND 0.067 ± 46 0.368 ± 4
Mean 0.109 0.412
Significance value* 0.007
‘–’ Indicates that data could not be given because of lack of DNA
extract; ND indicates that the genes were not detected, because the
quantity was below the level of detection for the assay.
*The significance value calculated by paired samples t-test is below
0.05, indicating that the difference between mean value observed for
the two assays targeting P. aeruginosa genes is statistical significant.
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lung, which can be identified by culture analysis, corre-
lates with results we have previously published, where the
sole presence of P. aeruginosa in end-stage CF lungs was
found (Bjarnsholt et al., 2009). This is in contrast to most
other studies of diversity in CF, either performed on sam-
ples from ex-planted lungs (Willner et al., 2011) or expec-
torated sputum samples (Harrison, 2007; Worlitzsch
et al., 2009; Rogers et al., 2010; Stressmann et al., 2011).
The reason for this is probably the aggressive antibiotic
treatment administered in Denmark.
Table 3. Identification of microorganisms found in patients with end-stage and non-end-stage CF by culturing
Identified microorganisms
End-stage patient 1* Achromobacter xylosoxidans
End-stage patient 2* Pseudomonas aeruginosa
End-stage patient 3* P. aeruginosa
End-stage patient 4* P. aeruginosa Stenotrophomonas maltophilia
End-stage patient 5* A. xylosoxidans
Non-end-stage patient 1 P. aeruginosa Yeast
Non-end-stage patient 2 Staphylococcus aureus P. aeruginosa
Non-end-stage patient 3 P. aeruginosa Aspergillus sp. Yeast
Non-end-stage patient 4 P. aeruginosa
Non-end-stage patient 5 P. aeruginosa
Non-end-stage patient 6 S. aureus Burkholderia cepacia Yeast
Non-end-stage patient 7 P. aeruginosa Yeast
Non-end-stage patient 8 P. aeruginosa Yeast
Non-end-stage patient 9 S. aureus Haemophilus influenza Aspergillus sp.
Non-end-stage patient 10 P. aeruginosa
Non-end-stage patient 11 P. aeruginosa Yeast
Non-end-stage patient 12 S. aureus Haemophilus influenza Yeast
Non-end-stage patient 13 S. aureus S. maltophilia Aspergillus sp.
Non-end-stage patient 14 P. aeruginosa Yeast
Non-end-stage patient 15 P. aeruginosa S. aureus Yeast
*Data from Rudkjøbing et al. (2011).
(a) (b)
(c) (d)
Fig. 1. PNA FISH visualization of bacterial aggregates/biofilms in expectorated sputum of patients with non-end-stage CF. Frame (a), (c), and (d)
show Pseudomonas aeruginosa (red), and other bacterial species (green) and frame (b) show Staphylococcus aureus (red) and other bacteria
(green). As seen from the pictures, the biofilms of different species seem to be segregated from each other.
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The measurements of the two P. aeruginosa-specific
genes gave significantly different results, with the assay
targeting ecfX giving the highest numbers (Tables 1 and 2).
This could be caused by the use of different fluorescent
reporters in the assays or by the length of the amplicons
(ecfX amplicon was 64 bp, compared to 504 bp for oprL); a
smaller amplicon is preferable to ensure reliable amplifica-
tion. Further problems with the oprL assay have been dis-
cussed elsewhere (Anuj et al., 2009). The measurements
were normalized, both to the total number of bacterial cells
(based on number of 16S rRNA genes) and to the total
DNA content of the samples. It was found that P. aeruginosa
constituted more than 100% of all bacteria in all cases
except for two subsamples of patient 4 (Table 1). It is not
realistic, the reason probably being the general nature of
the 16S rRNA gene assay, because nucleotide mismatches
are allowed during primer design to target as many bacteria
as possible. The 907R primer has one mismatch in the 16S
rRNA gene of P. aeruginosa, so although the target
sequence is amplified, the efficiency may be insufficient to
provide correct quantification of P. aeruginosa 16S rRNA
genes. Also, it was not possible to quantify the 16S rRNA
genes in four samples (patient 3 subsamples sputum 1, spu-
tum 2, and tissue 3, and patient 4 subsample sputum 4)
(Table 2), although both P. aeruginosa-specific assays
showed that the number of P. aeruginosa was above the
limit of detection for the 16S rRNA gene assay. This indi-
cates that this 16S rRNA assay is not suitable for the task
and emphasizes the caution one should exercise when
examining these types of results. Therefore, the real-time
PCR measurements were normalized to the total DNA
content to give an impression of the heterogeneous distri-
bution of P. aeruginosa in the samples (Table 2). The low
percentage obtained by this normalization is because of the
large amount of DNA originating from host cells.
Molecular methods are strongly influenced by the DNA
extraction protocol. Despite this fact, generally, few publi-
cations exist where the extraction method is evaluated
before molecular methods are applied to CF-related sam-
ples. For CF sputum, one study exists, which is con-
ducted by Deschaght et al. (2009), where different
protocols were used to extract DNA from P. aeruginosa
and compared to culturing sensitivity. The extraction
protocol giving the best sensitivity included a proteinase
K pretreatment step with a sensitivity equal to that of cul-
turing (Deschaght et al., 2009). The extraction protocol
used in our study included proteinase K pretreatment.
We tested the efficiency of the selected extraction proce-
dure and found it to be appropriate for lung tissue sam-
ples when the target Gram-positive organism was present
in sufficient numbers (over 500 cells). However, the effi-
ciency of our protocol should be investigated with regard
to Gram-positive and Gram-negative bacteria and also
compared to other available DNA extraction protocols
before it can be recommended as a universal protocol for
lung tissue samples.
The low diversity found in Danish end-stage patients
does not represent the other levels of chronic infection in
the CF lungs. In fact, many of the patients with CF at the
Copenhagen CF Clinic harbor several species in their
lungs. The reports of the multispecies microbiota of the
CF lung (Rogers et al., 2010; Guss et al., 2011; Stressmann
et al., 2011) and other investigations of chronic infections
such as chronic wounds (Dowd et al., 2008) speculate that
an interaction occur between species, increasing the path-
ogenesis. In order for different species to interact, they
must reside within close proximity to each other. As seen
from the culturing (Table 3) and PNA FISH data from the
non-end-stage samples (Fig. 1), earlier in the chronic
infection, more species are often present. Depicted from
the PNA FISH observations, a direct interaction likely
does not take place, as we have previously discussed
(Burmølle et al., 2010). Whether a synergy exists between
the different species is difficult to determine at the present
time. The segregation of species is the same as has been
observed in chronic wounds (Bjarnsholt, 2008; Kirketerp-
Moller et al., 2008; Fazli et al., 2009), but very different
from the intestines and oral flora (Burmølle et al., 2010).
We believe that this is a general phenomenon of the
chronic infections we have studied and caused by the lack
of competition between the species. It is possible that the
bacteria signal to each other between the distinct micro-
colonies, a possibility we are currently testing in vitro. On
the other hand, the Danish patients with CF do not seem
to experience improvements in lung function going from
multispecies to a more monospecies infection. Factors
mediating an improvement or decline in lung function are
either eradication or shift of the dominating bacteria,
respectively, because of, at least in part, the intensive anti-
biotic treatment. A decline in lung function is observed
when the patient with CF experiences a downshift in
diversity, for instance when dominated by B. cepacia com-
plex (Hansen et al., 2010) or Pandoraea apista (Jørgensen
et al., 2003).
As the techniques for the identification of bacteria are
improved, our knowledge of the microorganisms present
during various diseases is expanded, and the challenge
becomes to identify whether the dominant bacterium alone
causes the pathology or the less abundant bacteria add to
this as well. To determine the role of these microorganisms
in a diverse community, we need to study these in the habi-
tat of interest (Koch, 1884; Bjarnsholt et al., 2011).
In conclusion, our results show that the microbial
diversity in Danish patients with CF is minimized by the
time of lung transplantation, compared to earlier stages
of chronic infection. Furthermore, even when multiple
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species were identified in CF sputum, no physical interac-
tion could be observed between the different species. The
results indicate that Danish patients with CF harbor more
homogenous microbiota than patients in other countries
because of administration of aggressive antibiotic treat-
ment and the fact that standard culturing identifies the
dominating pathogens.
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Abstract 
Cystic fibrosis (CF) is a genetic disease characterized by intermittent and chronic lung infections. Nearly all 
CF patients have bacteria in their sinuses, which may serve as reservoirs for lung colonizations. Culture often 
detects Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, coagulase-negative 
staphylococci, Aspergillus sp. and other known CF-related microorganisms in the sinuses, but surprisingly few 
anaerobic bacteria are cultured.  
In this study, sinus samples from 19 CF patients were examined using routine culture methods and molecular 
methods performed on microbial DNA of intact cells including broad-range 16S rRNA gene clone libraries 
and species-specific quantitative polymerase chain reaction (qPCR). The objective was to study the bacterial 
diversity, and determine if anaerobes were present in the sinuses. 
In 63% of the cases, polymicrobial infections were found by culture. The molecular methods found a greater 
bacterial diversity and 84% of cases were found to be polymicrobial. Some of the microorganisms found only 
by molecular methods were anaerobic and facultative anaerobic bacteria. The greater diversity found by 
molecular methods may be due to growth of microorganisms in biofilms, which represents a challenge for 
identification of microorganisms by culture. However, contamination by the nasal flora during sample 
acquisition cannot be ruled out and may influence the additional bacteria detected by the molecular methods. 
Using qPCR it was found that P. aeruginosa and S. aureus were generally more abundant than the anaerobe 
Propionibacterium acnes. Tests based on RNA indicated that the selective DNA extraction protocol using 
Molzym’s MolYsis™ pretreatment had worked and that DNA originated from intact bacterial cells. Though 
CF pathogens were extraordinary found by molecular methods, the clinical relevance of the diverse microbial 
flora found by these methods needs to be further examined.  
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Introduction 
Cystic fibrosis (CF) is an autosomal recessively inherited disease characterized by abnormal transport of 
sodium and chloride across epithelial cells, leading to increased mucus viscosity and decreased mucociliary 
clearance. This makes the mucus more susceptible to infections [1,2]. The disease affects several organs, and 
the primary cause of the high mortality in CF is chronic lung infections [3,4].  
CF patients have thickened mucosa in the paranasal sinuses, decreased oxygen tension [5], and most of them 
are thought to have bacteria in their paranasal sinuses [6]. Culture-based methods have shown that sinus 
infections in CF patients most often are caused by Staphylococcus aureus and Pseudomonas aeruginosa, 
[3,7,8] with some reports of Haemophilus influenzae [3,8,9], α-hemolytic streptococci [7,8] and few reports of 
anaerobes (including Peptostreptococcus sp., Bacteroides oralis and Propionibacterium acnes) [8]. Cross 
infections between sinuses and lower airways are likely to occur in CF patients since a high correlation 
between sinus and sputum cultures has been found [2–4,10,11]. Recent studies using DNA-based techniques 
have shown that the sinuses serve as a reservoir for lung colonization and infection of the lower airways 
[2,12]. Since the sinuses have some physiological similarities with the lungs, such as similar mucous lining 
and defective ion channel [5,12], the bacteria in the sinuses can become pre-adapted to the conditions of the 
lungs [12,13]. This may account for the recurrent lung infections after antimicrobial eradication and is a 
concern for lung transplant patients, since it is possible that the lung become re-colonized with pathogens from 
the sinus reservoir [2]. 
Eradication of pathogenic microorganisms in CF sinuses may delay chronic lung infections, thus improving 
morbidity and prolonging lifespan [4,14,15]. We have investigated the microbial community in sinus samples 
obtained during extended image guided functional endoscopic sinus surgery (FESS) [6]. The experience at the 
Copenhagen CF center has been that samples from such surgeries do not result in growth of anaerobic 
microorganisms. No anaerobic species have been cultured from the sinuses during a two-year sampling period, 
and anaerobic culture has been stopped for this sample type due to cost considerations, which has also been 
suggested by other authors [16]. This is in contrast to the findings by others, where anaerobes could be found 
in up to 15 % of CF sinus cultures [8,9]. The lack of anaerobic microorganisms in the sinuses of CF patients at 
the Copenhagen CF center, raises the question whether the used culture methods identifies all the 
microorganisms present in the sinuses. Since microorganisms may reside in biofilms within the sinuses, 
culture methods may not be able to identify them. In this study, we compared the findings of routine culture 
methods to molecular methods including construction of broad-range 16S rRNA gene clone libraries and 
species-specific quantitative polymerase chain reaction (qPCR).   
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Methods 
Patients and treatment 
All patients included in this study have been followed at the Copenhagen CF Centre in Denmark by monthly 
visits to the outpatient clinic. A total of 19 patients undergoing sinus surgery at the Department of 
Otorhinolaryngology, Head and Neck Surgery and Audiology (Rigshospitalet, Copenhagen, Denmark) were 
included in the study, 10 females, 9 males (age 6–45 years, median 22 years).  
Patients were selected for surgery based on the following criteria: 1) Intermittent lung colonization with 
prolonged declining lung function, despite intensive antibiotic-chemotherapy and/or increasing antibodies 
against pathogenic Gram-negative bacteria. 2) Patients who had undergone lung transplantation within one 
year. 3) Patients with severe symptoms of chronic rhinosinusitis according to European Position Paper on 
Rhinosinusitis and Nasal Polyps (EPOS) guidelines [17]. 
Ethics 
The study was approved by the local ethics committee (H-A-2008-141). All patients gave informed consent; 
for patients <18 years
 
of age a consent was also obtained from their parents. 
Surgical procedure 
Surgery was performed as an extended FESS, comprising at least an anterior ethmoidectomy and a medial 
antrostomy enlarging the natural maxillary ostium, so the sinuses could be explored and cultured during and 
post surgery, as described previously [6]. Briefly, visible intramucosal abscess looking structures were 
resected along with swollen and inflamed tissue when accessible. The purpose of surgery was to create 
ventilation and drainage for the sinuses, allowing postoperative medical irrigations. No local disinfectants 
were used in the nose. Samples for culture and molecular investigations were obtained in parallel. Multiple 
samples were prioritized for culture containing nasal secretions, pus, mucosal tissue and polyps (if present). 
Samples from each anatomic location where mixed and one sample containing tissue and secretions was taken 
for molecular investigations. Samples for culture were divided into subsamples and were investigated 
immediately, while samples for molecular methods were stored in glycerol for subsequent DNA extraction. 
For four patients (patient 14, 15, 16 and 19), an additional subsample was stored in RNAlater® solution 
(Invitrogen, Carlsbad, California) for subsequent RNA extraction. Stored samples were kept at -80 °C. All 
molecular investigations were performed at the Life Science Division (Danish Technological Institute, Aarhus, 
Denmark) and the Department of Biotechnology, Chemistry, and Environmental Engineering (Aalborg 
University, Aalborg, Denmark). 
Culture experiments 
Samples for culture were investigated at the Department of Clinical Microbiology (Rigshospitalet, 
Copenhagen, Denmark). Investigations included Gram-stained smears along with aerobic cultures on a range 
of media: Sabouraud plate, 7% NaCl plate, B. cepacia plate containing Colistimethate sodium and 
Gentamicin, “blue plate” (modified Conradi Drigalski’s medium) selective for Gram-negative bacteria and 
non-selective media including 5% Danish blood agar and chocolate agar (State Serum Institute, Copenhagen, 
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Denmark). Isolated bacteria were identified as previously described [18]. Direct plating of tissue samples and 
pus on a 14 cm blood agar plate with discs containing anti-pseudomonas antibiotics was used for primary 
susceptibility testing (Rosco® Neosensitabs, Taastrup, Denmark). The culture reports included only 
microorganisms known as potential human pathogens. 
DNA extraction 
Genomic DNA (gDNA) from intact bacterial cells was extracted from all 19 samples using MolYsis Basic 
(Molzym, Bremen, Germany) followed by the FastDNA® SPIN Kit for Soil (MP Biomedicals, Illkirch, 
France) according to the manufacturers’ protocols. The gDNA was eluted in 75 µL DEPC-treated water. 
RNA extraction and cDNA synthesis 
RNA was extracted from samples from four patients (patient 14, 15, 16 and 19) using the RNeasy PLUS mini 
kit (Qiagen, Hilden, Germany) according to the manufacturer's guidelines. The optional DNase treatment step 
was included to minimize the amount of gDNA co-eluting with the RNA. To secure a cleaner product, the 
RNA extraction was repeated for each extract. The RNA concentration was measured using the NanoDrop 
1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, Delaware), and complementary DNA 
(cDNA) was synthesized from 100 ng RNA using the SuperScriptTM III First Strand Synthesis System for 
RT-PCR (Invitrogen) with random hexamers according to the manufacturer's guidelines. Controls without 
reverse transcriptase were included to check for the presence of gDNA. 
Construction and analysis of clone libraries 
Clone libraries were constructed for the extracted gDNA and analyzed as described previosly [19]. Briefly, 
PCR amplicons of near full-length 16S rRNA genes were cloned using TOPO TA Cloning ® kit (Invitrogen) 
and DNA templates were prepared by rolling circle amplification with Illustra
TM
 TempliPhi Kit (GE 
Healthcare, Buckinghamshire, United Kingdom) according to the manufacturer’s instructions. Sequencing was 
performed by Macrogen Inc. (Korea) using M13F primer (and M13R primer in some cases). Manual 
refinement of sequences and construction of consensus sequences were done in CLC Main Workbench (CLC 
bio, Aarhus, Denmark). Sequences were checked for chimeras using the Mallard software package [20], 
aligned using SINA Web Aligner [21] and imported into the ARB software package [22] for taxonomic 
lineage assignment, using the non-redundant (NR) SSU Ref database from SILVA Release 106 as reference 
database. Operational taxonomic units (OTUs) were constructed across all patient samples for clones having a 
sequence similarity of more than 97% since these sequences are typically assigned to the same species [23]. 
One clone from each OTU was sequenced with both M13F and M13R primers. The resulting consensus 
sequences and their closest relatives in the database were selected to calculate phylogenetic trees using 
neighbor joining, maximum parsimony and maximum likelihood methods. The non-redundant, near full-
length 16S rRNA gene sequences, representing each OTU obtained in this study, were deposited in GenBank 
under the accession numbers JQ794610-JQ794658. The proportion of the population represented in the clone 
library was estimated by the coverage ratio                    . Here n1 is the number of OTUs 
containing only one sequence and N is the total number of sequences in the clone library [24].  
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Quantitative PCR 
Based on the findings in the clone libraries and by culture, a variety of qPCR assays were applied to the gDNA 
and cDNA obtained from the patient samples. The assays used hydrolysis probe chemistry and targeted P. 
aeruginosa, P. acnes and S. aureus (Table 1). For each sample triplicate 25 µL reactions were run, each 
containing: 12.5 µL Brilliant® qPCR Master mix (Agilent Technologies, Santa Clara, California), 25 µg BSA 
(Sigma-Aldrich, Brøndby, Denmark), appropriate concentration of primers and TaqMan® probes (Table 1), 
0.75 µM ROX reference dye (Agilent Technologies, Santa Clara, CA) and 2 µL of template DNA. The DNA 
standard was synthesized plasmids containing the respective target gene sequences (GenScript, Piscataway, 
New Jersey). The standard curve was prepared from serial dilution of plasmid (10
0
 to 10
7
 copies µL
-1
). 
Reactions were run on an Mx3005P (Agilent Technologies) with the following program: 10 min at 95°C, 
followed by 40 cycles of 30 s at 95°C, 30 sec at 60°C and 60 s at 72°C.  
Analysis of quantitative data 
The number of gene copies measured by qPCR on gDNA was converted to number of CFU per gram sample 
using C   g 
Cmeasured Cgenome ( total  used )
msample
  . Here Cmeasured is the number of copies measured and 
Cgenome is the number of gene copies in the genome of one CFU. The standard deviation of all measurements 
above the detection limit of the assays was calculated. For samples where more than one bacterium could be 
quantified, a two tailed T-test was used to provide a hypothesis test of the difference between population 
means. A statistical value of ≤ 0.05 was considered significant.  
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Results 
Molecular methods 
The 16S rRNA gene clone libraries constructed for all 19 patients showed a great diversity of microorganisms 
with clones grouped into 49 OTUs. All clone libraries had a coverage ratio above 90%, except for patient 5 
(86% coverage ratio), indicating that the majority of microorganisms in the samples was detected. Identity of 
the clones was determined based on their closest relatives in the SILVA NR SSU Ref database, release 106. 20 
of the found OTUs consisted of only 1-2 sequences found in the clone library of a single patient. The identity 
of the clones were either opportunistic human pathogens (Brevundimonas vesicularis, Brevibacterium 
frigoritolerans, Alcaligenes faecalis, Aerococcus viridians, Dermabacter hominis and Massilia sp.), 
environmental bacteria (Mesorhizobium plurifarium, Telmatospirillum siberiense, Alkalibacterium pelagium, 
Shimazuella kribbensis, Burkholderia tuberum, Burkholderia soli, Defluviicoccus sp., and Myxococcales sp.) 
or bacteria where the source could not be determined (6 different OTUs identified as uncultured bacteria). For 
clarity reasons these 20 OTUs were not included in the following analyses. The phylogenetic trees constructed 
from near full-length consensus sequences, representing each OTU, were considered to be robust, as congruent 
phylogenetic relationships were obtained by neighbor joining, maximum parsimony and maximum likelihood 
methods. Sequences were distributed into 6 phyla: Proteobacteria, Actinobacteria, Firmicutes, Bacteroidetes, 
Cyanobacteria and Acidobacteria. The last three phyla contained only one OTU each (OTU-26, OTU-13 and 
OTU-23 respectively). Maximum likelihood trees of the three major phyla are available as supporting 
information (Figure S1).  
The most frequently detected sequences across all clone libraries were identified as Cyanobacterium sp. (95 
clones in 9 patients), P. acnes (65 clones in 9 patients), Ralstonia sp. (57 clones in 9 patients), S. aureus (166 
clones in 6 patients), A. xylosoxidans (125 clones in 6 patients), P. aeruginosa (47 clones in 3 patients), 
Serratia marcescens (28 clones in 2 patients) and Streptococcus salivarius (35 clones in 2 patients) (Table 2). 
These 8 OTUs constituted 82% of all sequences. QPCR was performed to confirm presence of P. aeruginosa, 
P. acnes and S. aureus and determine the relative abundance of these pathogens in the samples (Table 3). For 
P. aeruginosa and S. aureus (except for patient 17), qPCR confirmed the findings in the clone libraries. For P. 
acnes, qPCR confirmed the clone libraries in only one of nine cases (patient 11). The quantitative 
measurements indicated that P. aeruginosa and Staphylococcus sp. were generally present in high numbers, 
whereas P. acnes was less abundant than other species in the same sample. For patient 2, 8 and 11 it was 
possible to quantify more than one bacterium, and the measurements obtained by the different assays were 
statistically significant (P value 0.01, 0.0004 and 0.01 respectively). Surprisingly, in three cases (patient 8, 11 
and 18) it was possible to detect P. aeruginosa by qPCR, although this species was not found in the clone 
libraries. To confirm that the molecular findings resulted from intact living bacteria and not from naked DNA 
residing in the samples (which was the rationale for using the MolYsis technology for DNA extraction) RNA 
was extracted from four samples (patient 14, 15, 16 and 19) and cDNA synthesized before qPCR. The results 
of qPCR on cDNA were in accordance with the measurements made on gDNA (data not shown), indicating 
that the applied extraction protocol, targeting only intact bacterial cells, was effective. 
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Comparison of culture and molecular methods 
The bacterial diversity revealed by culture was generally smaller than what was found by molecular methods: 
overall, eight different microorganisms were identified by culture methods (Table 2). Of all microorganisms 
identified in this study, only a small part could be identified by both culture and molecular-based methods, as 
illustrated in Figure 1 A and B. These microorganisms were P. aeruginosa, S. aureus, S. marcescens, A. 
xylosoxidans and coagulase-negative staphylococci (CNS) (Table 2 and 3). Although the methods had the 
ability to identify these microorganisms, culture results could not be confirmed by molecular methods in all 
cases or vice versa (Table 3); importantly, the CF pathogen A. xylosoxidans was not found by culture in two 
patients (patient 12 and 13), where molecular methods indicated the pathogen was present. Furthermore, for 
five patients, none of the microorganisms identified by culture was found by molecular methods, as illustrated 
in Figure 1 C and D. The molecular methods identified eight different anaerobic and facultative anaerobic 
bacteria (Table 2), which could not be found by culture due to lack of anaerobic testing. 
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Discussion 
The realization that cross-infections between sinuses and lower airways take place in CF patients has led to 
increased focus on eradication of pathogenic bacteria from the sinuses. FESS enables irrigation of the sinuses 
with antibiotics, which may hamper microbial colonization of the sinuses and thereby possibly reduce the 
incidence of lower airways infection. Correct identification of the involved microorganisms is important to 
target the microorganisms present in the sinuses. The literature regarding sinus flora in CF patients has 
primarily been based on culture methods. The microorganisms found by culture in this study (Table 2) 
generally corresponded to findings by other authors; P. aeruginosa and S. aureus [2,3,7–9], Aspergillus sp. 
[2,7], S. marcescens, Enterobacter aerogenes and CNS [2]. A. xylosoxidans is a recently recognized pathogen 
in CF and may as such be found in the sinuses [9]. The remaining cultured microorganism is Bordetella 
bronchiseptica, which is a respiratory tract pathogen of mammals [25]. However, this bacterium has a high 
phenotypic affinity to A. xylosoxidans [26] and has probably been misidentified based on the findings in the 
clone library (Table 2). By culture methods, a total of eight different microorganisms were found in 19 
patients, with a median value of two different microorganisms per patient. The incidence of polymicrobial 
infections was 63%, which is higher than reported elsewhere [3,8,9].  
The flora found in the sinuses by molecular methods was very diverse compared with that found by culture 
(Table 2). The clone libraries revealed that anaerobes and facultative anaerobes (OTU1-8) were present in the 
sinuses of Danish CF patients followed at the Copenhagen CF center, although lack of anaerobic growth over 
a two-year period had led to discontinuation of anaerobic culture of sinus samples. A reason for the lack of 
anaerobic detection may be that organisms such as P. acnes (which were identified in the sinuses of nine 
patients) may require >10 days’ incubation [27], or that species such as P. acnes are not reported since they 
are considered a part of the normal skin flora. Overall, the clones were grouped into 49 OTUs, with a median 
value of 5 OTUs per patient. The incidence of polymicrobial infections found by molecular methods was 84%. 
Of the 49 OTUs identified in the clone libraries, only five of the bacteria could be found by the used culture 
methods (Figure 1 A and B), these bacteria were: A. xylosoxidans, P. aeruginosa, S. aureus, S. marcescens and 
CNS (since some clinical strains of S. aureus may be atypical and have no production of coagulase [28], CNS 
were considered found in the clone libraries if S. aureus was identified). However, the two methods did not 
agree in all cases where these five bacteria were identified (Table 2). A. xylosoxidans was found in the clone 
libraries for two patients and S. aureus in one clone library, where culture could not confirm the findings. Both 
bacteria are known to be CF pathogens, and therefore the lack of detection by culture is serious. Conversely, 
there were several cases where the microorganisms detected by culture could not be confirmed in the clone 
libraries or by qPCR; for CNS, a total of eight cases, four cases of P. aeruginosa and two cases of A. 
xylosoxidans. For P. aeruginosa there were 3 additional cases where the bacterium could not be found in the 
clone library but was quantified by qPCR (Table 3). It is possible that the universal primers that were used 
during construction of the clone libraries have a low affinity to the target region in the P. aeruginosa genome 
or that the high G+C content in the genome (approximately 66% [29]) influenced the efficiency of 
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amplification. Generally, the so-called universal 16S rRNA primers are not truly universal since no primers of 
sufficient length can be designed to match all bacteria [30]. 
The clinical relevance of the diverse microbial flora detected in the clone libraries is unknown, and evaluation 
of the findings is a recurring issue for studies using similar molecular methods. It has been suggested that the 
mere presence of a bacterium does not necessarily mean that it contributes to the pathogenesis of an infection 
and, thus, may not merit treatment [31]. However, it has also been argued that high bacterial diversity 
promotes persistence of chronic infections [32]. Besides the bacteria described above, most of the OTUs 
consisting of many clones have previously been identified in the sinuses of CF patients. These included P. 
acnes [8], corynebacteria (in this study C. appendicis and C. simulans) [2,7], Ralstonia sp. [2], α-haemolytic 
streptococci (in this study Streptococcus salivarius) [2,8] and Stenotrophomonas maltophilia [2,3]. 
Furthermore, many of the microorganisms detected in this study are known CF pathogens (indicated by * in 
Table 2). Some of the identified microorganisms may be contaminants from the skin, which are liberated on 
squamous epithelial cells and inhaled through the nose which will indiscriminately be detected by molecular 
methods. There seemed to be no clear correlation between frequency of detection in clone libraries, number of 
bacteria (based on qPCR measurements) and identification by culture. By performing qPCR, the presence of 
P. aeruginosa, S. aureus and P. acnes was confirmed in some but not all cases, and their relative abundance in 
the samples could be determined. Although only one sample (patient 11) contained sufficient amounts of P. 
acnes genes for reliable quantification, a low level amplification just below the quantification limits was 
observed in samples where bacterium was found in the clone libraries. The results indicated that P. aeruginosa 
and S. aureus were more abundant than the anaerobic P. acnes.  
The finding of a larger microbial diversity by molecular methods compared to the findings by culture is 
common for this type of comparison. An explanation of this discrepancy is often that molecular methods 
cannot distinguish living and dead microorganisms, whereas culture only identifies living and dividing 
microorganisms. This should not be the case in this study, since the DNA extraction protocol was targeted 
DNA of intact microbial cells by inclusion of a MolYsis (Molzym, Bremen, Germany) pretreatment step that 
degrades human DNA as well as any naked bacterial DNA residing in the sample. Since qPCR on gDNA and 
cDNA gave comparable results for the four samples where RNA had been extracted, our results suggest that 
the DNA extraction protocol yielded DNA from active microorganisms.  
It has been proposed that chronic sinus infections are due to formation of biofilm [33]. The bacteria in the 
sinuses can be locally faced with nutrient limitations i.a. reduced airflow, lower oxygen tension and anoxic 
conditions [5], which may facilitate mucoid phenotypes and biofilm formation abilities [12]. Bacterial biofilm 
represents a challenge for culture methods, which are primarily suitable for planktonic microorganisms. It is 
now recognized that this phenotype represents only a minor aspect of the life cycle of microorganisms 
involved in chronic diseases. It is therefore highly probable that culture methods underestimate bacteria 
present in disease [31,32]. Biofilms have now been implicated in many infectious diseases and it has been well 
established that these exhibit a heterogeneous distribution of microorganisms, with a trend of monospecies 
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aggregates even though the infection overall is multispecies [31]. This may account for the discrepancy 
between findings by the different methods in this study, since it is possible that the one sample used for 
molecular methods from each patient does not represent the entire microbial community. Also, since the 
results from culture were based on several samples it is possible that these samples contain microorganisms 
that were not present in the one sample used for molecular methods. 
The clinical implication of the microbial flora found in the sinuses of CF patients is difficult to ascertain. 
Studies have been conducted where the isolates of normal sinus flora were identified [34], but to our 
knowledge no studies have compared the normal and CF sinus flora as determined by molecular methods. 
Such a comparison will be of interest to perform in future studies of the sinus flora in CF patients. 
Study limitations 
When obtaining samples from the sinuses, we cannot exclude that the samples were contaminated with flora 
from the air and anterior part of the nasal cavity, since the focus during the FESS operation was to avoid upper 
pharynx flora. This may account for presence of environmentally related microorganisms found using 
sensitive molecular methods. Further these microorganisms may not be included in the culture reports from 
the Department of Clinical Microbiology where only microorganisms known as potential human pathogens 
were reported.  
Furthermore, we cannot be certain that the samples for culture and the sample for molecular methods 
contained exactly the same bacterial species, since the sample volume for culture was larger than for 
molecular methods. A future study should include investigations by molecular methods on multiple samples in 
order to enable investigation of a possible heterogeneous distribution of the microorganisms. Also, different 
sample types (nasal secretion, mucosal tissue, polyps etc.) should be segregated in order to access which 
sample types has the highest yield of microbial diversity and quantity of different species.  
  
12 
 
Conclusion 
Of potentially great clinical importance is the detection of anaerobic bacteria, which were not cultured due to a 
discontinuation of anaerobic cultures for CF sinus samples. The anaerobic and facultative anaerobic bacteria 
may be relevant human pathogens, and calls into question the used diagnosis methods. Anaerobic and other 
microorganisms may reside in biofilms in the sinus, which could explain the lack of detection by culture. 
Another important finding involves A. xylosoxidans, a CF-related pathogen of great clinical relevance due to 
its ability to rapidly develop multi-drug resistance, spread from patient to patient and cause lung morbidity. 
Detection of the pathogen by culture and molecular methods gave discrepant findings and in two cases culture 
was not able to detect the bacterium (either due to lack of growth or misidentification). Such lacks of 
identification can have major implications for the patients e.g. delayed antibiotic therapy, decreased lung 
function and patient to patient spread. The findings in this study indicate that a combination of culture and 
molecular methods may improve diagnosis of sinus infections, since both methods have advantages and 
limitations. If bacteria are cultured, their antibiotic susceptibility can be easily investigated, but the bacterial 
flora may be underestimated. For molecular methods, the problem is that extraction of DNA/RNA may be 
insufficient. The ability of performing sensitive molecular-based detection of microorganisms has posed a 
great challenge of our understanding of pathogenesis of infection and the definitions of positive culture 
reports, which needs to be addressed before the full potential of the methods can be exploited. 
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Figures 
 
Figure 1: Venn diagrams of microbial findings. A: the number of microorganisms found only by molecular 
methods and B: the number of microorganisms found only by culture, five microorganisms could be found by 
both types of methods. C: The patients, where all the cultured microorganisms could be found by molecular 
methods, and D: patients, where none of the cultured microorganisms could be found by molecular methods. 
For seven patients some, but not all, of the cultured microorganisms could be confirmed by molecular 
methods. 
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Tables 
Table 1: Assays used for qPCR in this study. 
Target (gene)  Sequence (5’→3’) Conc. [nM] Ref. 
P. acnes (16S rRNA) F GCGTGAGTGACGGTAATGGG 500 [35] * 
P. acnes (16S rRNA) R TTCCGACGCGATCAACCA 500 [35] 
P. acnes (16S rRNA) TM FAM-CGCCCAATAAATCCGGACAACGCT-BHQ 200 [35]* 
P. aeruginosa (GyrB) F CCTGACCATCCGTCGCCACAAC 250 [36] 
P. aeruginosa (GyrB) R CGCAGCAGGATGCCGACGCC 250 [36] 
P. aeruginosa (GyrB) TM FAM-CCGTGGTGGTAGACCTGTTCCCAGACC-BHQ 200 [37] 
S. aureus (FemA) F TGCCTTTACAGATAGCATGCCA 1000 [38] 
S. aureus (FemA) R AGTAAGTAAGCAAGCTGCAATGACC 500 [38] 
S. aureus (FemA) TM FAM-TCATTTCACGCAAACTGTTGGCCACTATG-BHQ 200 [38] 
Table 1 footnote: * the sequence has been modified from that in the reference by removing the last two 
nucleotides in F primer and using the reverse complimentary sequence for the TM probe. 
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Table 3: Overview of patients with P. acnes, P. aeruginosa or staphylococci (both S. aureus and CNS). 
The microorganisms were found either by culture (marked C), in the clone libraries (marked M) or by qPCR 
(marked by number of CFU ± the standard deviation).   
 Previous findings CFU per gram sample 
Patient 1 P. acnes
M
 - 
 P. aeruginosa
C, M 
3.3*10^6 ±1% 
 CNS
C
 - 
Patient 2 P. aeruginosa
C, M
 1.3*10^6 ±6% 
 S. aureus
C, M
 and CNS
C
 2.1*10^7 ±15% 
Patient 3 P. acnes
M
 - 
Patient 4 P. aeruginosa
C
 - 
Patient 5 S. aureus
M
 and CNS
C
 4.5*10^7 ±21% 
Patient 6 CNS
C
 - 
Patient 7 P. aeruginosa
C, M
 1.5*10^7 ±7% 
Patient 8 P. aeruginosa
C
 1.8*10^6 ±3% 
 S. aureus
M
 and CNS
C
 1.1*10^4 ±4% 
Patient 9 S. aureus
C, M
 1.1*10^9 ±16% 
Patient 10 P. acnes
M
 - 
 CNS
C
 - 
Patient 11 P. acnes
M
 3100 ±7% 
 P. aeruginosa
C
 3.6*10^4 ±6% 
Patient 12 P. acnes
M
 - 
 CNS
C
 - 
Patient 13 P. acnes
M
 - 
 P. aeruginosa
C
 - 
 CNS
C
 - 
Patient 15 CNS
C
 - 
Patient 16 P. acnes
M
 - 
 P. aeruginosa
C
 - 
 CNS
C
 - 
Patient 17 P. acnes
M
 - 
 P. aeruginosa
C
 - 
 S. aureus
M
  - 
Patient 18 P. acnes
M
 - 
 P. aeruginosa
C
 8.3*10^4 ±20% 
 CNS
C
 - 
Patient 19 S. aureus
M
 and CNS
C
 1.2*10^5 ±7% 
Table 3 footnote: - denotes a qPCR result below the detection limit. 
Supporting information 
 
Figure S1: Maximum likelihood trees of the three major phyla found in sinuses of Danish CF patients. 
All trees were calculated with an outgroup consisting of 21 sequences from Thermotogae (not shown) and 
have a scale bar representing 10% estimated sequence deviation. The number in parenthesis indicates the 
number of clones belonging to the OUT and type strains are marked by T. In all 14 OTUs, corresponding to 
307 clones, were assigned to Proteobacteria (A), 6 OTUs, corresponding to 230 clones, were assigned to 
Firmicutes (B) and 6 OTUs, corresponding to 114 clones, were assigned to Actinobacteria (C). 
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ABSTRACT
The bacterial microbiota plays an important role in the prolonged healing of
chronic venous leg ulcers. The present study compared the bacterial diversity
within ulcer material from 14 skin graft operations of chronic venous leg ulcers
using culture-based methods and molecular biological methods, such as 16S
rRNA gene sequencing, fingerprinting, quantitative polymerase chain reaction,
and fluorescence in situ hybridization. Each wound contained an average of 5.4
species but the actual species varied between wounds. The diversity determined
by culture-based methods and the molecular biological methods was different.
All the wounds contained Staphylococcus aureus, whereas Pseudomonas aerugi-
nosa was in six out of 14 wounds. Molecular methods detected anaerobic patho-
gens in four ulcers that were not detected with anaerobic culture methods.
Quantitative polymerase chain reaction was used to compare the abundance of
S. aureus and P. aeruginosa at different locations in the ulcers and their numbers
varied greatly between samples taken at different locations in the same ulcer. This
should be considered when ulcers are investigated in routine clinical care. The
differences between the results obtained with culture-based and molecular-based
approaches demonstrate that the use of one approach alone is not able to identify
all of the bacteria present in the wounds.
Chronic venous leg ulcers (CVLU) are a debilitating and
often painful disease that affects approximately 1% of the
world’s population.1,2 Apart from the human conse-
quences, the treatment of wounds is expensive; in
Denmark alone, wound treatment has been estimated
to cost approximately two billion Danish kroner per
year (US$360 million),2 and in the United Kingdom,
France, and Germany an estimated 1.5–2% of the annual
healthcare budget.3,4
The conditions leading to a CVLU are not fully under-
stood; however, the primary cause is most likely insuffi-
cient valvular function of the veins in the legs causing
increased hydrostatic pressure leading to edema of
the subcutaneous tissue, which predispose to ulceration.
This is linked to old age, obesity, height of the person, he-
reditary increased risk, number of births (more births
lead to increased risk) and occupations in which the
person is mainly standing. By removing edema with com-
pression therapy, most CVLU will heal, but a number of
ulcers will not despite effective treatment. In these cases, a
well-documented and effective treatment is surgical
debridement and split skin transplant.2 Other treatments
like topical negative pressure therapy have been found
useful. Maggot debridement therapy have also proved
promising, which involves having larvae from the fly
Lucilia sericata removing necrotic tissue and bacteria
from the wound, and in this way aiding the wound healing
process.5
One of the factors affecting the effectiveness of wound
healing therapies is the specific microorganisms that colo-
nize the CVLU.6 For example, the presence of Pseudomo-
nas aeruginosa can retard the healing of wounds due to
their ability to form biofilms.6 Many studies describe bio-
film as an important factor for the chronic behavior of
chronic wounds,6–10 and the spatial organization of these
biofilms in a wound might be complex due to, for example,
variations in environmental conditions and population
composition.11 Initial experiments by Bjarnsholt et al.6
showed that P. aeruginosa in CVLU were assembled in
microcolony-based structures unevenly distributed across
the wound surface, and this uneven distribution might lead
to insufficient sampling and wrong diagnosis.6
Until recently, the bacteria associated with CVLU have
only been examined by culture-dependent methods by tak-
ing a swab or biopsy from the wound and using it as inoc-
ulate for various bacterial cultures. The emergence of
molecular biology methods has illustrated that culture-
dependent methods often underestimate the bacteria pres-
ent, and especially ulcers with slow growing, fastidious, or
anaerobic microbes.9,12–14 Davies et al.15 found that 40%
of the organisms identified from CVLU by molecular bio-
logical methods could not be identified by culture-depen-
dent methods, although most were species that are
normally considered culturable.
The purpose of this study was to investigate the micro-
bial diversity of chronic ulcers with molecular biological
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Table 1. Summary of patient datan
Wound
Age of
patient Sex
Treatment of sample
before extraction Antibiotic treatment
Dressing at time
of sampling
Duration
of ulcer
Additional
information
A 85 Male DNA extracted from
the entire wound
None Nonsilver 12 months
B 76 Male DNA extracted from
the entire wound
None Nonsilver 6 months Diabetic
C 54 Male DNA extracted from
the entire wound
None Aquacell Ag Years
D 87 Female DNA extracted from
the entire wound
None Nonsilver 4 months
E 85 Female Wound was cut into
five parts and DNA
extracted separately
None Biatain AG 7 months
F 71 Female Wound was cut into
five parts and DNA
extracted separately
Sulfametizole due to
urinary tract infect
Biatain AG 5 months Diabetic
G 88 Female DNA was extracted
from six biopsies
across the wound
None Biatain AG 4 years
H 82 Male DNA was extracted
from six biopsies
across the wound
None Nonsilver 6 months Diabetic
I 81 Female DNA was extracted
from six biopsies
across the wound
Phenoxymethylpenicillin
until 2 months before
sampling
Nonsilver 4 years
J 78 Female DNA was extracted
from six biopsies
across the wound
Phenoxymethyl-penicillin Nonsilver 6 months
K 65 Male DNA was extracted
from four biopsies
across the wound
None Nonsilver 6 months Diabetic,
impetigo
L 85 Female DNA was extracted
from four biopsies
across the wound
None Biatain AG 7 months
M 69 Female DNA was extracted
from four biopsies
across the wound
None Nonsilver 6 months
N 46 Male DNA was extracted
from four biopsies
across the wound
None Nonsilver 3 years Sample from
Achilles
tendon
Average
age
75.2
nAll DNA extractions were done using a DNeasy Blood and tissue kit except for the samples from wound F and wound E (center),
which was extracted with an E.Z.N.A. Tissue DNA kit due to their greater size. Registered antibiotic treatment 3 months before
sampling is mentioned.
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methods and to compare these results with the conven-
tional culture-dependent techniques. Furthermore, the
spatial organization of bacteria in CVLU was examined.
MATERIALS AND METHODS
Patient population, sampling, and DNA extraction
The excision of biopsies and swabs of the wounds for
culture-dependent and -independent experiments was per-
formed by Copenhagen Wound Healing Center, Bispeb-
jerg Hospital (Copenhagen, Denmark). Samples were
obtained from patients diagnosed with chronic venous leg
wounds just before surgical debridement and split skin
transplant. In total, chronic wounds from 14 patients were
investigated (named as wound A–N). The patients’ age,
sex, antibiotic treatment, dressings at the time of sampling,
and additional information are described in Table 1. Pa-
tients with wound B, F, H, and Kwere also diagnosed with
diabetes mellitus.
All ulcers were chronic and nonhealing despite optimal
wound care and compression therapy. The duration of the
ulcers are shown in Table 1. The patients were not receiv-
ing antibiotic treatment during the three months before
sampling with three exceptions: Patient F was receiving
sulfonametizole at the time of sampling, and patients J and
I had received phenoxymethylpenicillin up until 3 days and
2 months before sampling, respectively. Five of the pa-
tients’ wounds had been dressed with a silver-releasing
dressing in the period before sampling (patient C, E, F, G,
and L). The samples were collected with the patients’ ac-
ceptance and in accordance with the biomedical project
protocol (KA-20051011) approved by the Danish scientific
ethical board.
On the day of surgery, the area surrounding the ulcer
was swabbed with chlorhexidine in 70% alcohol but the
surface of the ulcer was not disturbed. The excised wound
material from the patient was transferred to a sterile
Greiner tube and stored at 20 1C until DNA extraction.
Before DNA extraction, the frozen wounds were
thawed and cut to smaller pieces using sterile disposable
scalpels. The total DNA content of wound F and E was
extracted using an E.Z.N.A Tissue DNA kit (Omega Bio-
Tek, VWR, Herlev, Denmark). Other wounds were cut to
smaller pieces and were extracted using a DNeasy Blood
and Tissue kit from Qiagen (Hilden, Germany). Both kits
are based on proteinase K digestion for 2–4 hours.
Culture analysis
Identification of bacteria from the wounds by culturing
was performed by the Department of Clinical Microbiol-
ogy, Hvidovre Hospital, according to their standard pro-
tocols. Tissue samples were transported in sterile
containers and swabs were transported in Stuart medium.
Anaerobe culturing was performed on anaerobe plates
(Statens Serum Institute [SSI], Copenhagen, Denmark) in
a CO2 atmosphere at 37 1C for 2 and 4 days. Aerobe cul-
turing was performed on horse-blood agar (SSI) and Blue
plates (SSI) for 1 and 2 days, respectively.
16S rRNA gene amplification
The 16S rRNA genes were amplified by polymerase chain
reaction (PCR) using Taq DNA polymerase with primers
targeting conserved domains. The primers were 8F16 and
1390R17 and the samples were amplified according to
Thomsen et al.18 Negative controls including water and
PCR mix were included for every five samples and were
always negative indicating that there was no contamination
of the reagents. Stringent procedures were generally used to
avoid contamination, e.g., by using a PCR cabinet withUV
light and all DNA handling was carried out with aerosol
filter pipette tips to avoid cross contamination.
Cloning, sequencing, and phylogenetic studies
The amplified 16S rRNA gene products were purified with
a Qiaquick PCR purification kit (Qiagen), according to the
manufacturer’s instructions. Cloning was performed using
a TOPO TA Clonings kit (Invitrogen, Taastrup, Den-
mark) for sequencing. Plasmids were purified using a
Fastplasmid mini kit (Eppendorf, Horsholm, Denmark)
and purified plasmids were amplified usingM13 primers to
test for inserts with the correct length. The plasmids were
sequenced by Macrogen Inc. (Seoul, South Korea) using
the M13F primer. The closest relative of the clones were
identified by performing a BLAST search of the sequences
at http://www.ncbi.nlm.nih.gov/blast. At least one repre-
sentative clone from each species was additionally se-
quenced using the M13R primer, in order to obtain
consensus sequences covering the entire length of the
DNA fragments. Checks for chimeric sequences were con-
ducted using the program BELLEROPHON.19
The ARB software20 was used for the alignment of
imported sequences with the FastAligner tool, and align-
ments were subsequently refined manually and phyloge-
netic analysis was performed. Only unambiguously
aligned sequences were used for the calculation of trees
using distance matrix, parsimony, and maximum likeli-
hood approaches using default settings in the ARB
software. The Bacteria sequence conservation filter of the
ssu_jan04_corr_opt ARB database [available at http://
www.arb-home.de]) in addition was applied. Phylogenetic
trees were initially constructed using the consensus se-
quences representing the different groups of bacteria. Sub-
sequently, partial sequences were added to the existing
consensus trees by the ‘‘add species to existing tree’’ func-
tion in the ARB software. Priorly, a filter was carried out
to define which positions to be used in adding the partial
sequences (data not shown). Generally, the results ob-
tained by the NCBI Blast Search corresponded well to the
phylogenetic identifications. The coverage ratio (C) for
each of the clone libraries were calculated with C ¼ ð1
ðn1 N1ÞÞ  100% where n1 is the number of operational
taxonomic units (OTUs) containing only one sequence
and N is the total number of clones analyzed.21
Denaturant gradient gel electrophoresis (DGGE)
fingerprinting
Amplification of samples for DGGE was performed using
primers 341F-GC 22 and 907R.17 The PCR products were
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run on 8% polyacrylamide gels containing denaturant gra-
dients of 30–70%, in 1TAE buffer at 100V overnight us-
ing the D-GENEt gel system (Biorad) and stained with
SYBR Gold (Invitrogen). The most intensive DGGE
bands were excised and prepared for sequencing. The
excised bands were reamplified with PCR, and the PCR
products were thereafter purified using a NucleoSpin
Extract II Machery Nagel and sequenced commercially
by Macrogen Inc.
Quantitative PCR (qPCR)
Pure culture DNA was extracted using a FastDNAs Spin
Kit for Soil (MP Biomedicals, LLC, Illkirch, France), ac-
cording to the manufacturer’s instructions. qPCR targeting
the nuc gene23 and oprL gene24 was used to measure the
amount of Staphylococcus aureus and P. aeruginosa, re-
spectively. For each determination, triplicates of 20mL re-
actions were run with each containing: 12.5mLBrilliants II
SYBRs Green qPCR Master mix (Stratagene, AH Diag-
nostics, Aarhus, Denmark), 25mg BSA, 10mM of each
primer, and 0.75mM reference dye and 5mL of template or
standard. Reactions were run on an Mx3005P (Stratagene)
for 10 minutes at 95 1C, 40 cycles of 30 seconds at 95 1C, 30
seconds at 62 1C (nuc)/ 62 1C (oprL), 60 seconds at 72 1C
and 15 seconds, and SYBR data capture at 80 1C (nuc)/
82 1C (oprL). For S. aureus, the specific product was sepa-
rated at 79 1C and forP. aeruginosa at 90 1C. The specificity
of the PCR reactions performed for each run was con-
firmed by the melting curve analysis and gel electrophore-
sis. Standard curves were prepared from serial dilutions of
S. aureus (DSM 6148) and P. aeruginosa (DSM 1253) ge-
nomic DNA (5106–5101) in AE buffer (Qiagen). The
limit of detection was 100 gene copies per PCR.
Fluorescence in situ hybridization (FISH)
After removal from the patient, the tissue sample was
transferred to 4% neutral formaldehyde buffer and em-
bedded in paraffin wax, cut into 4-mm–thick slides, and
stored at room temperature. Before the hybridization, the
paraffin was removed by xylene. The slides were treated
using a Histology FISH Accessory Kit from DAKO cyto-
mation according to the protocol. Hybridization was per-
formed by covering the slide with 20 mL of hybridization
buffer containing 0.9M NaCl, 0.02M Tris/HCl, 0.01%
SDS, and formamide, depending on the requirement of the
probes and probe mix (5 ng/mL). The probes used were an
EUB mix (EUB-338,25 EUB II-338,26 and EUB III-33826)
targeting most Bacteria; BET42a with GAM42a competi-
tor27 targeting most Betaproteobacteria; a mix of
LGC354b, LGC354A, and LGC354C28 targeting the
Firmicutes, and probe Sau29 targeting S. aureus. For more
information about the probes, consult probeBase.30
Lastly, the slides where treated with Vectashield hardset
mounting mediumwith DAPI (40,6-diamidino-2-phenylin-
dole). Unspecific binding was examined by applying Non-
EUB probes on a slide as described above. This revealed
sporadic nonspecific binding but only with little signal
intensity, and hence it was possible to use probes to
examine CVLU. PNA FISH was performed as described
previously.10
Nucleotide accession numbers
GenBank accession numbers for 16S rRNA gene consen-
sus sequences determined in this study are EU931393-
EU931450.
RESULTS
Culture analysis
Culture analysis of the 14 wounds (A–N) showed the pres-
ence of more than one species in all but one of the wounds
(Tables 2 and 3). Although a diversity of other bacteria
were isolated, S. aureus was detected in 13 wounds, P.
aeruginosa in six, Klebsiella oxytoca in three, and Enter-
ococcus sp. in three wounds. No obligate anaerobic species
were detected in any of the wounds.
DGGE fingerprinting
The results of DGGE fingerprinting are shown in Tables 2
and 3, indicated by an ‘‘S.’’ DGGE detected S. aureus in all
of the wounds except wound C, despite S. aureus being de-
tected by the culture methods. Wound E and F showed the
presence of additional uncultured bacteria. DGGE
showed that the wounds also contained a variety of anaer-
obic bacteria with multiple findings of species such as Fine-
goldia magna, Anaerococcus vaginalis, Peptoniphilus
asaccharolyticus, Peptoniphlus harei, and Peptostreptococ-
cus anaerobius, often with several of these species in the
same wound. P. aeruginosa was detected in only one
wound with DGGE fingerprinting despite its detection in
six wounds using the culture methods. An average of 3.2
species per wound were detected using DGGE fingerprint-
ing and 3.0 species per wound were detected using culture
methods. In combination, DGGE and culture identified
5.4 species per wound.
Clone library and sequence analysis
To elucidate the bacterial diversity in the samples, clone
libraries were constructed where the amplified 16S rRNA
genes were inserted into cloning vectors, thereby a separa-
tion of the different fragments and its subsequent sequenc-
ing were possible. The sequences from the two clone
libraries (clone library 1 from wounds A–F and clone li-
brary 2 from wounds G–N) were divided into OTUs using
a similarity level of > 97%. A total of 60 clones were
sequenced for clone library 1 and 94 clones for library 2.
Table 4 shows the name and accession number of the clos-
est relative for each OTU as identified by the phylogenetic
analysis.
Clone library 1 showed many S. aureus and some Alcali-
genes sp., Anaerococcus sp., Stenotrophomonas sp., Enter-
ococcus faecalis, and P. aeruginosa. Clone library 2 showed
a large amount of S. aureus and P. aeruginosa. Almost all
OTUs have a similarity of > 97% with their closest rela-
tives. Only OTU 9 (uncultured Anaerococcus) in clone li-
brary 1 and OTU 10 Helcococcus kunzii in clone library 2
had a smaller similarity than 97% indicating that these
OTUs had a lower phylogenetic resolution. The coverage
ratio for the clone library 1 was 87.7% and for clone li-
brary 2 was 93.5%.
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The consensus sequences in clone library 1 and 2 were
used to produce phylogenetic trees to determine the
detailed phylogenetic relationship of the 16S rRNA gene
of the clones. A neighbor joining tree, a maximum
parsimony tree, and a maximum likelihood tree all showed
congruent phylogenetic relationships, and the maximum
likelihood tree is shown in Figure 1. The locations on
the tree confirm the BLAST identification of the se-
quences. The sequences are distributed into five phyla:
Proteobacteria, Firmicutes, Bacteroidetes, Fusobacteria,
and Actinobacteria. Similar bacteria were identified in
the two clone libraries, although clone library 1 did not
detect any bacteria from the phylum Fusobacteria
and clone library 2 did not detect any Bacteriodetes. The
clone libraries were dominated by sequences related to
S. aureus and P. aeruginosa, but also contained many se-
quences from E. faecalis, Alcaligenes faecalis, and
Stenotrophomonas maltophilia.
All 110 partial 16S rRNA gene sequences obtained from
DGGE were added to the consensus maximum likelihood
tree (data not shown) to confirm the result of the BLAST
search. While the BLAST result was confirmed for most of
the sequences, the phylogenetic analysis showed that it was
not possible to distinguish the sequences identified as
different Alcaligenes and Ahcromobacter species and no
Peptoniphilus could be differentiated to more than the ge-
nus level. It also showed that the DGGE fingerprinting se-
quences most related to Fusobacterium equinum according
to the BLAST were located closer to Finegoldia gonidia-
formans on the tree. F. gonidiaformans was also found in
clone library 2.
Quantitative PCR
The abundance of S. aureus and P. aeruginosa was found
to vary considerably between the different wounds (Tables
2 and 3). While S. aureus could be detected by DGGE and
by culturing in most samples, they were only above the
limit of detection using the qPCR approach in four of the
14 ulcers investigated. P. aeruginosa could be quantified in
three of the ulcers investigated.
Spatial location
To determine whether the bacterial composition varied
throughout the wound, three wounds (D–F) were each
Table 2. A condensed overview of the bacteria found in wound A–F1
Species Clone lib. 1 A B C D E F
Staphylococcus aureus 1 S, C, 220  6% S, ND C, ND S, C S,C,n S,C,n
Pseudomonas aeruginosa 1 ND ND C, ND C,n C,n
Staphylococcus sp. 1 S S S,C S,C
Stenotrophomonas maltophilia 1 S
Alcaligenes sp. 1 S
Enterococcus sp. 1 C
Enterococcus faecalis 1 C S
Actinobaclulum schaalii 1 S
Helcococcus kunzii 1 S
Finegoldia magna 1 S
Staphylococcus cohnnii S
Corynebacterium amycolatum S
Achromobacter xylosoxidans S
Unidentified Gram-negative rod C
Proteus sp. C
Morganella morganii C
Klebsiella oxytoca C
Enterobacter cloacae C
Peptoniphilus sp. S
Uncultured Clostridia S
Uncultured Clostridia S
Uncultured Porphyromonas S
Uncultured Bacterium S
1Bacteria identified from wounds A–F using culture-based methods (C) and sequencing of DGGE bands (S). Quantitative PCR data
are presented for S. aureus and P. aeruginosa (copies/ng DNA  standard error of the mean, n53).
nThe spatial orientation of bacteria was examined in wound D, E, and F revealing a diverse microbiota in wound E and F. Data for
these two wounds are described in Table 5. Sequences also found in Clone library 1 are indicated with ‘‘1’’.
ND, not detected.
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divided in five parts and DNA was extracted from each of
them. Each part was separately examined by DGGE fin-
gerprinting and by subsequent sequencing of bands (Table
5). In wound D, only S. aureus could be detected by
DGGE fingerprinting and it was present in all examined
parts of the wound (data are not included in Table 5).
Wound E was dominated by the aerobe S. aureus, the
facultative aerobe E. faecalis, and the two anaerobes
Actinobaculum schaalii and F. magna, and wound F was
dominated by S. aureus and an uncultured Clostridia bac-
terium.
S. aureus and P. aeruginosa qPCR detected these species
in all parts of wound E and F, except in subsample 3 in
wound E (E3) (Table 5). The abundance of S. aureus and
P. aeruginosa was, however, found to vary significantly
depending on the location in the wound. This was partic-
ularly apparent for P. aeruginosa, which varied by three
orders of magnitude in the various samples from wound F.
Thus, not only the bacterial diversity but also the abun-
dance of organisms were found to vary throughout the
wound. To examine further the spatial organization of the
CVLU, thin histological slides of wound H and another
CVLU known to contain P. aeruginosa were produced and
examined with FISH and PNA-FISH (Figure 2). It was
found that the bacteria on the histological slides known to
contain P. aeruginosa were located very locally (areas of
Table 3. A condesed overview of the bacteria found in wounds G–Nn
Species
Clone
lib. 2
Wounds
G H I J K L M N
Staphylococcus aureus 1 S, C, ND S, C, 120 14% S, C, 5600 13% S, C, NT S, C, NT S, NT S, C, 100 5% C, ND
Pseudomonas aeruginosa 1 C, 1400 18% C, ND ND NT S, C, NT NT ND ND
Alcaligenes sp. 1 S
Proteus mirabillis 1 C
Alcaligenes faecalis 1 C
Enterococcus sp. 1 C
Coagulase negative
staphylococci
1 C C C
Staphylococcus epidermidis S
Peptoniphilus harei S S
Finegoldia magna S S S
Fusobacerium equinum S
Peptostreptococcus
anaerobius
S
Peptoniphilus asaccharolyticus S S S
Uncultured Clostridia S
Anaerococcus vaginalis S S
Peptostreptococcus micros S
Corynebacterium sp. S C
Brevibacterium casei S
Gram-negative rod C C
Morganella morganii C
Escherichia coli-like rod C
Hemolytic Streptococcus C C
Klebsiella-like rod C
Klebsiella oxytoca C
Bacillus sp. C
Enterobacter cloacae C
nBacteria identified from wounds G–N using culture-based methods (C) and sequencing of DGGE bands (S). Quantitative PCR data
are presented for S. aureus and P. aeruginosa (copies/ng DNA  standard error of the mean, n53). Sequences also found in Clone
library 2 are indicated with ‘‘1’’.
ND, not detected, NT, not tested.
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approximately 150mm) and nowhere else. This made it diffi-
cult to locate the area of infection if present. Wound H was
examined to see if the bacteria found with DGGE finger-
printing could be located. It was possible to find small pop-
ulations of S. aureus and Alcaligenes sp. using specific
probes, thus confirming their presence but no large area of
infection could be located.
DISCUSSION
There is an emerging body of evidence that bacteria play
an important role in the persistence of chronic wounds.
Using culture-based methods, the most frequently ob-
served bacteria in CVLUs are S. aureus, P. aeruginosa,
and E. faecalis, but the diversity is generally polymicrobial
and heterogeneous.31 To improve treatment of CVLUs, it
is necessary to identify whether the most frequently de-
tected bacteria are the critical causative agents or if other
bacteria may also contribute to wound persistence. The
choice of the analytical method, mode of sampling and the
compositional variety of the wounds all play an important
role in the results obtained from bacteriological studies.
Some studies have been conducted to identify the impor-
tant bacteria in wounds, however, the conclusions from
the studies differ. Stephens et al.8 focused on anaerobic
bacteria and concluded that anaerobic bacteria play an
important role in mediating the chronicity of CVLU.
Gjodsbol et al.32 in comparison suggested that P. aerugi-
nosa is most important, rather than anaerobes, as it is
P. aeruginosa that induces ulcer enlargement and delays
healing. In the present study, it was examined how molec-
ular methods could contribute to the characterization of
the bacteria in CVLUs. As has been reported previously,
the molecular biological methods uncovered a different
and more diverse microbiota than the culture-based meth-
ods. Bacteria were detected that had not previously been
identified from wounds but the potential virulence of these
bacteria and their impacts on wound healing needs further
investigation. Ultimately, the eventual significance of the
different wound bacteria requires the determination of
their pathogenesis and in order to do this, all of the bacte-
ria that are present must be identified. The differences
Table 4. Closest relatives of the bacterial OTUs in clone libraries
OTU Numbern Species (BLAST) Acc. number Similarity (%)
Clone library 1
1 [8/28] Staphylococcus aureus BX571856 97.1–100
2 [2/6] Alcaligenes sp. AY331576 99–100
3 [2/4] Anaerococcus sp. AM176522 99
4 [4/4] Stenotrophomonas sp. AM402950 99–100
5 [1/3] Uncultured Porphyromonas DQ130022 99–100
6 [2/3] Enterococcus faecalis DQ239694 99–100
7 [1/2] Pseudomonas aeruginosa EF064786 99–99.6
8 [1/1] Anaerococcus vaginalis AF542229 98
9 [0/1] Uncultured Anaerococcus DQ029049 95
10 [1/1] Enterobacter sp. EF088367 99
11 [1/1] Bacteroides tectus AB200228 99
12 [1/1] Actinobaculum schalli AF487680 98
13 [1/1] Helcococcus kunzii X69837 97
14 [1/1] Finegoldia magna AB109772 99
Total 57
Clone library 2
1 [7/46] Staphylococcus aureus DQ997837 98.8–99.9
2 [6/14] Pseudomonas sp. AY914070 98.7–99.0
3 [3/3] Uncultured bacterium EF511972 99.7–99.9
4 [1/3] Fusobacterium gonidoformans M58679 98.6–99.8
5 [2/2] Enterococcus faecalis DQ239694 99.8–100
6 [2/2] Acinetobacter junii AB101444 99.9
7 [1/2] Proteus mirabilis AF008582 98.6–99.8
8 [1/1] Actinobaculum schaalii AY957507 98.4
9 [1/1] Alcaligenes faecalis AY548384 97.2
10 [1/1] Helcococcus kunzii X69837 96.7
11 [1/1] Uncultured bacterium AM697030 98.2
12 [1/1] Uncultured Clostridia AY383733 99.7
Total 77
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CONR89
CONR59
CON8
CON32
CON41
CON39
CON29
CONR92
CONR2
CONR1
Staphylococcus aureus
CON10
CON59
CONR54
CONR3
CON36
CONR96
Enterococcus faecalis
CON18
CONR13
CON43
CONR90
Bacterium Str. Rauti
CONR27
CON40
Firmicutes
Helcococcus kunzii
CON53
Finegoldia magna
CON12
Anaerococcus vaginalis
CONR87
CON7
CON35
CON31
CONR9
Fusobacterium gonidiaformans
Actinobaculum schaalii
Fusobacteria
CONR17
CON19
Bacteroides tectus
CON6
CON26
UC Porphyromonas sp.
CON34
CON21
CON55
Stenotrophomonas maltophilia
Bacteroidetes
Actinobacteria
CON2
CONR19
Alcaligenes faecalis
CON58
CON54
CON22
CONR5
CONR23
Acinetobacter junii
Pseudomonas aeruginosa
CONR4
CONR36
Gamma-
proteobacteria
CONR79
CONR43
CONR95
CONR31
CONR45
CON57
CONR60
CONR41
CONR33
CONR21
Proteus mirabilis
CON3
Enterobacter sp.
Figure 1. Maximum likelihood (AxML) tree of consensus sequences (1364 nt compared) of consensus sequences from clone li-
brary 1 (CON#) and 2 (CONR#). The scale bar represents a 10% deviation of sequence.
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between the results obtained with the culture-based and
the molecular-based approaches demonstrate that the use
of one of the methods alone might miss potentially impor-
tant information about the bacteria present.
Comparison of culture and molecular biological
methods
All of the examined wounds contained a unique microbio-
ta. The DGGE fingerprinting and culture method identi-
fied an average of 3.1 and 3.0 bacterial species per wound,
respectively. Combined, 5.4 species were identified per
wound. In accordance with previous reports, e.g.,13 sepa-
rate bands were observed in some lanes in the DGGE gels
representing the same species. This may be due to more
than one type of active 16S rRNA genes in the same spe-
cies or the presence of different sub strains of the identified
microorganisms differing in only one or a few base pairs.
The presence of several species in the same wound compli-
cates the task of determining which bacteria are mainly in-
volved with infection. There might also be synergy
between some species, e.g., predisposing or additive
polymicrobial infections. For instance, species living
in immunocompromised pockets created by different
microorganisms are capable of killing leukocytes (like
P. aeruginosa6).
The results of the culture experiments showed the pres-
ence of 12 different species in the analyzed wounds com-
pared with 33 species found with molecular methods.
None of the species found using culture methods were an-
aerobic. DGGE fingerprinting showed the presence of
Table 5. A condensed overview of the spatial orientation of bacteria found in wounds E and Fn
Species Clone lib. 1
Wound parts
E, C E, 3 E, 6 E, 9 E, 12 F, C F, 3 F, 6 F, 9 F, 12
Pseudomonas
aeruginosa
510 18% NT 760 7% 47 9% 280 3% 920 9% 300 13% 8200 8% 800 10% 15 5%
Staphylococcus aureus 1 S, 89 11%B, NTB, 240  10% B, 310
13%
S, 180 8%S, 200 2%S, 86 8%B, 290 8%B, 80 5%B, 93 12%
Staphylococcus sp. 1 S B B B S B B S S B
Enterococcus faecalis 1 S S S S
Enterococcus sp. S S
Actinobaculum schaalii 1 S B B B B
Helicococcus kunzii 1 S
Finegoldia magna 1 B B B B S
Peptoniphilus sp. B S
Uncultured Clostridia
bacterium
S
Uncultured Clostridia
bacterium
B S B B
Uncultured
Porphyromonas sp.
B B S
Uncultured bacterium S B B
Besides wound E and F, clone library 1 represented wounds A–D.
nThe spatial orientation of wounds E and F was examined by applying molecular methods on samples taken at the center (C), and at
approximately 3, 6, 9, and 12 o’clock around the wounds’ periphery. Bacteria were identified by sequencing DGGE bands (S) and
putatively identified by comparison of bands to the sequenced bands at the same position on the gel (B). Sequences also found in
Clone library 1 are indicated with ‘‘1’’. Quantitative PCR data are presented for S. aureus and P. aeruginosa (copies/ng DNA 
standard error of the mean, n53). []NT, not tested; PCR, polymerase chain reaction.
Figure 2. A PNA-FISH micrograph. The green color is a general
probe for all bacteria and the picture was counter stained with
DAPI, a DNA stain to visualize the localization of the host cells
(blue).
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anaerobic bacteria in wound G, H, I, M, and N. The an-
aerobic species are often overlooked by culture methods
because they require longer culture times and previously
lacked a valid identification scheme.8 Many of the bacteria
identified by DGGE fingerprinting have close relatives
identified previously by culture experiments, and are there-
fore likely themselves to be culturable to some degree.
Some of the observed differences between the results
obtained by the culture and the molecular methods could
be due to the inability to differentiate species on the culture
plates or that some specimens were collected as a biopsy
and others using a swab. The differences may also be at-
tributable to a fraction of the bacteria being dead or in a
viable but unculturable state. This can be caused by the use
of antibiotics15; however, only wound F was receiving an-
tibiotics and indeed this wound showed the presence of
only one species. The other two wounds, which had been
treated with antibiotics until a short time before the study,
both showed a diverse microbiota detected by culture
methods. Based on these findings, there is no evidence of
large amounts of residual genetic material from organisms
no longer colonizing the ulcer bed.
Cultivation techniques have some limitations, but the
molecular biological methods also have biases. These in-
clude amplification of naked DNA, unknown DNA recov-
ery yields from extraction, differential amplification due to
PCR primer bias, 16S rRNA copy number, and heteroge-
neity and co-migration of bands on DGGE fingerprinting.
Some of the biases associated with, e.g., the DGGE ap-
proach were compensated by using the cloning approach, in
which different primers were used with different specificities.
Diversity of CVLU bacteria
The clone library and DGGE analysis revealed a large di-
versity of bacteria of which some have not been associated
previously with wounds: Brevibacterium casei, Corynebac-
terium simulans, Corynebacterium amycolatum. A. schaalii,
P. harei, F. gonidiaformans, Bacteroides tectus, Achromo-
bacter xylosoxidans, A. faecalis, and some uncultured bac-
teria. B. casei has been identified as an opportunistic
pathogen in immunocompromised patients. The case re-
ports by Reinert et al.33 and Brazzola et al.34 are examples,
describing that B. casei needs a host with reduced immune
system in order to initiate infection. Two other bacteria
from phylum Actinobacteria (C. simulans and C. amy-
colatum) were also identified. The Corynebacteria are
known as an aerobe and ubiquitous on human skin and
are all opportunistic pathogens. C. amycolatum is fre-
quently isolated from clinical specimens and infected
wounds and it is resistant to most antibiotics35 whereas
C. simulans is a rare species found previously in blood and
bile samples.36 A. schaalii is a Gram-positive bacterium re-
sembling normal skin flora and it is often overlooked by
culture methods due to its slow growth in ambient air. Re-
cently A. schaalii has been found as a pathogen in 10 cases
of urinary infection.37 P. harei belongs to the anaerobic
Gram-positive family Peptostreptococcaceae, which is a
heterogeneous family of opportunistic pathogens coloniz-
ing the skin and the mucosal surfaces of humans.35H. kun-
zii has been isolated previously from human skin and from
diabetic foot wounds. It is mainly identified as a part of a
polymicrobial community38 but it has also been seen as the
sole pathogen in a foot abscess.39 The Fusobacteria are
Gram-negative anaerobes found in the human gastroin-
testinal tract. Here, they are a part of the polymicrobial
flora but they are also involved in a variety of different
diseases.40 The phylum Fusobacterium is often associated
with chronic wounds.41 F. gonidiaformans is a rare type of
Fusobacterium species isolated previously from infected
dog bites42 and from skin infections.43 In both surveys, the
F. gonidiaformans constituted a very small percentage of
the isolated bacteria. A. xylosoxidans and A. faecalis are
both aerobe Gram-negative Betaproteobacteria from the
Alcaligenaceae family. They are ubiquitous in the environ-
ment but rarely involved with human disease. They have
been isolated from blood cultures of various immunosup-
pressed patients44 and also appeared in a recent study of
chronic wounds by Dowd et al.12 The uncultured
Porphyromonas (DQ130022) was identified previously
from the forearm of a healthy human45 and the uncultured
bacterium (AY958901) was identified from the vaginal ep-
ithelium of a healthy woman.46
Phylogenetic analysis showed that the 33 different species
belonged to six phyla. Both in terms of the number of differ-
ent species and the number of identified clones, the Proteo-
bacteria and the Firmicutes (Clostridia) were the dominating
phyla. Gao et al.45 examined the skin flora of healthy fore-
arms in a large molecular biological study. They found that
the dominating phylumwas theActinobacteria, although the
Firmicutes and Proteobacteria were also present in high
numbers. Healthy skin seems to be the only human environ-
ment where Actinobacteria are dominating.45 In compari-
son, the inner mucosal surfaces of humans (e.g., colon and
oral cavity) are dominated by Firmicutes and Proteobacte-
ria.45 This difference is probably due to environmental
changes such as humidity and changes in pH value.
Eleven of the species were confirmed with both the
cloning approach and DGGE fingerprinting. There
was not a complete overlap between the findings of the
two molecular methods and a reason for this might be that
the DNA from the wounds was pooled before cloning on
basis of the intensities of the bands on a gel. Another ex-
planation might be that the primers used in the two meth-
ods had different affinity. Differences between the findings
of the applied methods were also seen by Dowd et al.12
This study also indicated the presence of a varied anaer-
obic flora dominated by F. magna and P. asaccharolyticus,
which were found in three wounds each. Table 3 (repre-
senting wound G,M, and N) also shows that the anaerobic
species were often located in the same wound. This sug-
gests that anaerobic pockets were present in the wound
and that there is a possible synergistic effect between them.
Stephens et al.8 tested the effects of P. vaginalis, F. magna,
and P. asaccharolyticus on cellular wound healing re-
sponses and found that they caused delayed reepitheliaza-
tion and defective extracellular matrix reorganization and
angiogenesis in vitro. These are all important steps in
wound healing. They also compared this with the effect of
P. aeruginosa and found that this had less detrimental
effect compared with the anaerobes.
Spatial orientation of bacteria in CVLU
The results from the DGGE approach investigating the
spatial orientation of the bacteria in three wounds
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illustrated that if only one biopsy from a wound was ana-
lyzed it would most likely not represent the bacterial com-
position of the entire wound. The qPCR results
demonstrated that the abundance of S. aureus and P.
aeruginosa also varied depending on the different locations
in the wound. The technique is rapid and has recently been
used to determinate Pseudomonas in a chronic wound
within few hours, enabling fast decisions on treatment.47
In addition, multiple biopsies from the same wound can
also indicate which species of bacteria are most important
for the infection as these are probably present in large
numbers all over the wound. Furthermore, it supports the
claim that the bacteria found in wounds are located in
niches, which covers their needs. Using FISH, we detected
bacteria in microcolonies also known as biofilms (Figure
2), which might explain how the bacteria survive inside the
wound bed. This correlates with the finding that in some
CVLU, P. aeruginosa live in large biofilms underneath the
wound surface.6 Antibacterial dressings, e.g., silver con-
taining dressings are likely to influence the bacterial flora
on the surface of the wounds. However, as the PNA-FISH
pictures show that the bacteria reside deep in the tissue, it
is not likely that bacteria will be influenced by the dress-
ings. Furthermore, all swabs were taken after thoroughly
surgical revision far away from local antimicrobial
dressings. This indicates that the diversity was probably
not influenced by the dressing, but by other factors such
as antibiotics and difference in skin flora. The FISH
technology increases the understanding of the pathology
of bacteria in chronic wounds and how it might impact
therapies.
This study compared the bacterial flora of different
types of wound material from 14 skin graft operations of
CVLU. Results from the culture methods were compared
with the results from the molecular biological methods,
which showed that the flora of the wounds varied, as did
the number of S. aureus and P. aeruginosa investigated
by qPCR. Each wound contained multiple species but
apart from that the methods detected rather different
floras. An average of 5.4 species were found in each
wound by the methods combined. All of the wounds
contained S. aureus but P. aeruginosa was also frequent.
The molecular biological methods detected a varied
anaerobic flora in four of the wounds and species not
found previously in CVLU were identified. All of these
were known pathogens. No anaerobes or new species
were detected with culture methods. It was also found
that the wound flora was different and that the number
of the pathogens S. aureus and P. aeruginosa varied,
depending on which location and depth of the wound
was examined. Three wounds were examined and they
showed that some species were present all over while
some were only present in parts of the wounds. This
emphasizes the need for multiple samplings when exam-
ining wounds, and swabs and biopsies each have specific
advantages as sampling technologies.
qPCR is a promising fast method for fast characteriza-
tion of the bacteria present in ulcers, and importantly
the running cost is comparable with the cultivation
techniques. The next important step is to elucidate the bac-
teria that contribute to the pathogenicity of these chronic
wounds. This information could be used to develop the
optimal sampling, identification, and treatment regimes.
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Abstract
Formation of biofilm is a prominent feature of prosthetic joint infections (PJIs)
and constitutes a challenge to current sampling procedures and culture prac-
tices. Molecular techniques have a potential for improving diagnosis of bio-
film-adapted, slow-growing and non-culturable bacteria. In this exploratory
study we investigated the bacterial diversity in specimens from 22 patients clin-
ically suspected of having PJIs. Bacteriological cultures were performed accord-
ing to standard practice. A total of 55 specimens from 25 procedures
(‘specimen sets’) were submitted to broad range 16S rRNA gene PCR, cloning,
sequencing and phylogenetic analysis. More than 40 bacterial taxa within six
phyla were identified in 14 specimen sets originating from 11 patients. Direct
observation of biofilm was made in selected specimens by fluorescence in situ
hydridization. 16S rRNA gene analysis and bacteriological cultures were con-
cordant for 15/25 specimen sets (60%; five positive, 10 negative); additional
taxa were detected in four sets by gene analysis, and discrepant results were
obtained for six sets, five of which were negative on culture. Polymicrobial
communities were revealed in 9/14 sets by gene analysis and 1/10 sets by cul-
ture (P < 0.05). Although our study was not conclusive, these findings are con-
sistent with a primary role of biofilm formation in PJIs.
Introduction
Joint replacement is one of the most common surgical
procedures in industrialized countries. In Denmark the
combined incidence of primary hip and knee arthropla-
sties was 280 per 100 000 inhabitants in 2008 (DHAR,
2011; DKAR, 2011). Revisions accounted for 40 addi-
tional operations per 100 000 inhabitants (DHAR, 2011;
DKAR, 2011). The main causes for revisions are aseptic
biomechanical failure and infection (Trampuz et al.,
2003). After primary arthroplasty the cumulative preva-
lence of infection is estimated to be 0.5–2% (Spangehl
et al., 1999; Zimmerli et al., 2004; Kurtz et al., 2008;
Pulido et al., 2008) and it is even higher after surgical
revision (Trampuz & Zimmerli, 2008). The burden
of morbidity and the economic costs associated with
prosthetic joint infections (PJIs) are significant (Hebert
et al., 1996; Lavernia et al., 2006). Both diagnosis and
treatment of PJI remain complex, which can to a large
extent be attributed to protected growth of bacteria in
biofilms (Trampuz et al., 2003; Trampuz & Widmer,
2006). The biofilm mode of growth renders bacteria resis-
tant to the host immune system and most antimicrobial
agents (Stewart & Costerton, 2001).
Culture techniques have been the mainstay for the
diagnosis of PJIs, with synovial fluid and surgical
periprosthetic soft tissue biopsies being the preferred
specimen types (Bauer et al., 2006). Nevertheless, culture-
based methods often fail to demonstrate bacterial agents
in patients with a high likelihood of PJI (Zimmerli et al.,
2004; Mikkelsen et al., 2006; Berbari et al., 2007; Tram-
puz et al., 2007). This has called for reconsideration of
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sampling and laboratory procedures. Biofilms on the sur-
face of the prosthesis may be important because this
niche can remain undetected when biopsies are taken from
periprosthetic tissues or the synovial membrane (Gomez &
Patel, 2011). Sonication has proved effective for dislodge-
ment of biofilms from removed prostheses or prosthetic
components (Trampuz et al., 2007) but even with these
precautions, biofilm bacteria may grow poorly on agar
plates (if at all), and some bacteria may be viable but non-
culturable (Zimmerli et al., 2004; Costerton, 2005).
To overcome these limitations, culture-independent
molecular methods have been introduced (Costerton,
2005; Fenollar et al., 2006; Vandercam et al., 2008). Still,
the number of published PJI studies using molecular
methods remains small. Complex bacterial communities
are a hallmark of biofilm infections and in this study we
have specifically addressed bacterial diversity in samples
from patients suspected of PJI. Broad range 16S rRNA
gene PCR, cloning, sequencing, phylogeny and quantita-
tive PCR (qPCR) were applied to different types of speci-
mens with the aim of helping to devise effective strategies
for the diagnosis of PJI.
Methods
This exploratory non-interventional study was conducted
within the framework of ‘PRIS’, a Danish multidisciplin-
ary project on prosthesis-related infection and pain. The
‘PRIS’ project was approved by the regional research eth-
ics committee for North Denmark (N-20110022).
Patients and sampling procedures
Specimens for bacterial DNA analysis were obtained in
parallel with specimens for bacteriological culture in 22
patients with suspected PJI during a planned diagnostic
procedure – a preoperative aspiration of synovial fluid
(n = 11), a surgical revision (n = 9) or both (n = 2).
Four patients had a hip prosthesis and 18 a knee prosthe-
sis. Except for the surgeon’s suspicion of infection, no
fixed criteria were set for inclusion of patients.
Sampling was carried out once in 20 patients and three
and two times in one patient each (nos 1 and 2, respec-
tively). Both patients had a preoperative aspiration of syno-
vial fluid and subsequent removal of the prosthesis within
10 days. Patient 1 had a previous specimen set obtained
during debridement with retention of the prosthesis
7 months earlier. The median time (interquartile range)
from implantation of the prosthesis to the diagnostic proce-
dure was 4.5 months (1–12 months); if more than one pro-
cedure was performed, the first defined the insertion period.
Periprosthetic surgical biopsies (approximately 0.15 cm3)
were taken under sterile conditions with separate instru-
ments and placed in sterile tubes (Greiner Bio-One, Ger-
many); biopsies for culture were stored in Stuart transport
medium (SSI Diagnostika, Denmark). Specimens from the
surface of the prosthesis (approximately 2–5 cm2) were
obtained with a flocked swab placed in Amies transport
medium (ESwab, Copan, Italy); the material was released
from the swab and the medium subsequently analyzed.
Prostheses or spacers removed during revision were placed
in sterile containers of the appropriate size. All specimens
were transported within a few hours to the laboratory at
ambient temperature.
DNA extraction
Biopsies of soft tissue or spongious bone were cut into
small pieces under sterile conditions. Removed prostheses
or spacers were either sampled with an ESwab or submitted
to sonication (42 kHz ± 6%, 10 min) in autoclaved MilliQ
water. Subsequently, the sonication fluid was centrifuged
(6000 g, 10 min) and the pellet was resuspended in
1–5 mL of diethylpyrocarbonate (DEPC)-treated water.
For one patient (no. 2B) both procedures were performed.
In two patients (nos 1B and 3) extraction of total DNA
was performed with DNeasy® Blood & Tissue kit (Qiagen,
Germany) according to the manufacturer’s protocol. For all
other patients, bacterial DNA was extracted with MolYsis
Basic (Molzym, Germany) followed by DNeasy® Blood &
Tissue kit according to the manufacturers’ protocols. Unlike
the DNeasy® Blood & Tissue kit, which resulted in a mix-
ture of eukaryotic and prokaryotic DNA, MolYsis Basic pre-
treatment enabled the selective preparation of prokaryotic
DNA from intact cells, significantly lowering the back-
ground in PCR analyses. Before extraction with MolYsis
Basic, 150 lL of DEPC-treated water were added to biop-
sies. Aliquots (200 lL) of synovial fluid, Amies transport
medium and sonication fluid were processed directly. DNA
was eluted in 200 lL of DEPC-treated water.
16S rRNA gene PCR amplification
The 16S rRNA gene was amplified in nearly full length
using universal bacterial primers 5′-AGAGTTTGATCCT
GGCTCA-3′ (26F) and 5′-GACGGGCGGTGTGTACAA-3′
(1390R) (Lane, 1991) according to Thomsen et al. (2001).
The amplified DNA was subjected to agarose gel electro-
phoresis. Stringent procedures were employed to prevent
contamination. Each reaction mixture excluding DNA
template was prepared in a BiocapTM (Erlab, France) with
UV light exposure for at least 10 min before each PCR
setup. DNA templates were added to the reaction mixtures
in a separate room, where post-PCR analysis was also car-
ried out. Negative and positive controls were included
within each batch of specimens. Positive controls
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contained the standard reaction mixture with DNA
extracted from an activated sludge sample, whereas
negative controls contained DEPC-treated water instead of
specimen.
Cloning and sequencing
After the 16S rRNA gene PCR products were confirmed to
be of the correct size by agarose gel electrophoresis, the
PCR products were purified with Nucleospin Extract II
columns (Machery-Nagel, Germany) according to the
manufacturer’s instructions. The PCR fragments were then
ligated into the pCT 4-TOPO-plasmid and transformed
into One Shot® TOP10 chemically competent Escherichia
coli as described in the TOPO TA Cloning® Kit for
Sequencing (Invitrogen) protocol. The transformed cells
were spread on Luria–Bertani agar containing 50 lg mL1
kanamycin and 50 lg mL1 X-gal (5-bromo-4-chloro-
3-indolyl-b-D-galactopyranoside) and incubated overnight
at 37 °C.
From each clone library, 24–48 colonies were randomly
selected and the plasmids were amplified using rolling
circle amplification with IllustraTM TempliPhi Kit (GE
Healthcare, UK) according to the manufacturer’s instruc-
tions. Presence of an insert of the correct size was analyzed
by PCR using M13 primers followed by agarose gel electro-
phoresis. The plasmids were sequenced by Macrogen Inc.
(South Korea) in both directions using the M13 primers.
Phylogenetic analysis
A consensus sequence was compiled by assembling the for-
ward and reverse sequences for each clone and trimming
vector sequences in CLC Main Workbench (CLC bio, Den-
mark). Sequences were checked for chimeras using the
MALLARD software package (Ashelford et al., 2006). The
BLASTN function was used for initial identification of the
closest relatives of the consensus sequences in the NCBI
database (http://www.ncbi.nlm.nih.gov/) with standard
parameters except that ‘Nucleotide collection’ was the cho-
sen database and ‘Entrez Query’ was limited to ‘Bacteria
[ORGN]’. Afterwards, the consensus sequences were aligned
using SINA Web Aligner (Pruesse et al., 2007) and imported
into the ARB software package (Ludwig et al., 2004) for taxo-
nomic lineage assignment using the non-redundant SSU
Ref database from SILVA Release 106 as reference database.
The sequences were assigned based on their position after
parsimony insertion into the database using a filter which
was defined by applying the SAI sequence ‘pos_var_ssuref:
bacteria’, using only sequences between E. coli nucleotides
27–1390, and omitting hypervariable portions of the rRNA
gene. The consensus sequences and their closest relatives in
the database were then selected to calculate phylogenetic
trees using neighbor-joining, maximum parsimony and
maximum likelihood methods.
Additionally, all clones having a 16S rRNA gene sequence
similarity of more than 97% with each other were grouped
into an operational taxonomic unit (OTU), roughly corre-
sponding to the bacterial species level (Juretschko et al.,
2002). Only representative sequences from each OTU were
selected to construct the phylogenetic trees. The coverage
ratio (C) for each of the clone libraries was calculated using
the equation Ccoverage = [1  (Nsingletons·Ntotal1)]·100%,
where Nsingletons is the number of OTUs containing only
one sequence and Ntotal is the total number of 16S rRNA
gene clones analyzed (Juretschko et al., 2002).
The non-redundant, near full-length 16S rRNA gene
sequences representing each OTU obtained in this study
were deposited in GenBank under the accession numbers
JN584679–JN584724.
Quantitative PCR
Quantification of Propionibacterium acnes in specimens
positive by the 16S rRNA gene clone library approach
was done with qPCR according to Eishi et al. (2002). The
target sequence was a 131-bp portion of the P. acnes 16S
rRNA gene. The primers were PA-F (5′-GCGTGAGT
GACGGTAATGGGTA-3′) and PA-R (5′-TTCCGACGC
GATCAACCA-3′), and the TaqMan probe was PA-TAQ
(5′-AGCGTTGTCCGGATTTATTGGGCG-3′). Triplicate
25 lL qPCR reactions were run containing 5 lL of a
DNA specimen, 12.5 lL Brilliant® II QPCR Master Mix
(Stratagene), 38 nM ROX (Stratagene), 1 lg lL1 bovine
serum albumin (Sigma, Germany), 100 nM of each pri-
mer and 40 nM of the probe (Eishi et al., 2002). Reac-
tions were run on an Mx3005P (Stratagene) with 5 min
at 95 °C, 50 cycles of 15 s at 95 °C and 1 min at 60 °C.
The DNA standard was synthesized plasmid containing the
131-bp target gene (GenScript). The standard curve was
prepared from serial dilution of the plasmid (2·100 ?
2·107 copies lL1). In all, 0–11 copies of the P. acnes
target gene were detected in the controls without tem-
plate, and the lower detection limit of the assay was
therefore set to be 50 copies per reaction.
Fluorescence in situ hybridization (FISH)
Fluid samples (synovial fluid and Amies transport med-
ium) were fixed in ethanol (50% v/v) for detection of
Gram-positive bacteria (Roller et al., 1994) and parafor-
maldehyde (40 g L1) for detection of Gram-negative
bacteria (Amann et al., 1990). The samples were analyzed
by FISH using a universal bacterial peptide nucleic acid
(PNA) probe according to the manufacturer’s instructions
(UNIBAC; AdvanDx, Inc., Woburn, MA). Visualization
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was carried out with a Zeiss LSM 510 confocal laser scan-
ning microscope (Carl Zeiss, Germany).
Bacterial culture
All bacteriological cultures were performed in the Depart-
ment of Clinical Microbiology, Aalborg Hospital. Synovial
fluid was centrifuged at approximately 1400 g and the
pellet was used for Gram stain and inoculation. Aerobic
culture was done on 5% horse blood agar and chocolate
agar at 35 °C in 5% CO2 (incubation period: 4 days);
anaerobic culture was done on 10% horse blood agar for
4 days, chocolate agar enforced with menadione and cys-
teine for 6 days, and in semisolid thioglycollate agar for
4 days (all media were from SSI Diagnostika).
Tissue biopsies were cut into smaller pieces and
imprints were made on the agar media listed above (for
further details see Kamme & Lindberg, 1981). Incubation
temperature and time were as described above. Interpre-
tive criteria were in accordance with Kamme & Lindberg
(1981). Culture from at least three biopsies of one or
more phenotypically identical bacteria was deemed to be
a significant finding; the number of colony forming units
was not a criterion in itself, as enrichment culture was
performed for each biopsy and contributed equally to the
result. Identification to species level or a provisional
group was done according to Murray et al. (2007). Coag-
ulase-negative staphylococci and coryneform rods were
identified with API Staph and API Coryne, respectively
(bioMérieux, France). Hemolytic streptococci were
grouped by agglutination for Lancefield antigens A, B, C
and G. If a good identification was not obtained, provi-
sional names were retained in the final report.
Data analysis
Any number of specimens obtained concurrently by either
joint aspiration or surgical revision was defined as the unit
of observation and was referred to as a ‘specimen set’
(n = 25).
Information on bacteriological cultures was retrieved
from the laboratory information system after completion of
molecular analyses whereby blinding was obtained de facto.
Differences in proportions were assessed by the Fisher
exact test (2-tailed) with P < 0.05 deemed to be statisti-
cally significant.
Results
16S rRNA gene analysis
A total of 55 specimens were available for 16S rRNA gene
analysis and PCR was positive for 25 specimens from 14
different sets and 11 patients (Table 1). Specimens of
synovial fluid were positive in two patients and intraoper-
ative specimens in 12. A clone library was constructed for
each positive specimen, giving 25 clone libraries and 666
consensus sequences of high sequence quality. A total of
41 OTUs were formed based on 16S rRNA gene sequence
similarity. Except for one bone specimen, all clone
libraries had a coverage ratio above 85%, indicating that
the majority of the microorganisms in the specimens were
detected (for more details, see Supporting Information,
Data S1).
The phylogenetic trees constructed from consensus
sequences were robust, as congruent phylogenetic rela-
tionships were obtained by neighbor-joining, maximum
parsimony and maximum likelihood methods. Sequences
were distributed into six phyla: Proteobacteria, Actinobac-
teria, Firmicutes, Bacteroidetes, Cyanobacteria and Fusobac-
teria, with the majority of the sequences belonging to the
first three phyla (Table 1). Maximum likelihood trees of
Proteobacteria, Firmicutes and Actinobacteria are shown in
Figs 1–3.
Table 1 shows that the most frequent species were
Staphylococcus epidermidis and P. acnes, each were
detected in six specimen sets. However, the majority of
the identified species were detected only in a single
patient. Multiple species were detected per specimen set
in nine patients. Of note, in four specimen sets (patients
4, 6, 8 and 11) some species were present in all PCR-
positive specimens, whereas other species were only
detected in some specimens. The presence of P. acnes was
confirmed by the specific Taqman qPCR assay in six of
nine specimens and in four of six patients (Table 2). Both
sonication and sampling by ESwab were applied to the
prosthesis from patient 2B yielding the same species,
namely S. epidermidis.
The polymicrobial communities comprised a broad
range of bacteria, some of which have rarely been
reported from clinical specimens, e.g. Wautersiella falsenii,
Dietzia cinnamea and Propioniferax innocua. Among the
OTUs there were 10 uncultured taxa, whose closest
known relatives were determined by phylogenetic analysis
(Figs 1–3).
Comparison of 16S rRNA gene analysis with
culture reports
Results obtained by 16S rRNA gene analysis and conven-
tional bacterial culture are summarized in Table 3.
Results were concordant in 15 of the 25 specimen sets
(five positive and 10 negative). In four cases the culture
report was corroborated by 16S rRNA gene analysis; how-
ever, the analysis revealed multiple additional species.
Results were discrepant for six specimen sets (gene analy-
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Rhodoferax antarcticus (T), GU233447
Rhodoferax sp. Asd M2A1, FM955857
Rhodoferax fermentans (T), D16211
OTU 3 (17)
uncultured Rhodoferax sp., HQ111149
Curvibacter gracilis (T), AB109889
Curvibacter lanceolatus, AB021390
uncultured Curvibacter sp., FJ572671
OTU 4 (5)
Rhizobacter fulvus (T), AB245356
uncultured Comamonadaceae bacterium, AM935634
uncultured bacterium, HM270718
OTU 5 (3)
uncultured beta proteobacterium, AJ422163
lt d B kh ld i EU071528uncu ure ur o er a sp., 
OTU 7 (5)
Burkholderia fungorum (T), AF215705
Achromobacter xylosoxidans subsp. xylosoxidans, HM137034
Alcaligenes faecalis, FN433013
OTU 6 (1)
Bordetella avium (T), AF177666
beta proteobacterium HTCC525, AY584575
OTU 8 (4)
Oxalobacteraceae bacterium Gu-R-25, AB545759
Undibacterium pigrum (T) AM397630, 
Aminomonas aminovorus, AY027801
Methylobacillus flagellatus, DM169692
Methylobacillus sp. Lap, GU937478
OTU 9 (2)
Methylobacillus pratensis (T), AY298905
uncultured Neisseria sp., FJ191689
OTU 10 (1)
Neisseria meningitidis, FJ932762
Neisseria subflava (T), AJ239291
Neisseria flavescens (T), L06168
Stenotrophomonas maltophilia (T), X95923
OTU 11 (2)
Escherichia coli, FJ463818
OTU 1 (1)
Escherichia fergusonii ATCC 35469 (T), CU928158
Escherichia coli, AY319393
Pseudomonas mediterranea (T), AF386080
OTU 2 (3)
Pseudomonas sp. LD11 partial 16S rRNA gene, AM913885
Sphingomonas sp. MBHLY-1, HM243762
OTU 12 (4)
Sphingomonas yanoikuyae (T), D13728
0.10
Outgroup Streptococcus (4)
Fig. 1. Maximum likelihood tree of Proteobacteria. Twelve OTUs, corresponding to 48 clones (consensus sequences), were assigned to
Proteobacteria. For simplicity, only representative sequences from each OTU were used in tree calculation. The outgroup consists of four
sequences from streptococci. The scale bar represents 10% estimated sequence deviation. The number in parentheses indicates the number of
clones belonging to the OTU. Type strains are marked by (T).
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sis positive and culture negative for five and the reverse
result for one).
In general, the culture reports fell short of the precise
species diagnoses obtained by 16S rRNA gene analysis.
Accordingly, only six species or provisional groups were
identified by conventional phenotypic methods as
compared with 45 species by gene analysis. Nonetheless,
S. epidermidis was the most common species using either
culture or the molecular approach.
The gene analysis revealed a mixed bacterial flora in
more positive specimen sets (9/14; 64%) compared with
conventional culture (1/10; 10%); the difference was sta-
tistically significant (Fisher exact test, 2-tailed, P = 0.013).
Findings in three patients pointed to a heterogeneous
distribution of bacteria (Table 1). Thus, in patient 8,
Staphylococcus aureus was cultured from periprosthetic
biopsies and confirmed by molecular analysis. Neverthe-
less, three additional species were detected in the speci-
men from a prosthesis and from a bone biopsy. A
mixed flora was found by 16S rRNA gene analysis in
patients 1B and 5, in either Amies transport medium
(ESwab from the prosthesis) or a bone biopsy, whereas
a tissue biopsy was negative in both. Nonetheless,
culture of periprosthetic biopsies revealed a single spe-
cies in both cases.
Fluorescence in situ hybridization
PNA-FISH was performed with a universal bacterial
probe on nine selected specimens that were 16S rRNA
gene PCR-positive (from patients 4, 5, 8 and 9, respec-
tively). Both single cells and microcolonies/biofilms were
visualized. Figure 4 features a large microcolony of coc-
coid bacteria sampled with the flocked swab from the
surface of the prosthesis (patient 8). The observation cor-
related with the finding of S. aureus by 16S rRNA gene
analysis and culture.
Discussion
In this study of patients with suspected PJI, notably
higher bacterial diversity was detected by broad range 16S
Streptococcus thermophilus CNRZ1066, CP000024
OTU 36 (3)
Streptococcus salivarius subsp Salivarius (T) AY188352. , 
Streptococcus salivarius subsp. thermophilus, HQ293117
Streptococcus sanguinis (T), DQ303192
OTU 35 (1)
Streptococcus mitis (T), AF003929
OTU 35 (1)
Streptococcus agalactiae (T), AB023574
OTU 38 (14)
Streptococcus dysgalactiae subsp. equisimilis (T), DQ232540
OTU 37 (107)
Lactobacillus curvatus (T), AJ621550
Lactobacillus graminis (T) AJ621551, 
Lactobacillus sakei subsp. Carnosus (T), AY204889
uncultured bacterium, HM272366
OTU 39 (1)
Staphylococcus aureus subsp. anaerobius (T), D83355
OTU 41 (144)
Staphylococcus aureus, DQ997837
Staphylococcus epidermidis (T), D83363
OTU 40 (153)
Staphylococcus hominis, EU071623
Staphylococcus hominis subsp. Novobiosepticus (T), AB233326
OTU 40 (1)
uncultured bacterium, HM276014
Staphylococcus caprae (T), Y12593
OTU 40 (1)
Outgroup Proteobacteria (13)
0.10
Fig. 2. Maximum likelihood tree of Firmicutes. Seven OTUs, corresponding to 426 clones (consensus sequences), were assigned to Firmicutes.
For simplicity, only representative sequences from each OTU were used in tree calculation. The outgroup consists of 13 sequences from
Proteobacteria. The scale bar represents 10% estimated sequence deviation. The number in parentheses indicates the number of clones
belonging to the OTU. Type strains are marked by (T).
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rRNA gene analysis than with conventional bacteriological
culture. Still, there was a fair agreement between results
obtained by culture and molecular analysis (Table 3). It is
noteworthy that 10 sets of specimens concurred in being
negative in both diagnostic setups.
Figures 1–3 highlight the many exotic bacteria detected
in this study. The various Proteobacteria have an acknowl-
edged environmental distribution and occur regularly in
clinical specimens, although their clinical significance is
often doubtful (Murray et al., 2007). The flavobacterium
Corynebacterium tuberculostearicum, AJ438051
OTU 19 (1)
Corynebacterium tuberculostearicum (T), X84247
Corynebacterium tuberculostearicum (T), AJ438050
OTU 19 (16)
Corynebacterium tuberculostearicum, AJ438049
Corynebacterium accolens ATCC 49725 (T), ACGD01000048
OTU 19 (4)
Corynebacterium durum (T), Z97069
OTU 24 (2)
Corynebacterium pseudodiphtheriticum (T), AJ439343
OTU 23 (1)
Corynebacterium aurimucosum (T), AY536426
OTU 20 (2)
Corynebacterium lipophiloflavum DSM 44291 (T), ACHJ01000075
OTU 22 (1)
Corynebacterium sp. 25850 16S ribosomal RNA gene, AY581881
OTU 25 (7)
Corynebacterium jeikeium (T), U87823
Corynebacterium amycolatum (T), X84244
OTU 21 (35)
Corynebacterium sp. 'Smarlab BioMol-2301292’ , AY230773
Dietzia cinnamea (T), FJ468339
OTU 26 (1)
Dietzia sp. SK79, EU417672
Dietzia maris AM990540, 
Rothia mucilaginosa 16S ribosomal RNA gene, DQ409140 
OTU 32 (1)
Rothia mucilaginosa (T), X87758
Rothia sp. oral taxon 188 16S ribosomal RNA gene, GU470892
OTU 33 (1)
Rothia aeria (T), AB071952
Gram-positive bacterium Wuba45, AF336354
Kocuria palustris (T), Y16263
OTU 34 (1)
Micrococcus luteus 16S rRNA gene, isolate CV31., AJ717367
OTU 31 (8)
Micrococcus luteus NCTC 2665 (T) CP001628,  
Micrococcus sp. kera1, HM204502
Propionibacterium avidum (T), AJ003055
OTU 29 (3) 
Uncultured Propionibacterium sp. clone PmeaMucG8, EU249977 
Propionibacterium acnes (T), AB042288
OTU 27 (93)
Propionibacterium granulosum (T), AJ003057
OTU 28 (1)
Propioniferax innocua (T), AF227165
OTU 30 (1)
Outgroup Proteobacteria (13)
0.10
Fig. 3. Maximum likelihood tree of Actinobacteria. Sixteen OTUs, corresponding to 179 clones (consensus sequences), were assigned to
Actinobacteria. For simplicity, only representative sequences from each OTU were used in tree calculation. The outgroup consists of 13 sequences
from Proteobacteria. The scale bar represents 10% estimated sequence deviation. The number in parentheses indicates the number of clones
belonging to the OTU. Type strains are marked by (T).
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W. falsenii was first described in 2006 and multiple clini-
cal isolates, including blood isolates, were included in the
first publication (Kampfer et al., 2006). The actinobacteri-
al genus Dietzia is very similar to Rhodococcus and may
be an emerging pathogen with a role in PJI (Pidoux
et al., 2001; Koerner et al., 2009). Propioniferax (formerly
Propionibacterium) innocua is a member of the skin flora
in humans and has not yet, to our knowledge, been
assigned a pathogenic role (Yokota et al., 1994). It should
not be precluded that exotic bacteria may have been a
regular presence in clinical samples and have now become
detectable with new techniques. Studies of intravenous
catheters and wounds point in that direction (Larsen
et al., 2008; Thomsen et al., 2010). A better understand-
ing of the pathogenic potentials of these less described
bacteria in a polymicrobial biofilm is essential for man-
agement of such infections, and currently different theo-
ries exist in the literature. Burmølle et al. (2010)
suggested that the presence of a bacterium does not nec-
essarily imply that it contributes to the pathogenesis of
the infection, and requires treatment. However, different
microorganisms may act synergistically in a polymicrobial
infection (Brogden et al., 2005) and some authors advo-
cate that bacterial diversity in itself promotes the persis-
tence of chronic infections (Ehrlich et al., 2005) and
increased pathogenicity, e.g. in wounds (Bowler, 2003).
The total number of different bacterial species present,
rather than some particular species, was found to corre-
late positively with impaired wound healing (Edwards &
Harding, 2004). Further studies are warranted to deter-
mine the function, interaction and clinical implications of
the exotic bacteria as well as the polymicrobial flora
detected by 16S rRNA gene analysis. However, circum-
stances strongly suggest that they are part of a complex
biofilm community that is not sampled and/or cultured
properly with conventional methods. Most likely the spe-
cific growth requirements of these bacteria are not met by
standard culture conditions and overgrowth by other
pathogens may be an additional problem. It was not pos-
sible to assess the significance of each identified species in
the current study. To fulfil that aim, systematic applica-
tion of broad range molecular techniques is required in
patients suspected of PJI.
PNA-FISH was applied to selected specimens to obtain
visual support for the organization of bacteria into bio-
films, but the current results should be regarded as preli-
minary. It was clear, however, that some bacteria were
present in microcolonies or pieces of biofilms.
This study was conceived as an exploratory study and
the molecular work-up of specimens was more extensive
than would be practical for routine diagnosis. The use of
clone libraries would probably be too cumbersome for
clinical use but it was pivotal for the demonstration of
bacterial diversity in this study. Even without a firm basis
for clinical interpretation, our study provides useful guid-
ance for handling of specimens from orthopedic implants.
The use of the MolYsis DNA extraction kit made it safe to
conclude that the preparations of DNA originated from
intact and viable bacteria (Horz et al., 2008; Handschur
et al., 2009). The first preparatory step comprised lysis of
human cells while leaving bacterial cells unaffected, and
the following DNase treatment degraded human DNA as
well as DNA from dead microorganisms. This approach
mitigates the impact of high amounts of human DNA and
PCR inhibitors, which have previously been found to
impede studies of, for example, synovial fluid (van der
Heijden et al., 1999). Moreover, the origin of DNA from
viable bacteria should make the results of 16S rRNA gene
analysis directly comparable with culture reports.
The intraoperative sampling from the metal surface of
the prosthesis or spacer with a flocked swab was an
option when the prosthesis was retained, but the proce-
dure was also applicable in the molecular laboratory as an
alternative to sonication. An experimental study with bio-
film formed by Gram-positive bacteria on metal discs has
previously shown that sampling by scraping is less effec-
tive compared with sonication (Bjerkan et al., 2009). The
flocked swab merits consideration especially for intraop-
erative use, because it is easy to handle and bacteria are
eluted quantitatively to the medium (Van Horn et al.,
2008). However, sonication should be considered the best
option for in vitro use (Bjerkan et al., 2009).
In this study, P. acnes was detected in six patients by
16S rRNA gene analysis but was not isolated by culture
Table 2. Quantification of Propionibacterium acnes by Taqman qPCR
in specimens found positive by the 16S rRNA gene clone library
approach
Sample
Average ± STD
(copies lL1 DNA extract)
Patient 3
Periprosthetic biopsy –
Patient 4
Bone 23 ± 3
Periprosthetic biopsy 34 ± 8
Flocked swab (prosthesis) 28 ± 6
Patient 5
Flocked swab (prosthesis) 65 ± 22
Patient 9
Periprosthetic biopsy 16 ± 4
Patient 10
Sonication fluid (prosthesis) 111 ± 39
Patient 11
Sonication fluid (prosthesis) –
Bone –
– indicates that P. acnes was not detected in the sample or the num-
ber was below the detection limit of the assay.
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from any of the specimen sets, which may be due to a
relatively short incubation period for anaerobic media (4
and 6 days, respectively) (Lutz et al., 2005). As the qPCR
method can facilitate detection of pathogens within
hours, the P. acnes-specific qPCR assay was chosen to test
the feasibility of this method for PJI diagnosis. The dis-
crepant results obtained for P. acnes with clone libraries
and Taqman qPCR assay are most likely due to a lower
sensitivity of the qPCR assay, but unfortunately contami-
nation during broad range 16S rRNA gene PCR cannot
be precluded.
Currently, there are few studies with broad range 16S
rRNA gene analysis that allow a direct comparison with
our results. Vandercam et al. (2008) analyzed biopsies,
swabs or aspirates from 34 patients suspected of PJI and
found one patient with a polymicrobial flora comprising
two species. Fenollar et al. (2006) analyzed bone or joint
specimens from 525 patients, 155 of whom had either a
hip or knee prosthesis. A total of 121 specimens were
positive by either PCR or culture. Although results were
not analyzed separately for prosthetic implants, it is inter-
esting that a subset of specimens had a polymicrobial
flora (with two to eight bacteria). The bacterial spectrum
was wide and included approximately 20 exotic bacteria,
most of which were anaerobes.
There are a number of important limitations to our
study. A number of potential sources for contamination
with microbial DNA exist despite the precautions taken
when handling and processing the clinical specimens. The
number of patients was small and no fixed criteria were
Table 3. Overview of results obtained by culture-based methods and 16S rRNA gene analysis
Patient no. Culture 16S rRNA gene analysis
Concordance of positive results
1A Staphylococcus epidermidis Staphylococcus epidermidis
1C Staphylococcus epidermidis Staphylococcus epidermidis
2B Staphylococcus epidermidis Staphylococcus epidermidis
6 Hemolytic streptococcus group B,
coagulase-negative staphylococcus,
coryneform rods
Streptococcus agalactiae, Staphylococcus epidermidis, Corynebacterium amycolatum,
Corynebacterium aurimucosum, Corynebacterium sp.
7 Hemolytic streptococcus group G Streptococcus dysgalactiae ssp. equisimilis
Partial concordance of positive results
1B Coryneform rods Uncultured Curvibacter sp., Corynebacterium tuberculostearicum, Propioniferax innocua,
Staphylococcus aureus, Kocuria sp., Escherichia coli
2A Staphylococcus epidermidis Staphylococcus epidermidis, uncultured Burkholderia sp., Pseudomonas sp., uncultured
Lactobacillus
5 Staphylococcus epidermidis Staphylococcus epidermidis, Micrococcus luteus, Streptococcus dysgalactiae ssp.
equisimilis, Corynebacterium pseudodiphthericum, Corynebacterium accolens,
Corynebacterium durum, Rothia mucilaginosa, uncultured Burkholderia sp., uncultured
Cyanobacterium, Prevotella sp., Fusobacterium nucleatum, Propionibacterium acnes
8 Staphylococcus aureus Staphylococcus aureus, Streptococcus mitis, Rothia sp., Pseudomonas sp., uncultured
Bergeyella sp.
Concordance of negative results
12–21 Negative Negative
Discordance of results: PCR positive and culture negative results
3 Negative Staphylococcus caprae, Micrococcus luteus, Dietzia cinnamea, Corynebacterium
lipophiloflavum, uncultured Curvibacter sp., Streptococcus salivarius, Propionibacterium
acnes
4 Negative Streptococcus dysgalactiae ssp. equisimilis, Streptococcus sanguinis, Sphingomonas sp.,
uncultured Burkholderia sp., Neisseria sp., Alcaligenes faecalis/Achromobacter
xylosoxidans ssp. xylosoxidans, Propionibacterium acnes, Propionibacterium granulosum
9 Negative Staphylococcus hominis, Corynebacterium accolens, Corynebacterium durum,
Corynebacterium tuberculostearicum, Sphingomonas sp., Stenotrophomonas maltophilia,
uncultured Methylobacillus sp., Propionibacterium acnes, Propionibacterium avidum
10 Negative Propionibacterium acnes
11 Negative Uncultured Rhodoferax sp., Wautersiella falsenii, uncultured Betaproteobacteria,
uncultured Bacteroidetes, Propionibacterium acnes
Discordance of results: PCR negative and culture positive results
22 Coagulase-negative staphylococcus Negative
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set for inclusion except the suspicion of PJI. Culture
methods may not have been optimal with regard to dura-
tion of incubation of anaerobic media. Likewise, the phe-
notypic speciation of bacteria was not as precise as that
obtainable by 16S rRNA gene analysis. The flocked swabs
used intraoperatively were not submitted for culture
because they were not part of the diagnostic routine.
While each culture report for surgical biopsies was based
on five specimens (Kamme & Lindberg, 1981; Mikkelsen
et al., 2006), most 16S rRNA gene analyses were carried
out on one specimen per anatomic site. Even with the
best precautions contamination can occur, and the find-
ing of bacterial species that have not previously been
associated with PJI should be interpreted with caution.
The inference concerning biofilm formation in the PJIs
studied was indirect, and the visualization of bacteria by
PNA-FISH and confocal microscopy was carried out with
selected specimens only. These limitations not withstand-
ing, our study strongly suggests that 16S rRNA gene anal-
ysis can detect a more diverse bacterial flora than
conventional culture methods. However, 16S rRNA gene
analysis combined with cloning as carried out this study
is labor-intensive and time-consuming and therefore not
applicable for routine diagnosis.
Considering these results, the location and composition
of biofilms in PJIs should be addressed more directly in
future studies. This can be done by new intraoperative
sampling strategies and the use of newer and faster
molecular techniques such as direct 16S rRNA gene
sequencing combined with the use of the software RIPSEQ
(Kommedal et al., 2009) or the IBIS T5000 Biosensor
System (Costerton et al., 2011).
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Overview of coverage ratio of each clone library  
The coverage ratio of each clone library (25 in total) is given in the table. The numbers are given with the number 
of analysed clones followed by coverage ratio in brackets. The 16S rRNA gene PCR negative samples are 
indicated as “-“, while the samples unavailable for analysis are indicated by “N/A”. Generally 24-48 clones were 
selected from each clone library. However, several clone libraries have less than 24 clones,. This was either due to 
a low sequence quality of the clones or fewer than 24 colonies formed in the clone library. For patient no. 1B, only 
1 good sequence was obtained from synovial fluid, and the coverage ratio of the bone sample was only 76% based 
on 21 sequences. Attempts to make new clone libraries from these two samples failed due to difficulty in 
obtaining new 16S rRNA gene PCR products (samples from patient no. 1B were not extracted with MolYsis 
Basic). All the remaining clone libraries had coverage ratio above 85%, indicating that the majority of the 
microorganisms in the samples were detected.   
Patient 
no. 
Bone Periprosthelic 
biopsy 
Synovial fluid Flocked swab 
(prosthesis) 
Sonication fluid: 
Prosthesis or  
spacer  
Flocked swab 
(spacer) 
1A N/A N/A 25 (100%) N/A N/A N/A 
1B 21 (76%) - 1 (100%) - N/A N/A 
1C - - - 27 (100%) N/A N/A 
2A N/A N/A 40 (98%) N/A N/A N/A 
2B - - - 34 (100%) 17 (100%) N/A 
3 - 22 (91%) - - N/A - 
4 29 (90%) 9 (89%) 13 (100%) 19 (89%) N/A N/A 
5 - - - 39 (85%) N/A - 
6 - 27 (96%) - N/A 42 (100%) N/A 
7 - - - - N/A 45(100%) 
8 20 (85%) 26 (100%) 30 (100%) 33 (100%) N/A 40 (100%) 
9 - 42 (93%) - N/A N/A - 
10 - - - N/A 22 (100%) N/A 
11 31 (100%) - - N/A 13 (92%) N/A 
 

